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“The patient is the centre of the medical universe around which all our work 
revolves and towards which all our efforts tend” (William Murphy 1892-1987).
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General introduction
Healthcare is fragmented and does not pay enough attention to patients’ needs 
and values. As is true of other diseases that require complex multidisciplinary 
care, reproductive care is generally offered by various types of independently 
organized professionals (e.g. general practitioners, gynaecologists, and urologists). 
Furthermore, the care provided is usually based on evidence or professional 
consensus irrespective of patients’ needs and values. Well-developed clinical 
practice guidelines (CPGs) could be valuable tools to close the gap between this 
fragmented continuum of evidence-based reproductive healthcare and infertile 
couples’ need to be in charge of their own care pathway.
However, individual professionals are traditionally the ones who define 
and describe optimal patient care in CPGs, as well as develop performance 
measurements for monitoring the quality of care [1, 2]. A reliable contribution of 
other stakeholders – especially infertile patients – is mostly lacking. Furthermore, 
guideline development methodologies mainly focus on the disease instead of 
on patients’ clinical pathways [3]. Hence, William Murphy’s statement (see the 
cover to this thesis) does not apply to guideline development in fertility care at all: 
infertile patients are not in the centre! Therefore, this thesis focuses on shifting 
the role of Dutch infertile patients in guideline development from the periphery 
towards the centre and introduces “shared guideline development” in fertility care. 
This introductory chapter will start with a description of the actual prevalence 
of infertility and infertile patients’ clinical pathways according to the treatment 
options that are currently available in the Netherlands. Next, the importance 
of patient-centredness in fertility care will be addressed. Third, the process of 
guideline and quality indicator development will be described and the potential 
role of patients in these development processes will be addressed. Fourth, an 
overview of guidelines and performance measurements that are currently available 
for Dutch fertility care will be provided and the role that patients have played in 
the development process will be addressed. Lastly, this introduction will end with 
the research questions that led to the studies performed within this thesis, as well 
as with a brief outline of the thesis.
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Fertility care
Fertility care concerns the infertile couple failing to conceive after at least one year of 
regular unprotected sexual intercourse [4]. The prevalence of infertility is estimated 
to range from 4–30% and affects approximately 80 million couples worldwide [5, 
6]. In the Netherlands, the number of new cases of infertility in general practice 
is estimated at 9 per 1000 couples per year, affecting 1 out of 7 couples [5]. Dutch 
fertility care has been publically arranged on three levels. Primary care is provided 
by general practitioners and may comprise a part of an initial fertility assessment. 
Subsequently, a general practitioner (GP) can refer couples to a gynaecologist in a 
general (secondary care) or a university (tertiary care) hospital. The gynaecologist 
can complete this initial fertility assessment, determine a cause of infertility and 
define a suitable treatment plan. The initial fertility assessment generally comprises 
four parts: assessing ovulation, screening for Chlamydia Trachomatis, performing 
a semen analysis, and assessing tubal patency. Main causes of infertility in couples 
are: low sperm count or quality (30%), ovulatory disorders (27%), tubal damage 
(14%), and in smaller proportions endometriosis and decreased cervical mucus 
hostility [7-10]. The presence of disorders in both the female and male partner 
has been reported to occur in about 39% of cases [11]. However, in 8–28% of the 
couples, a cause of infertility cannot be identified [12]. If a severe male factor is 
diagnosed, couples can be referred to a urologist. 
Depending on the female’s age and the determined cause of infertility, couples can 
be treated with surgery, such as tubal reconstruction or various types of Medically 
Assisted Reproduction (MAR)-Techniques: Ovulation Induction (OI), Intra 
Uterine Insemination (IUI), In Vitro Fertilisation (IVF), and Intra Cytoplasmic 
Sperm Injection (ICSI), occasionally with surgically retrieved sperm [4].
Within assessments and preparations for MAR-Techniques, such as IVF, clinical 
chemists and embryologists are also involved. Since infertility has a high emotional 
and psychological impact, which also interferes with work, psychologists and 
occupational physicians are regularly involved in the care pathway. Dutch fertility 
care is organized around 13 licensed hospitals for IVF and ICSI, including: eight 
university hospitals, four general hospitals and one private clinic. OI and IUI are 
performed in all types of Dutch hospitals. OI, IUI cycles as well as the first three 
IVF or ICSI treatment cycles are reimbursed as part of the basic healthcare package, 
according to the Health Insurance Act. In the Netherlands, approximately 1 out of 
38 children is born after IVF or ICSI treatment (www.nvog.nl).
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Patient-centredness 
Besides safe, effective, timely, efficient, and equal access to health care, patient-
centredness represents one of the six key-dimensions of high-quality care [13]. 
Among the variously used definitions for patient-centredness, the Institute of 
Medicine (IOM) offers a well-accepted one: ‘providing care that is respectful of 
and responsive to individual patient preferences, needs and values and ensuring 
that patients’ values guide all clinical decisions’ [13]. Patient-centredness is a 
multidimensional and contested concept. According to the framework for 
patient-centred care created by the Picker Institute, patient-centred fertility 
care can be divided into 10 organisational and non-organisational dimensions 
of patient-centredness [14, 15]. Organisational dimensions of patient-centred 
fertility care include: coordination and integration of care; physical comfort; 
transition and continuity of care; access to care; and staff competence and 
technical skills. Non-organisational dimensions of patient-centredness include: 
respect for patients’ values, preferences, and needs; information, communication, 
and education; emotional support; partner involvement; and fertility clinic staff 
attitudes [14]. A number of published articles have stressed the importance 
of patient-centredness in fertility care. This emphasis is not surprising since 
infertile patients could especially benefit from patient-centred care for several 
reasons. Firstly, suffering from infertility is stigmatized and fertility treatments 
have considerable psychological impact, both of which affect quality of life. 
Moreover, the threat of staying childless, which unfortunately overcomes 30% of 
infertile couples, may mimic reactions seen in serious illness or loss of a relative 
[16-18]. Secondly, recent reports have confirmed that improvements in several 
dimensions of patient-centredness could play a major role preventing couples 
from deciding to drop out from infertility treatments [14, 15, 19-24]. Finally, 
patient-centred fertility care leads to increased patient satisfaction [25]. Thus, 
highly patient-centred fertility care enhances major benefits for both infertile 
patients and their caring professionals. 
Patient-centred fertility care is increasingly encouraged by the use of innovative 
tools involving the Internet, which can: promote communication between doctors 
and infertile couples; enhance information provision, education, and emotional 
support; and empower infertile couples in their care process [26]. The use of 
Internet tools to promote patient-centredness seems especially effective for the 
clinical area of fertility care, as many patients represent a relatively young patient 
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group that heavily uses the Internet, which can provide a considerable degree of 
anonymity in their individual search for information and support [26]. 
Clinical practise guidelines
A highly valuable tool for improving the quality of fertility care could be created by 
clinical practice guidelines (CPGs). CPGs are defined as “statements that include 
recommendations intended to optimize patient care, that are informed by a systematic 
review of evidence and an assessment of the benefits and harms of alternative care 
options” [27]. The development process of CPGs enhances a stepwise process, 
which starts firstly with clarifying the target audience and selecting or prioritizing 
the topic of the guideline [28]. Secondly, a deliberate scoping procedure should be 
performed and preferably guided by a bottleneck analysis, which aims to define the 
objectives and boundary conditions of the guideline as well as to identify potential 
implementation barriers [28, 29]. Preferably a multidisciplinary CPG development 
group should be constituted and include all relevant stakeholders [28, 30]. Thirdly, 
according to the scope of the guideline, key questions are formulated, prioritized, 
and answered by systematically reviewing and assessing the relevant literature [30]. 
Fourthly, recommendations are formulated, which should include considerations 
of applicability in practice, patients’ preferences, and cost-effectiveness [30]. 
Fifthly, an implementation strategy should be conceptualized and written down in 
the guideline. This strategy could include the development of derivative products, 
such as a patient version of the CPG, and address barriers for implementation in a 
separate section of the guideline. The sixth step includes an internal and external 
review procedure followed by the authorization of the final guideline. Lastly, the 
guideline should be disseminated and efforts to implement the guideline should 
be made, preferably followed by an evaluation that includes monitoring the quality 
of care by applying guideline-based quality indicators [31].
Application of the guideline and the development of quality indicators
To gain insight into the actual application of the guidelines and as one of the 
efforts to implement the guideline, the development of guideline-based quality 
indicators could be seen as a related product of the guideline development 
process. A quality indicator can be defined as: “a measurable element of practice 
performance for which there is evidence or consensus that can be used to assess 
the quality of care provided, and hence change the quality of care provided” [32]. 
In general, three types of quality indicators can be distinguished, which refer 
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to the process, outcome, and structure of care [33]. Quality indicators should 
preferably be developed through a systematic approach that ensures transparency 
[34]. Guideline-based quality indicators are generally based on selected 
recommendations extracted from guidelines and are comprised of a numerator 
(the case in which a recommendation is followed) and a denominator (all cases 
in which the recommendation is applicable). This step is mostly followed by a 
panel method to select final quality indicators and a practice test to evaluate its 
validity, reliability, and feasibility [1]. These last two steps are very important since 
judgements of quality of care based on measurements of quality indicators could 
have far-reaching consequences, such as when pay-to-performance models are in 
use.
Approaches to guideline development
In the presence of worldwide development of institutional manuals for developing 
CPGs, the processes described in these manuals are inconsistent and the assessed 
quality of the delivered guidelines is diverse [36]. 
Generally, two types of guidelines are currently developed: the monodisciplinary 
and the multidisciplinary CPG. The monodisciplinary CPG is developed and 
owned by an individual professional society. In addition to creating a sense of 
institutional ownership over the developed guideline, this approach has more 
disadvantages than advantages. Firstly, monodisciplinary guidelines are assessed of 
lower quality than multidisciplinary guidelines [38]. Furthermore, inconsistencies 
in recommendations for the same clinical topic in different societies’ guidelines 
may threaten the quality of care. The more recently introduced and recommended 
multidisciplinary CPG is developed by a collaboration of different stakeholders. This 
approach intends to improve the quality of CPGs and enhance its implementation, 
enabling broader support and adjustment between professionals. 
Although the development of CPGs has progressed enormously worldwide, 
unwarranted practice variation in daily care remains a problem. There are multiple 
reasons for these practice variations, including those on the personal, organisational, 
and systemic levels. However, by firstly concentrating on the approach used in the 
guideline development process and its consequences, several deficiencies can be 
identified. Among these, the lack of guideline ownership felt among the target 
users and the strong focus on clinical aspects rather than on the organisational 
and other aspects of patient-centredness of care impede full implementation [36-
Breejen, Elvira de.indd   14 15-02-17   14:56
1Introduction
15
38]. For resolving these deficiencies in the guideline development process, a new 
approach to multidisciplinary guideline development is necessary. Furthermore, 
the position of patients herein is unexplored as well.
Patients and guideline development
Patient involvement in guideline development is assumed to result in higher quality 
guidelines in terms of applicability, acceptability, usefulness, and enhancement of 
implementation [27, 38-45]. Patient involvement forms one of the key criteria of 
the Appraisal of Guidelines Research and Evaluation (AGREE) instrument used to 
assess the methodological quality of guidelines. Additionally, patient involvement 
is also widely advocated by institutional organisations as the National Institute 
for Health and Care Excellence (NICE), the National Health Service (NHS), 
the World Health Organization (WHO), and the Institute Of Medicine (IOM) 
[38]. Thus, guideline developers are increasingly urged to involve patients in the 
different steps of the guideline development process. Unsurprisingly, to increase 
the quality of care, which forms the major goal of guidelines, patients should play 
a considerable role. Professionals are the experts in the disease and treatment, 
but patients are the experts in having the disease and undergoing treatment. 
Nevertheless, patient involvement in guideline development is still challenging 
and only 25–50% of CPG developers regularly involve patients [43].
Therefore, patient involvement is not the common practice in current guideline 
development, which can be attributed to a number of practical difficulties. Firstly, 
various methods for patient involvement in CPG development could be used and 
practical guidance on how and when to apply these methods is lacking [40, 45-51]. 
Secondly, all methods are restricted to include a selected number of patients or 
patients’ representatives and do not involve a large population of patients. Thirdly, 
transparently integrating patients’ preferences into CPG recommendations 
is difficult and often unclear [2]. Fourthly, organisational (e.g. recruitment of 
participants), financial (e.g. costs of patients’ education or for conducting focus 
groups), and socio-political barriers (e.g. CPG developers’ resistance to including 
patients in the CPG group) exist [49]. Lastly, thus far, studies on the added value 
of patient involvement in the early stages of guideline development, as well as the 
effectiveness and impact of patient involvement, are limited [51]. This situation 
urges the development of new approaches to explore the possibilities of involving 
patients in the various steps of guideline development.
Breejen, Elvira de.indd   15 15-02-17   14:56
Chapter 1
16
Patients and guideline-based quality indicator development
High-quality fertility care comprises more than just the effectiveness of care. 
Regardless of medical-technical quality, patient-centredness also determines the 
quality of fertility care [13]. The patient-centredness of care comprises various 
aspects, such as the coordination and integration of care and the provision of 
emotional support [52,53]. Furthermore, professionals in the field have been 
shown to be unable to adequately evaluate their performance regarding patient-
centredness [54]. This inability hampers direct quality improvement regarding 
patient-centredness and illustrates the need for measurable elements of practice 
performance regarding this quality-of-care dimension. Since clinical practice 
guidelines recommend optimal patient care and are based on the best available 
evidence and consensus, guideline-based indicators are highly suitable for direct 
monitoring and improvement of the quality of care [13, 55, 56].
Thus far, several studies have reported on the development of guideline-based 
indicators within the field of fertility care [57-59]. However, in these studies, 
a particular focus on the patient-centredness of fertility care has been lacking. 
Furthermore, the involvement of patients in the guideline and indicator-
development process is still not common practice [2]. Only within the field of 
cancer care has the development of guideline-based indicators for patient-
centredness been reported [60,61]. Although patients played a minor role in these 
indicator-development panels, the results suggest that including patients leads 
to the identification of aspects of patient-centredness that may not have been 
considered previously. However, in these studies, the exact difference in choice 
of indicators between professionals and patients regarding patient-centredness 
remains unexplored. 
Current guidelines and related indicators in fertility care
In the past, both professional societies in the fields of reproductive medicine and 
governmental agencies have put major efforts into the development of CPGs 
for infertility. These institutions include the American Society for Reproductive 
Medicine (ASRM), the European Society of Human Reproduction and 
Embryology (ESHRE), the National Institute of Clinical Excellence (NICE), and 
the Nordic Federation of societies of Obstetrics and Gynaecology (NFOG). By 
the time the studies in this thesis were conducted, the Dutch society of Obstetrics 
(NVOG) in the Netherlands had an extensive guideline program, including 17 
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mostly monodisciplinary disease-centred CPGs that mainly refer to treatments 
for infertility, the National Embryo Act, and various protocols on the performance 
of various fertility treatments. Other allied Dutch societies that issued fertility 
guidelines concern the Dutch society of Clinical Embryologists (KLEM) (i.e. 
guideline on semen analysis), the Dutch College of General Practitioners 
(NHG) (i.e. standard on infertility), and the Dutch Society of Urologists (NVU) 
(i.e. guideline on male infertility). All Dutch guidelines on infertility had a 
monodisciplinary character and were mostly assessed to be of low quality by the 
AGREE instrument. This instrument is a 23 item-based validated instrument that 
assesses the methodological quality of CPGs on six domains: scope and purpose, 
stakeholder involvement, rigour of development, clarity and presentation, 
applicability, and editorial independence [39]. Remarkably, patient involvement in 
all these guidelines was lacking. Furthermore, guideline-based quality indicators 
related to any of these guidelines were absent.
Outline of this thesis
The aim of this thesis is to investigate ways to shift the role of Dutch infertile 
patients in developing guidelines from the outside to the centre through exploring 
methods for actively involving them in three different phases (e.g. scoping phase, 
development phase, implementation phase) of the Clinical Practice Guideline 
development process. Hence, we formulated the following research questions:
1)  What value do patients add to the scope of a Dutch multidisciplinary guideline 
on infertility when comparing perceived key clinical issues between professionals 
and patients? 
2)  To what extent does a patient-centred network approach to multidisciplinary 
guideline development in infertility provide a feasible format regarding the 
actual performance of a set of guidelines, its time investments, and experiences 
with the approach?
3)  To what extent does a participatory tool for Dutch infertile patients in guideline 
development provide a feasible tool to enhance shared guideline development, 
regarding its use, usability, benefits for the guideline, users’ experiences with the 
tool, and implementability in other clinical areas?
4)  What value do patients add to the development of guideline-based quality 
indicators for patient-centredness?
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In Chapter 1 of this thesis, we describe the context of this thesis in general. In 
Chapter 2, we explore patients’ value added to the scope of a Dutch multidisciplinary 
guideline on infertility by comparing perceived key clinical issues (clinical issues 
that need improvement) between professionals and patients. In Chapter 3, we 
evaluate a novel patient-centred network approach to guideline development. 
In Chapter 4, we investigate the feasibility of a wiki-based participatory tool for 
infertile patients in clinical guideline development. In Chapter 5, we evaluate 
the usability for both patients and guideline developers of a specialized online 
participatory tool for patients involved in guideline development. In Chapter 6, 
we explore patients’ value added to the development of guideline-based quality 
indicators for patient-centredness by comparing suggested indicators between 
infertile patients and professionals. Chapter 7 provides an overview of the main 
findings and their interpretation, a discussion on methodological issues, and the 
possible implications for clinical practice and future research. 
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Abstract 
Background: Patient involvement in scoping the guideline is emphasized, but 
published initiatives actively involving patients are generally limited to the writing 
and reviewing phase. 
Objective: To assess patients’ added value to the scoping phase of a multidisciplinary 
guideline on infertility. 
Design: Qualitative interview study.
Setting and participants: We conducted interviews among 12 infertile couples 
and 17 professionals.
Intervention: We listed and compared the couples’ and professionals’ key clinical 
issues (=care aspects that need improvement) to be addressed in the guideline 
according to four domains: current guidelines, professionals, patients and 
organization of care. 
Main outcome measures: Main key clinical issues suggested by more than three 
quarters of the infertile couples and/or at least two professionals were identified 
and compared.
Results: Overall, we identified 32 key clinical issues among infertile couples and 
23 among professionals. Of the defined main key clinical issues, infertile couples 
mentioned eight issues that were not mentioned by the professionals. These main 
key clinical issues mainly concerned patient-centred (e.g. poor information 
provision and poor alignment of care) aspects of care on the professional and 
organizational domain. Both groups mentioned two main key clinical issues 
collectively that were interpreted differently: the lack of emotional support and 
respect for patients’ values. 
Conclusions: Including patients from the first phase of the guideline development 
process leads to valuable additional main key clinical issues for the next step of a 
multidisciplinary guideline development process and broadens the scope of the 
guideline, particularly regarding patient-centredness and organizational issues 
from a patients’ perspective. 
Key words: infertility, guideline development, patient-centred care, quality of care. 
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Introduction 
Several prominent organizations have emphasized the importance of patient 
involvement in Clinical Practice Guideline (CPG) development [1-8]. This has 
been resulted in special programmes and toolkits that aim to embed patient 
involvement in the guideline development process, such as the NICE’s Patient 
and Public Involvement Programme, the SIGN’s patient network, the Dutch 
participation guide and the G-I-N PUBLIC Toolkit [9-12]. The CPG development 
process generally comprises several phases, i.e. defining the scope (topic selection) 
of the guideline, formulating key questions, systematically reviewing relevant 
literature and appraising its quality, formulating recommendations, writing the 
draft version, reviewing and finalizing the guideline [2, 13, 14]. 
Organizations emphasize the involvement of patients in an early phase of CPG 
development, but published initiatives on this topic generally focus on the writing 
and reviewing phase of the CPG development process or on written consultation 
of patient organizations when the scope has been drafted yet [6, 9-12, 15, 16]. By 
defining a well-constructed scope of the CPG together with a group of patients 
and different stakeholders, the CPG will focus on care points susceptible for 
improvement. This could facilitate its implementation and increase its potential 
benefit. Such a multidisciplinary and patient-centred approach seems especially 
beneficial to diseases requiring complex healthcare [3, 17-20]. For example, 
within fertility care, couples having problems to conceive can meet different 
disciplines, such as general practitioners (GPs), gynaecologists, urologists, clinical 
embryologists or clinical psychologists [21, 22]. Patients who are involved in 
such complex care paths are ‘the experts of their own healthcare’; they relate it to 
their personal circumstances (e.g. work, comorbidity) and their needs and values, 
while surveying their whole care process beyond all their care providers from a 
different point of view and with different expectations of care [23]. Consequently, 
they might identify different care aspects compared with professionals that need 
improvement and need to be addressed in guidelines (i.e. key clinical issues) [24-
30]. Therefore, this study aims to assess patients’ added value to the scoping phase 
of a multidisciplinary guideline on infertility. For this purpose, we compared the 
identified key clinical issues to be addressed in this guideline between infertile 
patients and professionals in fertility care.
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Materials and Methods
Setting
Infertility is defined as the failure to conceive after at least one year of regular 
unprotected intercourse [31,32]. Overall, Dutch fertility care has been publically 
arranged on three levels. Primary care is provided by the GP and comprises a 
part of an initial fertility assessment. Subsequently, the GP can refer couples to a 
gynaecologist in a general (secondary care) or a university (tertiary care) hospital. 
He/she can complete this initial fertility assessment, determine a cause of infertility 
and define a suitable treatment plan. If a severe male factor is diagnosed, couples 
can be referred to an urologist. 
Study design 
For assessing patients’ added value to the scope of a multidisciplinary guideline on 
infertility, we conducted explorative semi-structured interviews among infertile 
couples as well as focus group interviews with professionals involved in fertility 
care, using a similar interview guide, developed by three authors (E.M.E.D.B., 
W.L.D.M.N., R.P.M.G.H.). Consensus on the topics of the final interview guide 
was reached through discussion.
First, eight different phases of fertility care, based on known patients’ clinical care 
pathways, were included in a topic list: (I) initial fertility assessment by a GP and/
or (II) gynaecologist, (III) treatment with OI, or (IV) IUI, or (V) IVF or (VI) 
ICSI by a gynaecologist, (VII) TEsticular Sperm Extraction (TESE) by a urologist 
and (VIII) after care. Additionally, transitions between different phases of fertility 
care, such as referral from GP to gynaecologist were identified and added as 
topics. Furthermore, all inconsistencies within recommendations of the 11 actual 
Dutch monodisciplinary guidelines on infertility of the Dutch college of General 
Practitioners’ (GP), the Dutch Society of Obstetrics and Gynaecology’s (NVOG), 
the Dutch Society of Urologists and the Dutch Society of clinical embryologists 
and clinical chemists were identified and added as topics (www.nvog.nl; www.nhg.
org; www.nvu.nl; www.embryologen.nl). 
Interviews among patients (infertile couples)
Participating patients included infertile couples selected from all eight different 
phases of fertility care. These couples were consecutively invited to participate 
by means of an information letter, conferred while they visited a gynaecological 
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resident working in a fertility clinic in two regions of the Netherlands (Nijmegen 
and Amsterdam). Potential participants, Dutch speaking infertile couples who 
reacted positively to the information letter, were contacted by telephone. A total 
of 12 couples were contacted (E.M.E.D.B.) and all of them agreed to participate in 
an interview. To increase the actual participation-rate and to put minimal pressure 
on the participants (travel requisites, possible emotional burden of confrontation 
with other patients), we conducted individual interviews of ~60 min at a location 
preferred by the couples. The structure of the individual interviews was as follows: 
after an explanation of the aim of the interview, namely to list key clinical issues 
to be addressed in a multidisciplinary guideline for fertility care and asking for 
participants’ characteristics, we asked them for their key clinical issues perceived 
across their own fertility care pathway. Summaries were sent to all participants 
for additions and verification. The inclusion of infertile couples was discontinued 
when saturation of data was achieved (no new emerging themes).
Focus group interviews among professionals
We performed two focus group interviews with professionals. The first focus group 
consisted of a broad collaboration of mandated experts from different disciplines 
within the field of fertility care that assembled the guideline development 
group, including a gynaecologist, urologist, GP, clinical embryologist, clinical 
psychologist, clinical chemist, an occupational physician and two board members 
of ‘Freya’, the Dutch infertility patients’ association. The focus group interview 
was performed during their first guideline development meeting. To broaden the 
view on key clinical issues in fertility care, a second focus group interview was 
performed including eight main professional target users of the guideline: four 
GPs, three gynaecologists and one urologist. All these target users were proposed 
by their professional societies. An independent gynaecologist not involved in the 
development of the guideline moderated both interviews. After an explanation 
of the aim of the interview, the focus group comprised both questions about 
participants’ characteristics such as age and the level of education and questions 
about their experienced key clinical issues across patients’ care pathway (from 
patients’ visit to a GP to aftercare and the transitions between these care phases). 
Both interviews lasted ~90 min. Written interview summaries were sent to all 
participants for additions and consensus. 
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Data analysis
All interviews including additions were transcribed verbatim and anonymized. 
Data were managed using Kwalitan (version 5.0, Malden, the Netherlands) [33]. 
The data were thematically analysed in four iterative steps [34]. Two investigators 
(E.M.E.D.B. and W.H.G.) independently coded the transcripts, searched for 
themes, refined themes and defined main themes (key clinical issues) and 
subthemes according to the four domains derived from the framework of Cabana 
et al. (i.e. key clinical issues at the level of actual guidelines and at professional, 
patient and organizational level) [35]. After each step, the results were compared 
and any discrepancies were discussed until consensus was achieved. Furthermore, 
an experienced third researcher (W.L.D.M.N.) checked the codebook, the initial 
themes, the refined themes and the defined main themes and subthemes and 
critically looked at possible inconsistencies across the defined main themes and 
subthemes that were placed into the framework. Inconsistencies were jointly 
discussed, which resulted in refinement of the themes and replacement of one 
main theme in the appropriate domain of the framework. To extract the main 
key clinical issues, the frequency of occurrence of all key clinical issues was 
determined. Key clinical issues became main key clinical issues when suggested 
by at least two different professionals in both focus groups or in more than three 
quarters of the infertile couples. 
 
Results
Participants
We interviewed 12 infertile couples and 17 professionals. Couples’ characteristics 
are presented in Table 1. Infertile couples were selected from all different phases of 
care. The main characteristics of the participating professionals are summarized 
in Table 2. In focus group one, two-thirds of participating professionals were male, 
whereas in focus group two, males and females were in equal proportion.
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Table 1: Demographic characteristics of infertile couples
Characteristic Participants in-depth interviews (n = 24)
Median age a (years)
Female
Male
32 (25-46)
35 (31-43)
Level of education b (%) (low/medium/high)
Female
Male
8/33/58
0/33/67
Last treatment (n)
GP (initial fertility assessment)
Initial fertility assessment by gynaecologist
OI 
IUI 
IVF 
ICSI 
TESE 
2
4
2
4
4
6
2
Pregnancy achieved (%)
Yes
No
25
75
GP, General Practitioner; OI, Ovulation Induction; IUI, Intra Uterine Insemination; IVF, In Vitro 
Fertilization; ICSI, Intra Cytoplasmic Sperm Injection; TESE, TEsticular Sperm Extraction
a Median age in years, range between brackets.
b  Low, primary or lower vocational education; medium, secondary or intermediate vocational education; 
high, higher professional education or university.
Table 2: Demographic characteristics of professionals
Characteristic Participants focus Group 1 
(n = 9)
Participants focus Group 2 
(n = 8)
Gender 
Male 6 4
Female 3 4
Discipline
GP 1 4
Urologist 1 1
Gynaecologist 1 3
Clinical embryologist 1
Medical psychologist 1
Chemist 1
Occupational physician 1
Members infertility patient 
association
2
GP, General Practitioner
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Key clinical issues
Overall, 32 key clinical issues among infertile couples (Table 3) and 23 key 
clinical issues among professionals (Table 4) were identified. The main key 
clinical issues (suggested by at least two different professionals in both focus 
groups or in more than three quarters of the infertile couples) are presented 
separately and per domain (i.e. key clinical issues at the level of actual guidelines 
(I) and at professional (II), patients (III) and organizational (IV) level). The 
presented main key clinical issues are accompanied by verbatim quotes taken 
from the interviews (Table 3).
Infertile couples’ key clinical issues:  
Domain I: guidelines (Table 3)
-
Domain II: professionals 
Lack of respect and autonomy. All participants mentioned their healthcare 
professionals’ attitude or behaviour as a key clinical issue, for example impersonal, 
uninterested or not serious. 
... it is all really very impersonal, you feel no more than a number.
Furthermore, the lack of partner involvement (male for GP and gynaecologist, 
female for urologist) was mentioned. 
... everything was concentrated on her, it often felt like I did not matter.
Insufficient information provision. Information provided by professionals was 
mostly on a medical-technical level and lacked attention for non-medical issues. 
Treatment alternatives were not proposed and explanations were unclear, resulting 
in obscure treatment plans. 
... our GP could have explained more to us, but she did not. I heard everything 
from the gynaecologist, I think that is a pity because our GP could have done a 
part of that.
Lack of emotional support. A lack of emotional support was mentioned as a key 
clinical issue for fertility care, delivered by both the GP and the gynaecologist. 
Although the need for emotional support differs among patients, it was rarely 
discussed in the consulting room. Furthermore, patients mentioned that the 
possibility of a referral to a psychologist is not enough: they clearly prefer emotional 
support to be embedded within daily care. 
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... at the advanced stage of care you are in, you will have more need for emotional 
support. Simply being able to talk about it may be enough, but that is lacking.
 
Domain III: patients
Taboo on infertility. In general, patients experienced difficulties in mentioning 
their infertility problem. They postponed visiting their GP and it proved difficult 
to discuss it with their employer. 
 ... it is very hard to talk about it to third parties, especially if you depend on 
them. 
Domain IV: organisation 
Poor care alignment. The poor alignment of care, especially between the GP and 
the gynaecologist, was mentioned most often. Furthermore, communication was 
lacking between primary and secondary care. Regularly, GPs had no notion of the 
phase of care the couple being treated were in.
I think the referral letter is the only alignment between the gynaecologist and the 
GP... I do not think my GP knows what we are going through. ... I do not think 
they’re communicating.
Lack of attention to work. Patients experienced problems with work, because 
appointments were only possible during working hours. Hence, they had to take 
time off or pay for their absence. 
...you need to make arrangements at work, because you have to visit the hospital 
at very inconvenient moments.
Lack of support after treatment. Currently, there is hardly any support after 
treatment, particularly for patients who remain childless. 
What was the support after treatment like? There was no support.
Standard treatment according to protocols. Patients did not always like to be treated 
according to protocols. Some couples experienced those as impersonal; others 
missed the liberty of having a free choice. 
... at the second attempt, they came back on it and said that they had to follow 
a protocol, and I did not have a choice anymore.
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Poor physical environment. The lack of separate waiting rooms for pregnant and 
infertile couples was mentioned the most. Furthermore, lack of privacy and a ‘cold 
appearance’ of the hospital were mentioned. 
...That is a disadvantage of our hospital: pregnant couples and people like us are 
sitting next to each other in the waiting room, I found that very hard.
Time pressure. Most patients mentioned time limits during appointments as a key 
clinical issue. 
For the ultrasound only five minutes are available, but I think they should take 
more time for it. It is like: five minutes, next patient please.
Table 3: Key clinical issues according to infertile couples
Domain I
Characteristics of 
the guidelines
Domain II 
Characteristics of the 
professional 
Domain III
Characteristics of the 
patient
Domain IV
Characteristics of the 
organization
Lack of evidence
Differing 
protocols
Poor communication
Lack of respect and 
autonomy**
Information provision 
not meeting expectations*
Lack of emotional 
support**
Lack of medical 
knowledge 
Lack of continuity of 
doctor
Unequal policy
Problems with 
examinations
  
Uncertain patient
Age-related problems
Desire for action
Taboo on infertility*
(Un)informed 
Liberty of choice
Patients with unrealistic 
expectations
Need for contact with 
other patients
Lack of contact with GP
Unclear distribution of tasks 
Poor alignment of care*
Lack of attention to work*
Poor quality of semen 
analysis
Poor insurance coverage
Lack of arrangements 
concerning work
Lack of continuity of care
Lack of support after 
treatment*
Non-fluent care path
Standard treatment 
according to protocol*
Difficulty making 
appointments
Poor availability by phone
Poor physical environment*
Time pressure*
* Main key clinical issues, suggested by more than three quarters of the infertile couples.
** Collective main key clinical issues, suggested by both patients and professionals.
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Key clinical issues among professionals 
Domain I: guidelines
Unclear treatment criteria. The description of treatment criteria in actual guidelines 
is unclear, resulting in different policies in the various hospitals (Table 4). Some 
gynaecologists treat women until the age of 40 years, others until the age of 43 
years, resulting in ‘hospital-shopping’ of patients. 
... age does not mean anything. For example: a 36-year-old woman may have a 
high FSH and a low AFC.
Unclear treatment policy. Treatment policies are seldom clearly described in actual 
guidelines, or still under discussion (i.e. lifestyle advices), just as criteria for 
referral, especially for GPs. Moreover, interpretation of the semen analysis’ results, 
the appropriate number of semen samples needed and best interval time to repeat 
them is unclear for GPs. 
...if the test results of the semen analysis are poor, you have to consider the 
possibility of repeating the test. ...whether this is after three months, or later, I 
am not sure.
Lack of evidence. While on some topics research is still in progress, on others the 
available evidence is unclear.
There is still no consensus about the varicocele: some urologists treat it, others 
do not.
Domain II: professionals 
Lack of respect and autonomy. Professionals mentioned the lack of partner 
involvement, especially by the GP, as a key clinical issue as well. 
It is a classical problem, the male who is only seen as a jar of sperm.
Lack of emotional support. Overall, emotional support, offered by professionals, is 
lacking. Moreover, timing is unclear and attention to childless couples is limited.
The process of loss is different for every couple, they have to let go of their wishes 
and dreams... every professional ought to be aware of this, but it is unclear who 
should actually provide emotional support.
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Lack of medical knowledge. GPs and psychologists especially mentioned their 
inexperience in treating infertile couples. 
Those psychologists do not have any expertise on childlessness.
Domain III: patients
-
Domain IV: organisation  
Unclear distribution of tasks. The unclearness of the distribution of tasks between 
different professionals within fertility care is an organizational flaw. Presently, it is 
unclear ‘who should do what’.
...sometimes patients tell me about poor information provision. That makes 
me wonder: who is able to pay attention to this, and where in the whole care 
pathway is this person who is responsible for this?
Poor quality of semen analyses. Presently, each laboratory has its own routine in 
performing a semen analysis (i.e. different tests, normal limits and measuring 
instruments), which can lead to different test results. 
The laboratory, performing the semen analysis, should at least have a 
certification.
Table 4: Key clinical issues according to professionals 
Domain I
Characteristics of 
the guidelines
Domain II 
Characteristics of the 
professional 
Domain III
Characteristics of the 
patient
Domain IV
Characteristics of the 
organization
Lack of evidence*
Unclear treatment 
criteria* 
Unclear treatment 
policy* 
Poor communication
Lack of respect and 
autonomy**
Information provision 
not meeting expectations
Lack of emotional 
support**
Lack of medical 
knowledge*
Uncertain patient
Age-related problems
Desire for action 
Taboo on infertility
Lack of motivation
Partner has different GP
Unclear distribution of tasks*
Poor alignment of care
Lack of attention to work
Poor quality of semen 
analysis*
Poor insurance coverage
Lack of arrangements 
concerning work
Lack of continuity of care 
Policy depends on
Ethical consequences of age-
criterion
* Main key clinical issues, suggested by at least two different professionals in both focus groups.
** Collective main key clinical issues, suggested by both infertile couples and professionals.
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Patients’ added value 
Infertile couples mentioned eight additional main key clinical issues that were not 
mentioned by the professionals: expectations on information provision, taboo on 
infertility, poor alignment of care, lack of attention to work, lack of support after 
treatment, too much standard treatment according to protocols, poor physical 
environment and time pressure (Tables 3 and 4). Two main key clinical issues 
were mentioned by infertile couples and professionals collectively, but interpreted 
differently, namely the lack of emotional support and the lack of respect and 
autonomy.  
Discussion
This study shows patients’ added value to the scope of a multidisciplinary CPG 
on infertility including all different care phases. Infertile couples broadened the 
scope of the CPG by adding patient-centred aspects of care (i.e. expectations on 
information provision, taboo on infertility, poor alignment of care, lack of attention 
to work, lack of support after treatment, too much standard treatment according 
to protocols, poor physical environment and time pressure) or addressing patient-
centred aspects in professionals’ issues (i.e. the lack of emotional support and the 
lack of respect and autonomy).
To date, this is the first study that focuses on patients’ added value to the scope of a 
multidisciplinary guideline, by comparing patients’ and professionals’ key clinical 
issues. Only two studies have reported on their positive experiences with patient 
involvement in an early phase of CPG development regarding anxiety, insomnia 
and kidney disease [16,36]. However, as these studies mainly focused on patients’ 
subjects relevant for the CPG instead of care aspects susceptible for improvement, 
the actual value for the development of key questions was lacking.  Furthermore, 
since insight into the differences between patients’ and professionals’ contributions 
were lacking, patients’ added value to the scope of the guideline remained 
unclear. The need for emotional support, improved professional behaviour and 
using shared decision-making principles have been described earlier [37-46]. 
However, in our study the need for emotional support for professionals reveals 
more organizational implications, since it is especially unclear to the professionals 
within our sample ‘who’ is responsible for providing emotional support and ‘when’ 
this should be offered. For patients, this key clinical issue reflects on the lack of 
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enabling to discuss emotional discomfort in the consulting room during daily 
care. Guideline recommendations based on this key clinical issue should therefore 
not only focus on ‘who’ and ‘when’, but also ‘how’ emotional support should be 
embedded within daily care provided by all involved fertility care professionals. 
Obviously, this addition highlights the surplus value of patient involvement in an 
early stage of the CPG development process. 
Beside different interpretations of key clinical issues, infertile couples in our study 
also broadened the scope of the guideline by identifying eight additional main 
key clinical issues that would otherwise not have been recognized. These main 
key clinical issues illustrate that patients do value or desire different aspects to 
be addressed in guidelines than their professionals. Professionals mainly consider 
multidisciplinary guidelines as instruments to reduce practice variation in specific 
cases (i.e. due to unclear treatment criteria, policy and quality of performing 
diagnostics), to address evidence gaps and to enhance the overall organization of 
multidisciplinary care on a policy level (i.e. secure distribution of tasks between 
different professionals). Patients enlighten aspects of patient-centred care (i.e. 
emotional support, information provision) as well as concrete organizational 
aspects focusing on the gaps in between different phases of care that professionals 
have not been putted forward (e.g. poor alignment of care, the lack of care after 
treatment) [47]. As widely discussed, complex and chronic care requires a fluent 
organization and central points of improvement herein may be well recognized by 
patients surveying their whole care process [17, 48]. This is especially illustrated 
by the mentioned poor alignment of care in our study that has not been addressed 
in the literature on guideline development before. 
The main strength of our study is that both infertile couples and professionals 
participated in it separately, which enabled us to assess patients’ added value to 
the scope of the guideline, covering all phases of care. Additionally, our scoping 
approach to CPG development provides a unique opportunity to reveal main key 
clinical issues, which are directly usable in formulating key questions as the next 
step of the CPG development process.
However, some limitations to our study need to be addressed. One may argue 
whether this approach can be directly translated to an international level, since 
for example some organizational and reimbursement aspects have been arranged 
differently elsewhere. However, also in other countries, different professionals 
treat patients, with comparable problems in patient-centred and organizational 
issues [37-39]. Furthermore, we acknowledge that the consecutive recruitment of 
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infertile couples to participate in our study can introduce a potential selection 
bias: we do not know if these couples are representative of the general infertile 
population. However, regarding the time restraints in the guideline development 
process and our aim of using input of patients in the first phase, we used a practical 
approach. The authors believe that this is a first initiative to involve patients in this 
first step of the guideline development process. Furthermore, the authors believe 
that a systematic literature search on patients’ preferences for care and outcome 
measurements should complete patients’ input in this first phase of guideline 
development.
The patients’ and professionals’ key clinical issues that resulted from this study 
could inform the next step of the guideline development process, namely in 
developing the key questions as well as form a valuable addition in defining 
the associated outcome measurements. Regarding the mentioned key clinical 
issues, this could result in key questions like: ‘how to treat patients best’ (attitude 
and partner involvement), ‘how to organize information provision to infertile 
couples and what kind of information do patients value’ and ‘which place does 
emotional support have in fertility care and when and by whom should this be 
provided’.
Although the direct impact of these study results is more or less specific for fertility 
care, we believe that this approach could form an example for guideline developers 
and policy makers (inter)nationally in making multidisciplinary guidelines as well 
as other quality derived products (e.g. protocols in which the organization forms 
an important aspect) more tailored to patients. However, guideline developers may 
approximately need an extra month to recruit patients, conduct interviews, analyse 
the results and receive patients’ remarks in order to precede the underpinning 
key questions. In the light of delivering high quality patient-centred care, the 
engagement of patients in an early phase of the development of products that 
guide the clinician, could form one of the strategies to bring this to a higher level. 
Finally, although suggestive, tailoring clinical guidelines to patients’ perspective 
in this way may suggest that the guideline will be well implemented it may also 
interfere in a positive way with patient satisfaction, costs and improved outcomes 
[46]. Hence, patients’ input to the scoping phase of guideline development may be 
worth the relatively small amount of extra time. For such, further studies on the 
effects on guideline implementation, the level of patient-centred care and patient 
satisfaction could build to the strength of the recommendation to move towards 
shared guideline development, from the first till the last step.
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In conclusion, within this sample, evidence exists of the potential benefits of 
including patients in an early phase of the CPG development process: it leads 
to valuable additional main key clinical issues to be addressed in the next step 
of a multidisciplinary CPG development process and broadens the scope of the 
guideline, particularly regarding patient-centred and organizational aspects. 
Therefore, actual involvement of patients from the start of the guideline development 
process could make the final guideline more tailored as well as responsive to 
patients. Internationally, guideline developers and policy makers can use this 
approach. Further studies on the actual impact on guideline implementation as 
well as multiple aspects of the quality of care may strengthen the recommendation 
to involve patients in the scoping phase of guideline development. 
Abbreviations: GP, General Practitioner; CPG, Clinical Practice Guideline; IUI, 
Intra Uterine Insemination; IVF, In Vitro Fertilization; ICSI, Intracytoplasmic 
Sperm Injection; OI, Ovulation Induction; TESE, Testicular Sperm Extraction.
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Abstract 
Background: Guideline development and uptake are still suboptimal; they focus on 
clinical aspects of diseases rather than on improving the integration of care. We used 
a patient-centred network approach to develop five harmonized guidelines (one 
multidisciplinary and four monodisciplinary) around clinical pathways in fertility 
care. We assessed the feasibility of this approach with a detailed process evaluation 
of the guideline development, professionals’ experiences, and time invested.
Methods: The network structure comprised the centrally located patients 
and the steering committee; a multidisciplinary guideline development group 
(gynaecologists, physicians, urologists, clinical embryologists, clinical chemists, a 
medical psychologist, an occupational physician, and two patient representatives); 
and four monodisciplinary guideline development groups. The guideline 
development addressed patient-centred, organizational, and medical-technical 
key questions derived from interviews with patients and professionals. These 
questions were elaborated and distributed among the groups. We evaluated the 
project performance, participants’ perceptions of the approach, and the time 
needed, including time for analysis of secondary sources, interviews with eight 
key figures, and a written questionnaire survey among 35 participants. 
Results: Within 20 months, this approach helped us develop a multidisciplinary 
guideline for treating infertility and four related monodisciplinary guidelines for 
general infertility, unexplained infertility, male infertility, and semen analysis. The 
multidisciplinary guideline included recommendations for the main medical-
technical matters and for organizational and patient-centred issues in clinical care 
pathways. The project was carried out as planned except for minor modifications 
and three extra consensus meetings. The participants were enthusiastic about the 
approach, the respect for autonomy, the project coordinator’s role, and patient 
involvement. Suggestions for improvement included timely communication about 
guideline formats, the timeline, participants’ responsibilities, and employing a 
librarian and more support staff. The 35 participants spent 4497 hours in total on 
this project.
Conclusions: The novel patient-centred network approach is feasible 
for simultaneously and collaboratively developing a harmonized set of 
multidisciplinary and monodisciplinary guidelines around clinical care pathways 
for patients with fertility problems. Further research is needed to compare the 
efficacy of this approach with more traditional approaches.
Breejen, Elvira de.indd   44 15-02-17   14:57
3Patient-centred network approach
45
Keywords Clinical practice guideline development; Evaluation; Patient 
involvement, Clinical care pathway; Infertility
Breejen, Elvira de.indd   45 15-02-17   14:57
Chapter 3
46
Background
Complex multidisciplinary care is often fragmented and suffers from so-called 
‘clinical linkage deficiencies’ [1]. To resolve such deficiencies, many published 
reports and articles have stressed the importance of implementing integrated 
and patient-centred care by building bridges between the groups involved [2-6]. 
Clinical practice guidelines (CPGs) are potential tools for facilitating this shift in 
clinical care. Unfortunately, the quality of the guidelines varies, and their impact 
on delivering integrated and patient-centred care is still suboptimal [7-12]. 
Several problems still hinder CPG development and uptake, namely, inadequate 
management of conflicts of interest (COIs), limited panel composition, lack of 
patient involvement, and lack of external review [9]. Furthermore, there is still a 
strong focus on the single clinical aspects of diseases described in the guidelines 
rather than on ensuring more integrated care for patients, including attention to 
matters such as patient-centredness, coordination and continuity of care. Because 
of all this, the target users feel no affinity with the guidelines, which impedes full 
implementation [7,8,10].
Clinical networks are defined as collaborative, professionalized structures ranging 
from fully integrated service delivery systems to informal communities of practice. 
These networks have previously proven effective in increasing evidence-based 
practice and improving care models [13,14]. We aimed to resolve the deficiencies 
in multidisciplinary guideline (MuG) development and to re-centre the focus 
on the patient’s overall clinical journey rather than independent contributions 
from each specialty or caring function. Thus, we used the network approach 
in a clinical area of complex multidisciplinary care, namely, fertility care. We 
developed a harmonized set of one MuG and four monodisciplinary guidelines 
(MoGs) around patient clinical pathways, including any care needed for infertile 
couples (such as aftercare and care given by physicians, gynaecologists, and/or 
urologists). We aimed to assess the feasibility of this patient-centred network 
approach in a detailed evaluation of the process, professionals’ experiences, and 
the time required.
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Methods
Setting
The Dutch Organization for Health Research and Development (ZonMw) funded 
our project, which took place within the Dutch program of Knowledge Quality 
and Curative Care. The program’s objective was to improve the development of 
multidisciplinary CPGs in terms of innovation, collaboration, and efficiency.
Fertility care
Infertility is commonly defined as ‘any form of reduced fertility with prolonged 
time of unwanted non-conception’, and it affects approximately 80 million couples 
worldwide [15,16]. Dutch fertility care takes place on three levels. Physicians 
provide primary care that includes an initial fertility assessment. A physician 
can refer couples to a gynaecologist in a general hospital (secondary care) or a 
university hospital (tertiary care). The gynaecologist completes the fertility 
assessment, determines the cause of infertility, and defines a treatment plan. If a 
relevant male factor is found, the couple may be referred to an urologist. Clinical 
chemists and embryologists are also involved in assessments and preparation for 
the use of medically assisted reproductive techniques, one of which is in vitro 
fertilization (IVF). Because infertility has a high emotional and psychological 
impact that can interfere with work, psychologists and occupational physicians 
are regularly involved with the clinical course of the infertility problem.
The network
Our steering committee, which included five guideline experts, one implementation 
expert, and one project coordinator, initiated and coordinated the patient-centred 
network approach to MuG development. A group of gynaecologists, physicians, 
urologists, clinical embryologists, clinical chemists, a medical psychologist, 
an occupational physician, and two patient representatives from Freya (the 
Dutch association for people with fertility problems) assembled to collaborate 
in developing the guidelines in February 2008. Four MoG groups, including 
participants mainly from single disciplines, and one MuG group convened to 
develop the guidelines.
An overlap of participants from the same discipline across the groups and the 
project coordinator facilitated guideline harmonization. The project coordinator 
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was a member of all five groups and gave feedback to the steering committee. 
The implementation expert assured attention to the future implementation 
and anticipated any potential barriers to guideline implementation during all 
development phases. An independent researcher (MS) evaluated the project.
The network structure consisted of three organized layers comprising seven 
groups: the centrally located infertile patients and the steering committee, the 
MuG group, and four MoG groups. For our purposes, this network was to produce 
one patient-centred MuG on infertility and four related, mainly monodisciplinary 
owned guidelines. These four included a guideline on general infertility for 
physicians, a guideline on unexplained infertility for gynaecologists, a guideline 
on male infertility for urologists and gynaecologists, and a guideline on semen 
analysis for clinical embryologists.
Guideline development
 
Managing conflicts of interest (COIs)
Before starting the guideline development, all members of the groups had 
to declare any COIs and be officially mandated by their societies. The steering 
committee discussed all COIs. Participants with significant COIs were excluded 
from discussions or voting on recommendations for which they had COIs.
Defining the scope and key questions
We explored the care aspects in the clinical pathways of infertile patients. We paid 
particular attention to improvements that the patients and professionals found 
necessary. Various methods were used to collect data about the most relevant 
aspects.
We conducted 12 exploratory interviews with couples facing the spectrum of 
issues in the main phases of the clinical pathways in fertility care. These phases 
may include a physician’s initial fertility assessment, a gynaecologist’s fertility 
assessment, treatment with ovulation induction, intrauterine insemination, IVF, 
and/or intracytoplasmic sperm injection by a gynaecologist, a urologist’s care, and 
aftercare (whether pregnancy occurred or not). The couples were consecutively 
invited to participate by means of an information letter that they received when 
they saw a gynaecologic resident in a fertility clinic in Nijmegen or Amsterdam. 
We phoned potential participants—Dutch-speaking couples with fertility 
problems who reacted positively to the information letter. The selection of couples 
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was random except for their phase in the clinical pathway. The steering committee 
translated care aspects that the couples said needed improvement into patient-
centred key questions.
Two focus groups were conducted among members of the MuG group, including 
the two patient representatives, and among main target users of the guideline, 
including four gynaecologists, three physicians, and a urologist. The steering 
committee translated care aspects that the professionals said needed improvement 
into medical-technical, organizational, and patient-centred key questions. Example 
questions for these three categories, respectively, are: ‘What are the indications for 
IVF treatment?’ ‘Which professionals should be part of the treatment team in a 
university hospital?’ ‘How should patients be informed about adoption?’
All key questions were given a format defined for the MuG. Then the MoG groups 
addressed the medical-technical questions and the MuG group addressed the 
organizational and patient-centred questions.
Elaborating key questions and formulating recommendations
The participants worked in pairs. They used the PICO (patient, intervention, 
comparison, and outcome) method to define their search strategy, conduct 
a systematic literature review, select relevant evidence, and summarize this 
evidence in formatted evidence tables. They rated (scale: 1 to 5) the evidence 
according to quality criteria adapted from the Centre for Evidence-Based 
Medicine, version 1999 [17]. The pairs of members then formulated one or more 
conclusions, their considerations, and one or more concept recommendations. 
A level of evidence (A to D) was given for each recommendation to be discussed 
in the particular guideline group [17]. The project coordinator was a member 
of all guideline groups and coordinated the entire process, which was part of 
a strategy for harmonizing recommendations across the groups. The project 
coordinator checked the rating of evidence and grading of recommendations 
for errors. The steering committee discussed and resolved any discrepancies. 
The implementation expert checked and improved the implementability of the 
concept recommendations and the guidelines as a whole using the items of the 
Guideline Implementability Appraisal (GLIA) Tool. An extensive internal review 
of the CPGs across the groups was used to harmonize the recommendations. Many 
patients also participated by formulating and prioritizing recommendations for 
the MuG [18].
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We used advertisements and mailings over a period of seven months to invite 
patients with fertility problems to formulate recommendations via the Dutch 
online wiki-based tool at www.freyawiki.nl [18]. A patient representative and two 
members of the steering committee including the implementation expert modified 
and assessed the implementability of the patient recommendations with the GLIA 
Tool. Then we asked patients to select their top three or five recommendations 
for each wiki section (General care, General practice care, Gynaecologic care, 
Urologic care, and Laboratory) [18]. The guideline group assessed the eligibility of 
the final set of patients’ recommendations within the scope of the guideline.
Integrating the guidelines
The MoGs addressed medical-technical aspects of care that needed improvement: 
physician care, care for patients suffering from unexplained infertility or male 
infertility, and fertility care given by clinical embryologists (semen analysis). 
The definitive MuG described the overall clinical pathway of patients with 
fertility problems by merging the main medical-technical, patient-centred, 
and organizational recommendations from the MuG and MoG groups and the 
prioritized patient recommendations from WikiFreya [18]. The medical-technical 
recommendations included transitions in fertility care and care alignment. 
The patient-centred recommendations dealt with respect for patients’ values, 
preferences, and needs; information, communication, and education; emotional 
support; partner involvement; and the attitude of the fertility clinic staff. The 
organizational recommendations addressed coordination and integration of 
care, physical comfort, transition and continuity of care, access to care, and staff 
competence and technical skills. All patient recommendations obtained via 
WikiFreya were classed as Level P (Patient) evidence. To express patients’ input in 
the guideline, two patient representatives reformulated patient recommendations 
as: ‘Patients want to…’ The whole project was planned to be completed in 18 
months.
Evaluation
We applied a stepwise process evaluation to the feasibility of this network 
approach [19]. The primary outcomes were ‘how’ the planned project was actually 
carried out and ‘how’ participants perceived the process; the secondary outcome 
was ‘what’ time was invested. We used a mixed-method evaluation including 
examination of secondary resources (such as project descriptions), interviews 
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with key figures, and a written questionnaire survey among all participants. An 
independent researcher (MS) conducted the interviews and collected the data.
Data collection
Examination of secondary resources
We collected all the project data from the project descriptions and minutes of 
meetings to determine whether the project was carried out as planned.
Interviews with key figures
We conducted eight semistructured, in-depth, telephone interviews with eight key 
figures: the chairpersons of the four MoG groups, four members of the MuG group, 
and the steering committee (one patient representative, two project leaders, and 
the project coordinator). We asked the interviewees to chronologically describe the 
guideline development and their activities in the project. We asked for comments 
on the overall organization, the methodology of the network approach, and the 
methods of patient involvement. Then we asked for suggestions to improve the 
approach. Full interviews took approximately 30 min each, and they were fully 
transcribed verbatim.
Questionnaire survey
We based our questionnaire on the interview results so that we could assess 
participant experiences and measure the time needed for the project. The first part 
of the four-part questionnaire asked about participants’ background characteristics. 
The second part pertained to participants’ involvement in the preparation and 
development phase and the time (excluding travel) needed for each of these phases. 
The third part included five open questions about the network approach (e.g., the 
methodology and guideline integration), patient involvement, wiki methodology, 
and patient contributions to the guideline. The fourth part asked participants to 
describe facilitators of and barriers to the approach and to suggest improvements. 
All participants received the questionnaire by post, after the draft guidelines were 
completed. A reminder was sent six weeks later.
Data analysis
We used SPSS (version 16.0 for Windows, Data Entry 4.0, SPSS, Chicago, Ill.) to 
perform descriptive statistics (frequencies, medians, and ranges) on participant 
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background characteristics and to analyse the time data. We used Kwalitan 
(version 5.0, Malden, The Netherlands) to qualitatively analyse the transcripts of 
the interviews and the free text responses from the second part of the questionnaire 
[20].
Project performance
Two authors (MH and RH) identified all activities and categorized them in the 
preparation phase or the development phase. The preparation phase included 
composing development groups, managing COIs, identifying care aspects to be 
improved, and developing WikiFreya. The development phase included attending 
meetings, formulating key questions, reviewing, selecting and assessing evidence, 
writing the guideline and formulating recommendations, harmonizing the 
guidelines, reviewing and revising draft guidelines, and aligning the guidelines 
with managing WikiFreya. We compared the actual activities with the planned 
activities and identified differences.
Time investments
We counted the regular and extra meetings on the attendance lists, and determined 
the mean meeting participation rates for each group and the steering committee. 
We calculated the total time the steering committee spent on the preparation 
phase. We computed the median actual time for the respondent meetings of 
each development group, total time for extra respondent meetings, and median 
extra time respondents spent for each development group and for each of the 
two phases. The total time for meetings for each group, including the project 
coordinator was assessed as the ‘mean participation rate’ x ‘number of meetings’ x 
‘median time investments.’ The total extra time needed was defined as the ‘number 
of participants for each group’ x ‘median extra time spent by each participant.’ 
The values were corrected for non-responders to the questionnaire. We calculated 
the project coordinator’s extra time separately. Our calculations totalled the time 
needed for the development phase.
Experiences
We analysed the data descriptively, and we used a special framework to analyse 
open question responses. We developed the special framework from the interview 
topic guide corresponding to our study objectives, which included experience 
with the methodology of the network approach, patient involvement, barriers 
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to and facilitators of the approach, and suggestions for improvement [21]. Two 
researchers (EB and MH) studied the interviews and the open question responses 
independently. They identified and coded the parts of the interviewees’ responses 
that were relevant to the study objectives. They then discussed key issues and 
discrepancies between their results. The key issues were structured with a view to 
the study objectives. The questionnaire was based on the interviews, so we only 
present the results of the questionnaire for each study objective, but no information 
found under the heading ‘Organization.’
Results
Participants
Five (four MoG and one MuG) groups were installed in May 2008. None of the 
members of the groups declared significant COIs, and all of them were officially 
mandated by their societies. One of the physicians involved in the MuG group 
dropped out for private reasons two months later. The MuG chairperson, a 
physician, concurrently fulfilled this role. Overall, 32 participants were involved 
in the five groups (Table 1). Four participants fulfilled multiple roles: the project 
coordinator was a member of the steering committee and all five guideline groups; 
the chairperson of the MoG group for general infertility was a member of the 
steering committee; one project leader was a member of the steering committee and 
chairperson of the MuG group; and one member of the MuG group was a member 
of the steering committee (Table 1). All participants received the evaluation 
questionnaire (one patient representative was unavailable). The response rate 
was 79% (n = 27). Table 2 summarizes the background characteristics of the 
respondents. Of the 59% who were experienced in guideline development, 63% 
were also experienced in MuG development.
Guideline development
The project was carried out as planned, except for minor modifications needed to 
improve the consistency between the concepts of the guidelines. Face-to-face 
meetings and additional conferences calls were necessary to discuss discrepancies 
between recommendations concerning the cut-off points for treating infertility. 
These recommendations were issued by guidelines for male infertility and 
unexplained fertility. The cut-off points were eventually based on the existing 
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Table 1: Organizations in the guideline development groups
Professional societies Number of members in development groups
M
ul
tid
isc
ip
lin
ar
y 
gu
id
el
in
e
M
oG
: 
ge
ne
ra
l i
nf
er
til
ity
M
oG
: 
un
ex
pl
ai
ne
d 
in
fe
rt
ili
ty
M
oG
: 
m
al
e i
nf
er
til
ity
M
oG
: 
se
m
en
 an
al
ys
is
Dutch Association of Obstetrics & Gynaecology 2 1 4 2 1
Dutch National Organisation of General 
Practitioners
2 5 1 1 0
Dutch Urological Association 1 0 0 2 0
Dutch Society for Clinical Embryologists 1 0 0 0 2
Dutch Society for Clinical Chemistry 1 0 0 0 1
Dutch Society of Occupational Physicians 1 0 0 0 0
Dutch Association of Psychologists 1 0 0 0 0
Dutch Patient Association for Fertility Problems 2 0 0 0 0
Number of participants 11 6 5 5 4
Total number of participants = 31a
aThe project coordinator took part in all working groups, which increased the total number of participants 
by one.
MoG = Monodisciplinary guideline.
Table 2: Background characteristics of questionnaire respondents
27 respondents n (%)
Gender
Male 14 (52)
Female 13 (48)
Age in years
26–35 4 (15)
36–45 9 (33)
46–55 11 (41)
>55 3 (11)
Median years of professional experience in fertility care (range) 9 (1–26)
Previous experience in guideline developmenta
Yes 16 (59)
No 11 (41)
MoG = Monodisciplinary guideline, MuG = multidisciplinary guideline.
aExperience in guideline development was determined by the authorship of one or more monodisciplinary 
or multidisciplinary guidelines.
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relevant evidence. Further, there was a lack of consensus on some recommendations 
in the four MoGs for life-style advices (e.g., alcohol and anabolic steroids use) 
issued in all four MOGs as well as lack of underlying evidence. This necessitated 
two additional consensus meetings, which were attended by four members of the 
MuG (including the chairperson) and the chairpersons of all MoG groups. These 
consensus meetings produced overall recommendations for life-style advice based 
on evidence regarding pre-pregnancy counselling. The MuG group reviewed the 
drafts of the MoG groups and vice versa. Then, the project coordinator initiated 
a conference call in order to reach consensus on the recommendations based 
on the expert opinion of the MoGs. Via WikiFreya, 298 patients formulated 289 
recommendations, which 80 patients prioritized into 21 recommendations. These 
recommendations were included in the definitive guideline [18].
Resulting guidelines
One MuG and four related MoGs were developed in 20 months; all were written 
in Dutch: http://www.nvogdocumenten.nl/uploaded/docs/Landelijke%20netwerk 
richtlijn%20Subfertiliteit%20def.pdf; www.nvog.nl; www.nhg.org; www.nvu.nl; 
www.embryologen.nl
The definitive MuG follows the overall clinical care pathway for patients with 
infertility problems. It addresses patient-centred, organizational, and medical-
technical issues on the clinical pathways, from first visiting the physician to 
completed treatment (with or without a pregnancy) and aftercare from the physician 
or medical psychologist (Table 3). The MuG consists of 198 recommendations 
based on the best available evidence or expert opinion; the level of evidence 
(A to D) is given for each recommendation. All recommendations were linked 
to the key questions formulated. Of these recommendations, 59% concerned 
organizational and patient-centred aspects of care (Table 4). The medical-technical 
recommendations for transitions in fertility care and supporting care alignment 
were derived from the MoGs. Twenty-one prioritized patients’ recommendations, 
obtained via WikiFreya, were included in the MuG and graded as level P evidence 
[18].
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Table 3: Contents of the final version of the patient-centred multidisciplinary guideline for infertility
Chapter 1: background Description of the patient-centred network approach 
Composition of the guideline development groups and methods used to 
involve patients
Definition of infertility and description of patients’ clinical pathway
Chapter 2: organisation Organization of fertility care
Registration of outcomes of infertility treatments
Care alignment
Chapter 3: physician Basic principles in fertility care for the physician
History, physical examination, and additional infertility assessments
Treatment policy
Referral
Information provision and education
Coordination of primary care with secondary/tertiary care
Attendant role after referral
Chapter 4: gynaecologist Basic principles of fertility care for the gynaecologist
History, physical examination, and additional infertility assessments
Treatment policy
Treatment criteria regarding age
Information provision and education
Referral
Coordination of primary care with secondary/tertiary care
Chapter 4: urologist Basic principles of fertility care for the urologist
History, physical examination, and additional infertility assessments
Treatment policy
Coordination of primary care with secondary/tertiary care
Chapter 5: semen analysis Basic principles for semen analysis
Collection of semen
Analysing the semen
Interpreting the results of a semen analysis
Reporting the results
Chapter 6: psychologist Basic principles in fertility care for the psychologist
Psychological screening of patients with fertility problems
Referral
Chapter 7: sexologist
Chapter 8: work and 
infertility
Infertility in relation to occupation
Exposure to harmful substances during work
Participation of infertile patients in work
Chapter 9: associations for 
fertility problems
Opportunities and legislation for adoption
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Table 4: Examples of recommendations integrated into the multidisciplinary guideline
Medical-technical recommendations Origin or guideline Chapter of the MuG
The physician should only physically examine the man if 
his semen analysis is irregular. LOE C
General infertility 
for physicians
Family physician 
(physical 
examination)
The gynaecologist should not test ovarian reserve capacity 
to predict probability of pregnancy (with or without 
treatment). LOE A
Unexplained 
infertility
Gynaecologist 
(assessments)
Organizational recommendations
The physician should order a semen analysis from an 
accredited laboratory (ISO15189) or from a referral 
hospital. LOE D
MuG Organization of 
fertility care
In accordance with the Dutch IVF planning decree, every 
licensed IVF centre and their corresponding transport and 
satellite centres must provide annual reports on treatment 
outcomes for uniform national IVF registration. LOE D
MuG Organization 
of fertility care 
(registration)
Patient-centred recommendations
Both partners of the couple should be involved in the 
assessment and management of infertility because it is a 
joint problem. LOE C
MuG Physician, 
gynaecologist, and 
urologist (basic 
principles)
The gynaecologist should offer couples with fertility 
problems psychological support throughout all phases of 
fertility care. LOE D
MuG Gynaecologist 
(information 
provision)
Patient recommendations
Patients want their gynaecologist to inform them about 
the different phases of treatment and their expected time 
spans. LOE P
MuG Gynaecologist 
(information 
provision)
Patients want their physician to make a referral 
immediately after they have been trying to conceive for 1 
year. LOE P
MuG Physician (referral)
MuG = Multidisciplinary Guideline, IVF = in vitro fertilization, LOE = level of evidence
Time investments
The median number of two-hour regular group meetings was 10 (range: 5 to 11). 
The median participation rate was 88% (range: 77 to 94%). Three additional two-
hour meetings were necessary for adjustment between guidelines. The steering 
committee needed 11 two-hour meetings for organizing the project. Seven 
participants (20%) were involved in the preparation phase, for which they needed 
471 h in total. In the development phase, the participants spent time on meeting 
preparation, two-hour face-to-face meetings, and minutes of meetings; and 
extra time on reviewing literature, writing guidelines, and commenting on draft 
versions. The time all participants spent in the development phase totalled 4,497 
hours, including the 281 hours the steering committee members spent organizing 
this phase (Table 5).
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Feedback
Interviews
Most of the eight interviewees thought the guideline groups were well composed. 
Nevertheless, they perceived combining the role of moderating the meetings and 
providing clinical input for the content as unsatisfactory. The two project leaders 
said they underestimated the project coordinator’s workload, particularly in 
combining the coordination tasks with writing the draft guidelines. Furthermore, 
views and preferences differed between the chairperson of the MuG and the 
project coordinator about the scope, format, and content of the guideline; this 
formed a time-consuming barrier.
Questionnaires
The 27 questionnaires showed that most participants perceived the methodology 
of the network approach on the one hand as ‘the promising future of guideline 
development’ and on the other hand as ‘complex and unclear.’ Positive notes included 
the perceived individual learning curves for guideline development, the opportunity 
of distributing key questions to participants with relevant knowledge, various 
participants’ perceived respect for autonomy, and the collaborative development of 
the one MuG. Furthermore, participants reported that the high level of coordination 
required to carry out the project as planned was a potential barrier to the approach. 
The different opinions among the professionals caused delays and tension in 
finalizing the guidelines. Clear expectations about the roles of the participants and a 
description of the final format for the guideline were lacking.
The integration of the MoGs into the MuG was seen as ‘powerful’, mainly 
regarding ‘special attention to transitions in different phases of care (alignment)’, 
‘the opportunity to check possibly underexposed topics’ and ‘the simultaneous 
development of all guidelines’. The final equalization of guideline content was ‘too 
late’ (e.g., when recommendations had already been formulated), ‘difficult’ (due to 
differing opinions), and ‘time consuming’ (extra meetings). One respondent said 
integrating MoGs into the MuG was ‘needless.’
Patient involvement
All MuG group respondents described the participation of patient representatives 
in their group as ‘valuable’ (e.g., influencing discussions by refocusing on 
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the patient) and their contributions as ‘beneficial to the final product’ (e.g., 
affecting formulations of considerations or expert-based recommendations). The 
representatives emphasized the need for information about the components of 
clinical care pathways before they discussed treatment options. More than one-
half of the respondents described the final patient recommendations as ‘valuable’ 
or ‘eye-openers’, and ‘useful’ in formulating professional recommendations. Some 
of them doubted the practical applicability of these recommendations. They 
questioned the fact that patients recommended that the physician immediately 
refer patients trying to conceive to the gynaecologist. They noted the lack of new 
insights in patient recommendations.
Facilitators and barriers
Facilitators for the network approach included the selection of the most competent 
and dedicated participants, the introduction of the project coordinator, and patient 
contributions. Perceived political barriers, competing professional interests of 
those involved, and the lack of a more detailed MuG format created barriers. 
Suggestions for improvement included communication of clear instructions for 
individual roles and responsibilities, a strict schedule including deadlines, and a 
clear format for the guidelines. Further, the need for supportive staff and support 
for literature searches were noted.
Discussion
This study provides detailed insight into the feasibility of a novel patient-centred 
network approach to MuG development for fertility care. This approach enabled 
the collaborative development of a harmonized set of one MuG and four MoGs 
for clinical care pathways for infertile couples. The approach helped us foresee 
possible barriers analogous to the US Institute of Medicine recommendations for 
developing trustworthy and transparent CPGs [9].
All the relevant stakeholders were included in the guideline groups. Collaboration 
between balanced groups of key stakeholders is an important success factor for 
clinical networks and may lead to a more valid method of developing guidelines 
[9,10]. A crossover of stakeholders from one guideline group to another helped 
harmonize the guideline content and distribute questions among the groups. This 
emphasized specific professional contributions and created a feeling of affinity 
Breejen, Elvira de.indd   60 15-02-17   14:57
3Patient-centred network approach
61
with the guidelines. The development required intensive patient engagement, 
and the contributions of patient representatives in the MuG group and individual 
patients acting via WikiFreya were considered valuable [18].
The MuG follows patient clinical pathways and uses a network structure that 
includes all stakeholders, so that it pays much attention to the organization of the 
different phases of fertility care and transitions from one phase to another. This 
ensures better-integrated care (e.g., referral from the physician to the gynaecologist) 
[22]. The attention to patient preferences, needs, and values may have increased 
the level of patient-centredness [23]. The approach included an extensive review 
of the guidelines throughout the development. It used the network structure for 
which extra time was needed, but it enabled broader support of the guidelines and 
may enhance future guideline implementation [24,25].
The participants liked the approach and viewed it as a promising format for 
developing MuGs. Enthusiastic patients and the energetic project coordinator 
helped make the approach work well. Suggestions for improving the approach were 
reported mainly at the organizational level (e.g., previous communication about 
individual roles and responsibilities, a detailed time line, and a detailed format for 
the guidelines). This correlates with the existing literature about clinical networks, 
which implies that using clinical networks requires a high degree of managerial 
organization [13,14,22,26]. More support staff might enhance the efficiency of 
the network approach. Engaging a librarian to help with literature searches might 
accelerate guideline development and increase efficiency [27]. However, the 
approach seemed time consuming for developing our set of five related guidelines 
simultaneously. Unfortunately, it is difficult to compare our time investments with 
those of regular guideline development, since there is a dearth of published studies 
about this topic.
Strengths and limitations
Although the use of a clinical network has been suggested as an effective strategy 
for implementing CPGs, this is the first study that has applied this approach in 
developing MuGs [28-31]. Our guideline development closely paralleled the main 
recommendations of the US Institute of Medicine [9]. However, recommendations 
were not graded and to express patients’ input, patients’ recommendations were 
secondarily reformulated to a non-actionable form incongruent to the GLIA 
instrument. This non-actionable form could impede harmonization of patients 
and stakeholders generated inputs. In addition to other studies on guideline 
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development approaches, we also evaluated the feasibility of the approach. 
Nevertheless, a basis for comparing time data is lacking, which is a limitation of our 
study and a major limitation of current study designs of guideline development. In 
our opinion, guideline development is time consuming and expensive. Time should 
always be weighed against benefits, especially for introducing new approaches.
We have applied the patient-centred network approach to a MuG program for 
fertility care. This clinical area is characterized by the involvement of intensively 
collaborating professionals and responsible patients, which might be an argument 
against generalizability for other clinical areas. However, addressing practice 
change and sustaining clinical networks generally requires great motivation and 
is not specific to fertility care [32,33]. In this light, the level of our participants’ 
experience may have been a success factor in realizing the project in a relatively 
short time, but it may also be an argument against generalizability. Nevertheless, 
basic knowledge of guideline development methodologies is necessary in all 
approaches. Moreover, not only were our participants pretty experienced in 
guideline development, they were also opinion leaders within their own medical 
specialties. This may be an important success factor for disseminating and 
implementing the definitive guidelines. Despite this, we realize that, because our 
participants are rather experienced in their own usual way of developing guidelines, 
they might have been more critical of such a new approach. For instance, they 
regarded the lack of a detailed format as a barrier. This factor may have hindered 
the guideline development.
Although the guidelines clearly address organizational and patient-centred aspects 
(altogether, in 59% of the recommendations), we did not compare the proportion 
of these aspects to proportions in conventionally developed guidelines. However, 
we expect that the proportion of patient-centred aspects is rather small in other 
guidelines because patient participation in guideline development is still not 
common practice [34]. This mechanism may also apply to the organizational 
aspects, which are mainly addressed in guideline-related products, such as local 
protocols.
Although the participating member societies and organizations are committed to 
disseminating the final, harmonized guidelines, our detailed process evaluation 
was limited to the first phases of the guideline development and did not include 
the dissemination and implementation phases. We assume that this approach will 
enhance the implementation and our network might be an effective strategy in the 
further efforts that are still required [28-32,35].
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Conclusions and implications for further research
The novel approach of the patient-centred network is feasible for simultaneously 
and collaboratively developing a harmonized set of MuGs and MoGs for the 
clinical pathways of infertile couples. The approach is a potential strategy for 
developing more trustworthy and transparent guidelines. If consensus on the 
guideline format is reached beforehand, instructions on individual responsibilities 
within the network are provided, more support staff is employed, and a librarian is 
engaged to conduct systematic literature searches, then the network approach can 
be used in other guideline development programs too.
We believe that this approach may apply especially to patients who travel 
numerous complex pathways. Our study focuses on the network needed for 
patients who receive multidisciplinary fertility care and form the centre of the 
network. However, other patients who travel different or multiple complex clinical 
pathways may also profit from this approach. Multiple networks can be connected 
or extended where necessary. However, this approach might be less valuable when 
patients travel a clear monodisciplinary pathway; for example, the pathway for a 
simple bone fracture. Further research is needed to compare the efficacy of this 
approach with more traditional approaches regarding content, time investments, 
and actual adoption of guidelines in a pragmatic randomized controlled trial.
Abbreviations:
CPG, Clinical practice guideline; IVF, in vitro fertilization; MoG, Monodisciplinary 
guideline; MuG, Multidisciplinary guideline.
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Abstract
Background: Patient participation is essential in developing high-quality guidelines 
but faces practical challenges. Evidence on timing, methods, evaluations, and 
outcomes of methodologies for patient participation in guideline development is 
lacking.
Objective: To assess the feasibility of a wiki as a participatory tool for patients in 
the development of a guideline on infertility determined by (1) use of the wiki 
(number of page views and visitors), (2) benefits of the wiki (i.e., number, content, 
and eligibility of the recommendations to be integrated into the guideline), and (3) 
patients’ facilitators of and barriers to adoption, and the potential challenges to be 
overcome in improving this wiki.
Methods: To obtain initial content for the wiki, we conducted in-depth interviews 
(n = 12) with infertile patients. Transcripts from the interviews were translated 
into 90 draft recommendations. These were presented on a wiki. Over 7 months, 
infertile patients were invited through advertisements or mailings to formulate 
new or modify existing recommendations. After modifying the recommendations, 
we asked patients to select their top 5 or top 3 recommendations for each of 5 
sections on fertility care. Finally, the guideline development group assessed the 
eligibility of the final set of recommendations within the scope of the guideline. 
We used a multimethod evaluation strategy to assess the feasibility of the wiki as a 
participatory tool for patients in guideline development.
Results: The wiki attracted 298 unique visitors, yielding 289 recommendations. We 
assessed the 21 recommendations ranked as the top 5 or top 3 for their eligibility 
for being integrated into the clinical practice guideline. The evaluation identified 
some challenges to improving the wiki tool, concerning its ease of use, website 
content and layout, and characteristics of the wiki tool.
Conclusions: The wiki is a promising and feasible participatory tool for patients in 
guideline development. A modified version of this tool including new modalities 
(e.g., automatically limiting the number and length of recommendations, using 
a fixed format for recommendations, including a motivation page, and adding a 
continuous prioritization system) should be developed and evaluated in a patient-
centred design.
Keywords: Wiki, patient participation, infertility, Web 2.0, guideline development.
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Introduction
Having patients participate in clinical practice guideline (CPG) development 
is essential but challenging [1,2]. Their participation is particularly assumed 
to result in higher-quality guidelines in terms of applicability, acceptability, 
usefulness, and enhancement of implementation [1-7]. For instance, patient 
participation is one of the key criteria of the Appraisal of Guidelines Research and 
Evaluation (AGREE) instrument [8], which is used to assess the methodological 
quality of guidelines. However, only 25%–50% of CPG developers regularly 
involve patients [9].
Several practical limitations could explain why patient participation is not common 
practice in CPG development. First, various methods for patient participation in 
CPG development can be used, such as conducting in-depth interviews or focus 
group meetings to explore patients’ preferences, asking patients’ representatives to 
comment on drafts of the CPG, or including patients’ representatives or patients 
in the CPG development group [3, 6, 10-14]. However, practical guidance on how 
and when to apply these methods is lacking [15]. Second, all methods are restricted 
to including a selected number of patients or patients’ representatives and do not 
involve a large population of patients. Third, transparently integrating patients’ 
preferences into CPG recommendations is difficult and often unclear [16]. Fourth, 
organizational (e.g., recruitment of participants), financial (e.g., costs of patients’ 
education or for conducting focus groups), and sociopolitical barriers (e.g., CPG 
developers’ resistance to including patients in the CPG group) may impede patient 
participation in CPG development [13]. Finally, studies on the effectiveness and 
impact of patient participation are limited [15].
A new methodology for patient participation in CPG development that enables 
overcoming most of these drawbacks is thus necessary.
Web 2.0 tools offer opportunities to let nonorganized groups participate in a 
complex process such as CPG development [17-20]. In particular, a wiki, such as 
Wikipedia, seems to be an easily accessed tool, which enables patients to collaborate 
in formulating guideline recommendations directly. Ideally, to test the feasibility 
of such a new method for patient participation in CPG development, an Internet-
using young target group such as infertile patients [21-23] is preferred. Infertility 
is commonly defined as “any form of reduced fertility with prolonged time of 
unwanted non-conception” [24] and affects approximately 80 million couples 
worldwide [25, 26]. In this study, we applied wiki technology as a participatory 
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tool for patients in the development of a multidisciplinary CPG on infertility and 
aimed to assess its feasibility.
Methods
Setting
Fertility Care
In the Netherlands, fertility care is mostly publically arranged and provided by 
various professionals. First, fertility care is provided by the general practitioner 
and may be part of an initial fertility assessment after a prolonged time of 
unwanted nonconception. Second, the general practitioner can refer couples 
to a gynaecologist in a general (secondary care) or a university (tertiary care) 
hospital to complete the fertility assessment, determine a cause of infertility, and 
define a suitable treatment policy. Third, if a severe male factor is diagnosed, a 
urologist may be consulted. Furthermore, since infertility has a high emotional 
and psychological impact, which also interferes with work, a psychologist 
and occupational physician are regularly engaged in the care pathway. In vitro 
fertilization and intracytoplasmic sperm injection are provided by 13 licensed 
hospitals (8 university hospitals, 4 general hospitals, and 1 private clinic). Ovulation 
induction and intrauterine insemination are performed in all Dutch hospitals. 
Ovulation induction, intrauterine insemination cycles, and the first three in vitro 
fertilization or intracytoplasmic sperm injection treatment cycles are reimbursed 
as part of the basic health care package according to the Health Insurance Act.
Guideline Development
In February 2008, a collaboration of stakeholders (a general practitioner, 2 
gynaecologists, a urologist/sexologist, a clinical embryologist, a clinical chemical 
specialist, a medical psychologist, an occupational physician, 2 patients’ 
representatives, and a researcher) was set up to develop a national multidisciplinary 
paper-based CPG on infertility. CPGs are defined as sets of evidence- or consensus-
based recommendations describing optimal patient care to assist health care 
professionals and patients in clinical decision-making [2]. The aim of the CPG 
was to focus on organizational and patient-centred aspects of fertility care. Two 
representatives of the Dutch patients’ association for infertility, Freya, participated 
Breejen, Elvira de.indd   70 15-02-17   14:57
4Wiki for patient participation 
71
in the CPG development group. However, for direct patient participation in this 
guideline, we applied a wiki concurrently with this guideline development phase.
Study Objectives
The objective of this study was to assess the feasibility of the wiki as a participatory 
tool for patient participation in CPG development. The feasibility of the wiki 
was determined by three end points: (1) use of the wiki and users’ characteristics 
(number of page views and visitors), (2) wiki content quality, particularly the 
assessment of various aspects of the final set of unique recommendations (i.e., 
number, content, and their eligibility for integration into the CPG) for high-quality 
fertility care, and (3) wiki system quality (i.e., patients’ facilitators of and barriers 
to adoption of this wiki as a participatory tool for direct patient involvement in 
CPG development, as well as potential suggestions for improvement).
Wiki Tool Development
We developed a conventional wiki website using MediaWiki software and 
made accessible through the Freya website, called FreyaWIKI [27]. During the 
preparation phase, we first conducted in-depth interviews to obtain initial content 
for the wiki. Next, we structured the wiki tool according to the topics of the 
recommendations derived from the interviews.
Obtaining Initial Content of the Wiki Tool from In-Depth Interviews
To obtain the initial content for this wiki, we first conducted 12 semistructured 
in-depth interviews with infertile couples during different phases of care, from 
the first visit to the general practitioner, to (non)pregnant status after completing 
medically assisted reproduction techniques [28]. Patients visiting outpatient 
clinics in Nijmegen and Amsterdam were consecutively invited to participate 
through an information letter. Subsequently, 1 researcher (EB) obtained the final 
consent by telephone. Participants were asked to specify perceived bottlenecks in 
their fertility care pathway, using an interview guide including the main treatment 
stages of their fertility care pathway (e.g., treatment by a general practitioner, 
gynaecologist, or urologist). Interviews were audiotaped and transcribed verbatim. 
Next, a researcher (EB) and the chief executive of Freya (JK) independently 
translated these bottlenecks into draft patient recommendations. These draft 
recommendations were formulated as “I want my doctor to....” Consensus on the 
formulation of patient draft recommendations was reached through discussion.
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Structuring the Wiki Tool
Division of the draft recommendations into sections and subsections determined 
the structure of the wiki. Draft recommendations were divided into 4 sections 
(EB, JK), consisting of 3 sections referring to the care delivered by the 3 most 
involved professionals and a general section for recommendations important 
to all professionals: general care, care delivered by a general practitioner, 
gynaecological care, and urological care. To provide more structure in the wiki, 
the draft recommendations in each of these 4 sections were subdivided into 8 
subsections (EB, JK) based on aspects of care that are known to be important 
to infertile patients: 3 medical–technical aspects (i.e., examination, therapy, 
and referral), 4 patient-centred aspects (i.e., organization of care, information 
provision, communication, and staff attitudes), and 1 general aspect (i.e., 
general) [29]. These subsections were presented on the wiki in the following 
order: general (recommendations in general and those that don’t apply to other 
care aspects), information provision (recommendations on oral and paper-based 
information provision), organization (recommendations on the organization 
of fertility care, for example, adjustment of care between different health care 
professionals, accessibility of care), staff attitudes (recommendations on the 
attitude of health care professionals toward the patient, for example, having 
empathy), communication (recommendations on communication between 
the health care professional and the patient), examination (recommendations 
on examinations during fertility care), therapy (recommendations on therapy, 
namely infertility treatment by, for example, in vitro fertilization), and referral 
(recommendations on referral from one health care professional to another, 
for example, from a general practitioner to a gynaecologist). Discrepancies in 
division and subdivision of the draft recommendations were resolved through 
discussion.
Patient Participation in CPG Development
Recruiting Participants
We recruited participants for the wiki evaluation through mailings to members 
of Freya, the Dutch patients’ association for infertility; advertisements in Freya’s 
quarterly journal; links on websites of Freya and the professional societies (e.g., 
general practitioners, gynaecologists, urologists, and clinical embryologists); and 
links in social media (e.g., Hyves, Twitter, and Facebook). In addition, we sent 
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advertising posters to all 103 clinics offering fertility treatments in the Netherlands 
for their waiting rooms.
Obtaining Recommendations from Wiki Participants
Formulating Recommendations
From May to December 2008, we presented the draft recommendations 
for fertility care on the wiki. Patients were invited to modify or refine these 
recommendations and to add new recommendations. During this process, we 
asked patients to subscribe voluntarily through an email address and to provide 
background characteristics for study purposes. After 2 months, when the number 
of recommendations started to increase, patients and patients’ representatives 
requested us to add 2 sections to the existing structure of the wiki: 1 regarding 
the care delivered by the laboratory (e.g., recommendations regarding semen 
analysis), and 1 regarding the care delivered by the remaining professionals who 
were not represented in a separate section (e.g., recommendations regarding the 
medical psychologist). Hence, we added 2 sections to the wiki: laboratory and 
remaining. Next, we recategorized recommendations from the general section 
regarding care delivered by the laboratory or care delivered by professionals other 
than the general practitioner, gynaecologist or urologist. After this restructuring of 
the wiki, the general section contained only recommendations on fertility care in 
general, thus not referring to the care delivered by 1 of the professionals involved.
Modifying Recommendations
After 7 months, we modified the recommendations in several steps. First, we removed 
duplicate recommendations. Then, if necessary, we moved recommendations into 
the appropriate sections (EB, JK). Since all recommendations in the remaining 
section turned out to be more suited to other sections, we eliminated this section. 
Next, 2 researchers (EB, WN) and the chief executive of Freya (JK) independently 
assessed the implementability of all recommendations using the Guideline 
Implementability Appraisal (GLIA) instrument [30]. Discrepancies were 
discussed and resolved through consensus. Based on the results of this assessment, 
the recommendations were independently textually refined or modified by a 
researcher (EB) and the chief executive of Freya (JK). Finally, after consensus was 
reached on the final formulation, we re-entered the recommendations into the 
wiki.
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Prioritizing Recommendations
All patients visiting the wiki website were invited to prioritize their top 5 
(modified) recommendations in each section (for the laboratory section, we asked 
them to identify their top 3 due to the small number of recommendations). This 
prioritization was privately conducted by assigning 5, 4, 3, 2, and 1 points for the 
most important recommendations for determining high-quality fertility care for 
each of the 5 sections and independently from the subsections.
Assessing Eligibility of the Selected Recommendations
Initially, the CPG development group had intended to integrate this final top 
selection of patients’ recommendations directly into the CPG. However, before 
integrating these recommendations, the entire CPG development group (n = 11) 
assessed the eligibility of the recommendations for inclusion in terms of the scope 
of the guideline.
Evaluation of the Wiki
To evaluate the feasibility of the wiki, we performed a multimethod evaluation 
study including three components [31]. First, to assess the ability to involve large 
and diverse patient populations compared with other methods such as interviews, 
we evaluated wiki use and users’ characteristics. Second, we evaluated wiki content 
quality (i.e., recommendations) and, third, wiki system quality (i.e., ease of use, 
layout), identifying factors that could potentially influence adoption of the wiki 
(barriers and facilitators) as well as potential factors for improvement.
Evaluation of Wiki Use and Users’ Characteristics
Data on actual use of the wiki (e.g., number of unique visitors, page views) were 
generated through log files on the website of the patient association (Freya). 
Unique visitors were determined by IP address logged and stored on the website.
Evaluation of Wiki Content Quality
To evaluate the content quality of the wiki, we assessed various aspects of the final 
set of unique recommendations, particularly the number of recommendations, 
their content, and their eligibility for integration into the CPG for high-quality 
fertility care.
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Evaluation of Wiki System Quality
To evaluate the quality of the wiki system and to identify facilitators, barriers, and 
potential areas of improvement, we conducted an online questionnaire. To gain 
insight into the thoughts underlying the resulting factors that formed potential 
facilitators of or barriers to adoption of the wiki and aspects of improvement, we 
conducted in-depth interviews with wiki users who completed the evaluation 
questionnaire.
Online Evaluation Questionnaire
During the prioritization phase, patients visiting the wiki website were invited to 
complete an online evaluation questionnaire. This questionnaire included items 
regarding users’ background characteristics (e.g., age, type of infertility), use 
of the wiki (e.g., number of visits), and factors that could potentially influence 
adoption of the wiki (quality of the wiki website, satisfaction, and net benefits) 
based on the relevant evaluation factors derived from the Human, Organization, 
and Technology-fit framework [32]. Questions on the potential influencing 
factors were grouped into 5 sections: ease of use of the wiki website, layout of 
the wiki website, value of the wiki methodology as a participatory tool for CPG 
development, content of the wiki website, and experienced privacy on the wiki 
website. Patients were asked to rate 22 accompanying positively formulated 
statements on these factors on a 5-point Likert scale from 1 (strongly disagree) 
to 5 (strongly agree) (Multimedia Appendix 1). After each section, patients were 
invited to comment. Next, patients were asked to describe their three advantages 
and disadvantages of the wiki website and potential areas of improvement. Finally, 
patients were asked for their willingness to participate again in a similar project 
and for their intention to recommend this wiki.
In-Depth Interviews with Wiki Users
We first summarized the identified influencing factors on adoption of the wiki 
website and suggested potential areas of improvement. Next, we translated these 
into a topic list to guide the in-depth interviews. To get both confirmation of and 
saturation in the thoughts underlying the facilitators of and barriers to adoption 
and potential areas of improvement of the wiki, 1 researcher (EB) conducted 
semistructured in-depth interviews with wiki users by telephone. Participants in 
the questionnaire survey who left their email address were randomly recruited by 
email. The first part of the interview consisted of open-ended questions, related to 
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thoughts underlying the identified influencing factors on adoption and potentials 
for improvement of the wiki. Next, patients were asked for additional influencing 
factors and suggestions for improvement of the wiki. Recruitment continued 
until saturation of data was achieved. Regarding the starting and stopping criteria 
according to Francis and colleagues [33], we started with 2 interviews and aimed 
to repeat cycles of 2 interviews until we obtained no new data. If data saturation 
was achieved, an additional interview was conducted to attain data saturation.
Data Analysis
We used SPSS 16.0 for Windows, Data Entry 4.0 (IBM Corporation, Somers, NY, 
USA) to perform descriptive statistical tests on the background characteristics of 
the wiki participants and to analyse patients’ top rankings of the recommendations. 
The final top selection of recommendations in each section was determined by 
identifying those with the highest sumscores derived. For analysing the results 
of the online evaluation questionnaire, we grouped the responses on the 5-point 
Likert scale into the categories agree (scores 1and 2), neutral (score 3), and disagree 
(scores 4 and 5). Items were a priori identified as facilitators of adoption if >50% 
chose agree (scores 1 and 2) and as barriers to adoption of the wiki website if 
>50% of the evaluators chose disagree (scores 4 and 5). We used the reported top 
three advantages and disadvantages and the potential areas of improvement of the 
wiki to determine the frequency of occurrence of each aspect. We conducted an 
initial content analysis of all free-text responses to the questionnaire, to determine 
additional points to be improved (EB, WN).
Qualitative Analysis of the Interviews
All interviews were audiotaped and transcribed verbatim. Data were analysed 
iteratively and thematically across accounts (EB, JK) [34], according to the 
relevant factors of the evaluation framework, as used in the questionnaire to 
identify barriers to and facilitators of adoption and potential areas of improvement 
of the wiki [32]. Another researcher (WN) independently checked the coding 
framework and analysis.
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Results
Wiki Tool Development
In-Depth Interviews
From the transcripts of 12 in-depth interviews with infertile patients, we translated 
the perceived bottlenecks into a set of 90 draft patient recommendations and 
entered them into the wiki (Figure 1).
Figure 1: The process of obtaining recommendations for CPG development
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For example, patients perceived a bottleneck in that appointments were possible 
only during working hours instead of also during the evening, which resulted in 
difficulties with work. The resulting draft recommendation was formulated as “I 
want the hospital to provide possibilities to make appointments during evening 
hours.” Other examples of the bottlenecks mentioned were the variation between 
hospitals’ laboratories in performing a semen analysis, unavailability of separate 
waiting rooms for pregnancy and infertility consultations, and gynaecologists’ 
lack of empathy.
Structure of the Wiki
FreyaWIKI was structured through the division of recommendations into 6 
sections. Each of these sections was subdivided into 8 subsections (Figure 2 and 3).
Figure 2: Screenshot of recommendations on FreyaWIKI 
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Figure 3: Screenshot of the FreyaWIKI homepage
Patient Participation in CPG Development
Wiki Use and Users’ Characteristics
During 7 months of access, 36,473 wiki pages were viewed. We identified 289 unique 
users, including 81 registered users who provided background characteristics 
(Figure 4). The majority of them were female 78/81 (96%), highly educated 
54/81(67%), and middle aged (mean 33 years). Median duration of infertility was 
30 months (range 0–71 months). More than half 43/81(53%) underwent medically 
assisted reproduction techniques during the period of their visit. Another 14% (n 
= 11) stayed childless despite treatment.
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Figure 4: Flow of wiki participants trough the study
 
91 
 
Figure 4: Flow of wiki participants trough the study 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Prioritizing wiki users 
n = 80 
Registered 
n = 81 
Nonregistered  
n = 217 
Total number of unique  
wiki users  
n = 298 
Wiki users completing evaluation 
questionnaire 
n = 45 
Wiki users participating in in-depth 
interviews 
n = 3 
Wiki Content Quality
Overall, we collected 265 recommendations and modified them into 289 
unique recommendations (Figure 1). After patients (n = 80) prioritized the 
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recommendations by ranking the top 5 or top 3 in each section (we had eliminated 
the remaining section) according to their importance to high-quality fertility care, 
we selected 23 recommendations (4 sets of top 5 and 1 set of top 3) for eligibility 
assessment by the CPG development group (Table 1). We excluded 2 insurance-
related recommendations, since they did not meet the scope of the CPG. The CPG 
development group accepted all of the remaining 21 recommendations, which 
were integrally integrated into the CPG. More than half (n = 11) of the final set 
of recommendations concerned the organization of care. Similar to the quality 
assessment scale used in evidence-based recommendations (levels of evidence 
A–D) [35], a level of P (patients) was provided for the patients’ recommendations 
and formulated as “Patients would like to...”. Participants were informed by email, 
on the wiki website, and through the websites of Freya and the professional 
associations of the final CPG that included the literally eligible recommendations 
of the patients.
Evaluation of Wiki System Quality
Online Evaluation Questionnaire
Of the 80 patients who participated in the prioritization, 45 completed 
the questionnaire. Of these, 53% (n = 24) visited FreyaWIKI at first while 
completing the questionnaire, and 93% (n = 42) had never worked with a wiki, 
other than this one, before. Other background characteristics of the respondents 
are presented in Table 2. Facilitators of adoption of the wiki, defined as >50% 
of respondents agreeing (scores 1 and 2) to the relevant statements, were not 
identified. Barriers, defined as >50% disagreeing (scores 4 and 5) to the relevant 
statements, were identified in 3 of the 5 sections: ease of use, content of the 
website, and value of the wiki methodology (Table 3). In decreasing order of the 
proportion of evaluators who disagreed with the relevant statement, the main 
identified barriers concerned the findability (82%) and accessibility (78%) of the 
website, and the suitability of this wiki for obtaining recommendations for CPG 
development (71%). 
Reported advantages of the wiki were the privacy they experienced on the website, 
the structure of the website linking recommendations to sections on care delivered 
by fertility professionals, ease of navigation through the website, and the additional 
value of the wiki website as a source of information and as an opportunity to 
provide feedback to the care services.
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Reported disadvantages of the wiki concerned the content of the wiki website, in 
terms of the unstructured recommendations not being formulated in a similar 
way, too much content being visible on one screen, and the nonattractive layout of 
the wiki website.
The main potential areas of improvement were providing information on 
treatment options and causal factors of infertility on the wiki website, broadening 
the marketing of the wiki by placing advertisements in commercial magazines, 
and communicating information on related activities (Table 4). Overall, 98% of 
the patients said they would recommend the website and 84% would participate 
again in a similar project.
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Table 1. Final set of the patients’ top-5 and top-3 recommendations (n = 23) for the 5 sections, ranked by 
importance to the quality of fertility care as formulated on the wiki website.
Section, rank, and recommendation Subsection 
(aspect of care)a
General care
1 I want insurance companies to reimburse six attempts at in vitro fertilizationb General
2 I want insurance companies to start counting in vitro fertilization attempts 
only after oocyte retrieval or even after embryo transfer has been performedb
General
3 I want my doctor to practice empathy, instead of only working on the 
technical or financial part
Staff attitudes
4 I want the hospital to have separate waiting rooms for pregnant women and 
couples being treated for infertility
Organization
5 I want to be able to arrange appointments during the daytime as well as in the 
evenings
Organization
General practice care
1 I want my gynaecologist and GPc to have good communication, so my GP 
knows what is going on with us
Referral
2 I want my GP to make a referral immediately after we have been trying to 
conceive for a year
Referral
3 I want to have my first medical consultation with my gynaecologist within 1 
month after referral
Organization
4 I want my GP to be informed of possible causes of infertility, in both women 
and men
General
5 I want my GP to pay attention to nonmedical issues, such as stress, anxiety, 
relational problems, and sexuality
Communication
Gynaecologic care
1 I want also to be able to receive treatments on weekends (Saturdays and 
Sundays)
Organization
2 I want all members of the fertility treatment team to apply one policy 
regarding my infertility treatment
Organization
3 I want my gynaecologist to inform me of all possible fertility treatment 
options, even if these are outside the hospital
Information 
provision
4 I want my gynaecologist to inform me about the different phases of treatment 
and their expected time span
Information 
provision
5 I want assisted hatching to be possible or available in the Netherlands Therapy
Urologic care
1 I want my urologist and gynaecologist to have good communication Organization
2 I want to be informed of the investigations that are to be performed by the 
urologist
Examination
3 I want to have a permanent urologist who is specialized in infertility Organization
4 I want to have a consultation with a urologist within 1 month after referral Organization
5 I want my urologist to involve my partner in the conversation Communication
Laboratory
1 I want to be informed as soon as possible when our embryos do not divide 
correctly
Organization
2 I want Dutch laboratories to share protocols and learn from each other’s 
experiences
Organization
3 I want to be informed of the causes of nonviability of our frozen embryos, if 
appropriate
Organization
a Subsections were derived from the website’s structure and located by the user.
b Recommendation was excluded, since it fell out of the scope of the clinical practice guideline.
c General practitioner.
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Table 2: Background characteristics of respondents (n = 45) to the evaluation questionnaire.
Characteristic Data
Gender, n (%)
Male 0 (0%)
Female 45 (100%)
Age (years), mean (SD) 35 (5.24)
Type of infertility, n (%)
Primary 15 (33%)
Secondary 30 (67%)
Duration of infertility (months), median (range) 36 (0–71)
Current phase in fertility care, n (%)
Gynaecologic 19 (42%)
No pregnancy after fertility treatment 8 (18%)
Pregnant achieved by fertility treatment 4 (9%)
Unknown 14 (31%)
Level of education, n (%)
Low 0 (0%)
Intermediate 14 (31%)
High 31 (69%)
Membership in Freya, n (%) 24 (53%)
Table 3: Patients’ barriers to adoption of the wiki (n = 45).
Factor influencing adoption of the wiki Proportion disagreeing 
with the factora
n %
Ease of use of the website
Findability of the website 37 82%
Accessibility of the website 35 78%
Clarity of log-in location on the website 27 60%
Clarity on the goal of the website 28 62%
Clarity on instructions for using the website 24 53%
Efficiency of the website (i.e., speed at which the website enabled users 
to accurately and successfully add and modify recommendations)
24 53%
Content of the website
Comprehensiveness of the clarifying text on the website 30 66%
Satisfaction with the content of the formulated recommendations 25 56%
Usefulness of clustering recommendations into sections in searching for 
existing recommendations
23 51%
Similarity between formulated recommendations and participants’ 
actual opinions on fertility care
23 51%
Value of using the wiki
Suitability of the wiki for obtaining recommendations for clinical 
practice guideline development
32 71%
Ease of using the wiki 24 53%
Accessibility of the wiki 27 60%
a Number (%) of participants who rated the positively formulated statements on the evaluation factors as 
disagree (scores 4 or 5).
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In-Depth Interviews
Overall, 11 of the 30 patients who gave their email address in the evaluation 
questionnaire agreed to participate in the interviews. We conducted 3 interviews. 
All 3 interviews confirmed barriers to adoption as well as suggestions to improve 
the wiki, and saturation of the related underlying thoughts was reached (Table 4). 
All patients reported problems with formulating a recommendation and expressed 
their wish to add a personal touch to the recommendation (e.g., to explain why 
something should be done). The introduction of a motivation page, where patients 
are able to describe why they formulated a recommendation might meet this 
request. Patients also embraced the missing community feeling as mentioned in 
the evaluation questionnaire. Introducing a monthly newsletter and automatically 
sending an email to the person who made the recommendation were suggested. 
Table 4: Participants’ (n = 45a) suggestions for improving the wiki website.
Aspect of improvement Respondents 
suggesting 
the aspect
Sample translated quotes from 
in-depth interviews (I) 
and online questionnaires (Q)
n %
Usability of the website
Findability of the website 10 22% Q: Hard to find 
Q: I think it is awkward that the website is only findable 
through the Freya website 
I: I wouldn’t know how to find the website, unless through 
the Freya website
Accessibility of the website 2 4% I:  I was unable to find the log-in location or request a 
new password
Content of the website
Comprehensiveness of 
clarifying text
1 2% Q: Unclear
Clearness of description of 
the goal of the wiki
4 8% I: The description is a bit unclear; therefore, I previously 
thought to check it more precisely, but I still haven’t done 
this 
I: I had not concluded that the recommendations were 
directly integrated in a professional guideline 
Clearness of instructions 
for use
1 2%
Satisfaction 
with formulated 
recommendations
8 16% I: but there are recommendations I am not satisfied 
with, I would suggest that participants can prioritize 
recommendations that they are satisfied with in 
an earlier stage, then you only have to list the most 
important recommendations in one screen
Similarity between 
actual preferences and 
recommendations
4 8% Q: I would like to see why a specific recommendation was 
formulated, separately from the recommendation 
I: There are too many recommendations on the website, 
but there are recommendations I am not satisfied 
with. I would suggest that participants can prioritize 
recommendations that they are satisfied with
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Aspect of improvement Respondents 
suggesting 
the aspect
Sample translated quotes from 
in-depth interviews (I) 
and online questionnaires (Q)
n %
Content of the website
Clarity of the structure in 
which recommendations 
are placed on the website
30 66% I: Structure is good but the provided sections are 
incomplete, for example the care provided by a 
psychologist or other forms of mental counselling. 
Psychosocial concerns are always underestimated in 
fertility care 
Q: The used structure is good, but for searching an 
existing recommendation it would be valuable to add a 
search function to the website 
Relationship between 
length and number of 
recommendations and 
their presentation on one 
screen
32 71% Q: There are too many recommendations on the website 
I: Recommendations are too long, sometimes it’s more 
like a story, which is very interesting, but I wonder if the 
doctors are taking this as serious input to a guideline 
Q: The prioritization is hard due to the large number of 
recommendations
Education provision on the 
website
19 42% Q: It might be valuable if the website provides usable 
links to high-quality websites 
Q: Information on treatment options might enrich the 
website 
Q: I would like to find information on causal factors of 
infertility 
Q: Practical information about compensations for 
treatment per insurance company, regional psychological 
services, plural miscarriages, infertility, and referral
Characteristics of the wiki
Usability of wiki 
methodology
6 13% Q:  The website is not user friendly...the number of visible 
recommendations makes it unclear 
Q: Recommendations given contain too many words 
I: I really don’t have a clue about what constitutes a high-
quality recommendation 
I: It would be valuable to apply an automatic 
program, through which patients are able to formulate 
recommendations
Accessibility of wiki methodology
Efficiency of wiki 
methodology
5 11% Q: Prioritizing is hard and not efficient in this stage; the 
list of recommendations is too long 
I: The efficiency might be improved if you ask patients 
immediately after formulating a recommendation to 
prioritize the most important recommendations
Layout of the website
Impression of the layout 33 73% Q: Nonattractive/not a modern/not a fashionable website 
Q: The layout is not from today 
Q: Looks unprofessional
Communication with wiki users
Marketing 6 13% Q: This good initiative requires a better marketing 
approach to reach more participants
Community feeling of the 
wiki
3 6% I: More communication on related activities and results 
will increase the number of patients that will come back 
Q:  Effect of the recommendations on the guideline is 
unclear
a45 participants completed the online evaluation questionnaire, of whom 3 participated in the in-depth 
interviews.
Table 4: Continued
Breejen, Elvira de.indd   86 15-02-17   14:57
4Wiki for patient participation 
87
All 3 interviewees regarded the website as a valuable source of information, rather 
than as a tool for modifying recommendations for CPG development. They 
mentioned that the content of the wiki had been helpful to them in searching for 
information on experiences regarding infertility treatment and in searching for 
recognition of their own experiences. Suggestions to improving the awareness of 
essence of use were suggested within improving the clearness of instructions.
Discussion
Principal Results
In this study, we showed that the wiki is a feasible tool to ensure active patient 
participation in the development of a Dutch multidisciplinary CPG on 
infertility. The high numbers of page views (36,473), unique visitors (298), and 
recommendations formulated (289) implies patients’ willingness and ability to 
contribute to CPGs through a wiki-based method. We also showed that such a 
wiki is a useful information source for patients.
Second, we gained a final set of 21 selected recommendations, which were 
assessed as being eligible to be integrated directly and transparently into the CPG. 
Third, patients had positive views on the experienced privacy, ease of navigation, 
divisional structure of the wiki, and its potential befits. A total of 98% of the 
patients would recommend the website and 84% would participate again in a 
similar project. This study also provided some important suggestions to improve 
this participatory tool for patients in the development of CPGs, concerning ease of 
use, content and layout of the website, and characteristics of the wiki tool.
Comparison with Existing Techniques
Several studies on specialized medical wikis (e.g., wikis that fall outside the 
scope of a general encyclopaedia) have been published, but most particularly 
focus on education of medical students [36] or collaboration between health 
care professionals [37,38], rather than on patients, and did not include a process 
evaluation. Only Gupta and colleagues [39] and Archambault [40] involved a group 
of preselected patients as well as professionals in the development of an asthma 
action plan through a wiki. However, results are premature, since this study was 
conducted over a very short time period (weeks), and a wiki needs more time to 
build content (approximately 7–8 months) [41]. Furthermore, their evaluation of 
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the wiki tool was not focused on patients’ experiences and was less extensive than 
our multifaceted approach to gaining insight into patients’ barriers to adoption of 
our wiki. In this study, we involved a large number of patients (298), which cannot 
be realized using traditional methods, such as focus groups, in which participation 
is generally restricted to a maximum of 8 participants [42]. We even assessed the 
final selection of top recommendations for their eligibility for direct integration 
into the CPG. Thus, the patients’ contribution to the CPG was clearly illustrated 
by integrating their recommendations in their entirety, indicated by the new P 
level (Patients). We also addressed other practical limitations of the methods used 
to enhance patient participation in CPG development, such as organizational 
(e.g., recruitment of participants), financial (e.g., travel costs), and socio-political 
(e.g., professional resistance to including patients in CPG development group) 
constraints.
Professionals and patients’ representatives could also use the wiki and had the 
opportunity to informed themselves about patients’ views and to bring up 
content for discussion in the CPG development group. According to the results 
of the evaluation questionnaire and the interviews, this content was also helpful 
to patients as an information source, which may also explain the relatively large 
number of page views. Although providing information was not the initial goal of 
this wiki, its relevance is in agreement with published literature on conventional 
wikis [19] and with European patients’ perception of the importance of the 
Internet as a source of information [43]. Hence, this unintended but solid flaw 
concurrently yields challenges for improvement and might be aided by providing 
clearer instructions for use and description of the goal of the wiki, but also addresses 
important implications for future studies in this field. Next to the informational 
value of formulated recommendations for high-quality care, attention should be 
paid to useful links to relevant websites that may potentially attract more patients 
to the wiki website and increase the chances for adoption of an improved version 
of the wiki.
Although drawbacks to active patient participation methods were reduced, this 
study drew attention to some other potential implications derived from patients’ 
suggestions that might improve the use of a future medical dedicated wiki for this 
purpose exclusively. First, structuring recommendations and limiting the number 
and length of recommendations to presentation on one screen may improve 
usability [44]. Second, using a fixed format in the formulation of recommendations, 
based on relevant items of the GLIA instrument, may not only improve usability 
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and accessibility of the wiki [30,44], but may also improve the efficiency of the 
wiki and the usefulness of recommendations in being integrated directly into 
the CPG. Introducing a motivation page might give patients the opportunity 
to add a personal touch to the recommendation. Third, a prioritization system, 
continuously refining the similarity between patients’ perspectives and the top5 
recommendations (e.g., by rating recommendations after every contribution), 
could improve the tools’ efficiency by avoiding separate prioritization of 
recommendations and could improve patients’ satisfaction with the highest-rated 
recommendations. This modality would also allow more flexible use by CPG 
developers at the time of their choosing. In addition to the suggested modalities, 
some known refinements in overall usability (e.g., findability, prominent log-in 
location), content (comprehensiveness of text), and layout of the website might 
improve use of the wiki and would be reduced by repeated cycles of design, 
evaluation, and redesign [45,46]. Furthermore, a user-centred design, in which 
patients codevelop such new modalities, may improve future implementability 
and provide chances for local adaptation of a redesigned wiki website [47,48]. 
Both the feasibility of a wiki as a participatory tool for patients in the development 
of CPGs and the recommendations for future wiki-based initiatives illustrate the 
value of eHealth. With this in mind, numerous participatory applications based on 
wikis are conceivable and may be valuable in various fields of research. In the field 
of guideline development, guideline-derived initiatives actively involving patients 
in the development of patient information leaflets or treatment action plans, in 
addition to fully online-based CPGs, may also benefit from our results. Finally, 
our results add to the knowledge base about wikis in health care [49].
Limitations
This wiki has been tested in the field of infertility care, representing a relatively 
young target group [50]. More than 98% of this group use the Internet [21]. 
This participant characteristic is associated with more frequent health-related 
Internet use [51-53]. Therefore, the participants in our study were an ideal 
subgroup for testing and evaluating a wiki-based method, which argues against 
the generalizability of our findings to other patient groups. Nevertheless, health-
related Internet use in Europe is increasing over time [54]. Hence, it seems to be a 
question of time until older people or their caregivers, or both, will be using such 
tools [55]. Furthermore, this feasibility study provided an important exploratory 
evaluation component, which resulted in valuable information for future studies 
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in this field but also had certain limitations. First, based on the results of a recent 
systematic review from Gagnon and colleagues [56], we acknowledge that the items 
used in our evaluation questionnaire might be incomplete. However, the results of 
our study add to those from the limited number of previously published studies 
on patients’ facilitators of and barriers to adoption of eHealth applications [57,58]. 
Second, the heuristics used were not based on a validated questionnaire and 
were too limited for drawing conclusions on the usability that patients perceived. 
Therefore, a next step in future development of a wiki-based participatory tool 
for patients in CPG development should be to include a broader evaluation of the 
potentially influencing factors on adoption, including more organizational factors 
and a heuristic evaluation.
Third, the participation rate in the evaluation of the wiki might have subjected 
our study to a participation bias of potentially the most motivated wiki users. 
However, this is a known limitation in the active use of wikis in general: the most 
motivated users provide most of the content [19]. Finally, this feasibility study 
did not assess the representativeness of either the participants or the final set of 
recommendations in the wiki.
Conclusions
The wiki is a promising and feasible tool to actively involve patients in CPG 
development. To improve the tool’s ease of use and practical aspects to enhance 
direct integration of recommendations into the CPG, a more specialized and 
refined wiki should be developed. This should include new modalities, such 
as automatically shortening the number and length of recommendations, 
using a fixed format for formulation of recommendations, using a continuous 
prioritization system for selection of the most important recommendations, and 
including a separate motivation page. Furthermore, in the development, attention 
should be paid to the informational character of such a wiki. To improve future 
implementability, a modified tool should preferably be codeveloped and evaluated 
by patients in a user-centred design study. Furthermore, representativeness of 
patients and recommendations should be integrated into this next phase. 
Abbreviations: AGREE, Appraisal of Guidelines Research and Evaluation; CPG, 
clinical practice guideline; GLIA, Guideline Implementability Appraisal
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Multimedia Appendix 1: Constructs of the online evaluation questionnaire
Statements (n=22) rated on a 5-point Likert scale (1= strongly agree, 5= strongly disagree)
Ease of Use of the website
⚫	 I am able to find the website easily
⚫	 The website has a good availability
⚫	 The website has a clear place for login
⚫	 The goal of the website is clear to me
⚫	 The instructions for use of the website are clear to me
⚫	 	The instructions for modifying previously formulated recommendations and adding new    
recommendations are clear to me
⚫	 	The use of the website is efficient 
(speed at which the website enables a user to accurately and successfully add and modify 
recommendations)
⚫	 Navigating through the website is easy
⚫	 The links on the website are functional 
⚫	 It is clear to me where to ask questions and/or report problems with the website
Layout of the website
⚫	 The used layout makes the website accessible
⚫	 The used layout encourages the use of the website
⚫	 The layout of the website is conveniently arranged
Content of the website
⚫	 The content on the website is well organized
⚫	 The clarifying text on the website is easily understandable
⚫	 I am satisfied with the content of the recommendations formulated on the website
⚫	 	The clustering of recommendations into different sections on the website is useful to search 
recommendations (general care, gynaecologic care etc.)
⚫	 	The recommendations formulated on the website are in agreement with my actual opinion on 
fertility care in the Netherlands
Value of the used wiki 
⚫	 The used wiki is a suitable way of gaining recommendations for a national guideline
⚫	 The used wiki is easy in use
⚫	 The used wiki is easy accessible
Privacy on the website
⚫	 I am not afraid for abuse of my personal data on the website
Additional open questions
⚪ Can you provide the three advantages of the website?
⚪ Can you provide the three disadvantages of the website?
⚪ Can you provide potentials for improvement of the wiki-website?
⚪ Would you recommend wikifreya to others?
⚪ Would you re-participate in a similar project in the future?
⚪ Do you have any additions to his questionnaire?
⚫	  = statement
⚪  = open question
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Abstract
Background: Participation of patients in guideline development is advocated, 
but transparent approaches to facilitate this have hardly been practiced. A 
collaborative writing tool such as a wiki is promising for such participation, but 
needs customization.
Objective: To evaluate the use and benefits of a specialized online participatory 
tool to facilitate patient partnership in guideline development. 
Methods: A specialized online participatory tool was developed based on (dis)
advantages that resulted from a previous pilot study of a wiki tool. We used a mixed 
method to evaluate its use and benefits. Outcome measurements for use included: 
actual use of the tool (number of unique visitors, registered participants, and visits), 
the usability of the tool measured on a SUS-scale (0–100), and representativeness 
of visitors compared to a valid representative Dutch hospital cohort. Outcome 
measurements for benefits on guideline development included: number of newly 
generated and modified recommendations, number of prioritizations, and the 
change over time of the top five recommendations.
Results: In 12 months, the tool welcomed 3028 unique visitors, of which 87 were 
registered participants. The tool enabled a broad and representative (age (P=0.39), 
type of infertility (P=0.31), and percentage of childlessness (p=0.71)) female target 
group (n=75) compared to a hospital group (n=200) to participate. Participants 
delivered a set of 50 clear and prioritized recommendations for clinical guidelines 
on Dutch fertility care. Overall, 39 out of 45 registered participants for the 
evaluation qualified the tool as highly usable (median SUS-score=82.5).
Conclusions: Using this specialized online participatory tool is a feasible method 
of involving a broad group of representative infertile patients in guideline 
development. This paper can be used as a practical guide for policymakers, 
guideline developers, and patients’ organizations that are willing to facilitate 
patient partnership in guideline development in any healthcare setting.
Key words: patient-partnership, patient-centredness, wiki, guideline development, 
infertility, E-Health.
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Introduction
To pave the way to patient-centred care, patient partnership as a basic principle 
of healthcare should be firmly embedded [1–4]. The Internet plays a crucial role 
herein. Patients become active partners in their own treatment by using online 
decision-making tools, accessing and writing patient information, accessing their 
personal health record, and even connecting to medical doctors or professionals 
via online communities [5–10]. However, in clinical guideline development, which 
can be seen as the basis for optimizing high-quality patient-centred care, patient 
partnership is still underdeveloped. Determining factors in choosing whether 
to more or less actively involve patients in the clinical guideline development 
process can probably be identified as practical barriers. These barriers include the 
various methods that exist for patient involvement in guideline development, the 
haziness in how and when to apply these methods most effectively, the difficulty in 
transparently integrating patients’ preferences into guideline recommendations, 
the representativeness of participating patients, and costs [11–19]. Likely, online 
tools are relatively new in this field, but may overcome these barriers and facilitate 
patient partnership in guideline development. Publications regarding the use 
and evaluation of collaborative online writing tools to involve patients in the 
development of quality instruments are scarce, but promising [20, 21].
A previous pilot study showed that a wiki is a promising and feasible tool for 
the participation of a broad group of non-organized infertile patients in Clinical 
Practice Guideline (CPG) development [20]. However, this tool still needs 
customization to bridge patients’ preferences for its use and the goal of directly 
collecting prioritized, authentic patient recommendations for CPGs [20]. 
Additionally, the lack of transferability of this tool to other target groups is a 
potential drawback. 
Therefore, we developed and implemented a specialized online participatory 
tool that can be adapted to various healthcare areas (in this study, fertility care) 
and that is tailored to the (dis)advantages that resulted from the pilot study. 
This preliminary tool presented in the pilot study includes a basic wiki tool for 
formulation and prioritization of patients’ recommendations. We evaluated this 
specialized online participatory tool for patients regarding its use and benefits for 
CPG development.
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Methods
Setting: Dutch fertility care
Infertility is estimated to affect 80 million couples worldwide [22,23]. It is defined 
as the couples’ inability to achieve pregnancy after having at least one year of regular 
unprotected sexual intercourse [24]. In the Netherlands, fertility care has been 
publicly arranged on three levels. Primary care is provided by general practitioners 
(GPs) and may comprise part of an initial fertility assessment. If necessary, a GP 
can refer couples to a gynaecologist in a general (secondary care) or a university 
(tertiary care) hospital, who can complete this initial fertility assessment, determine 
a cause of infertility, and define a suitable treatment plan. If a severe male factor is 
diagnosed, couples are also referred to a urologist. Nurses, biochemists, and clinical 
embryologists are also involved in assessments and preparations for Medically 
Assisted Reproductive (MAR) techniques, such as In Vitro Fertilization (IVF). 
Since infertility has a high emotional and psychological impact, which may also 
interfere with people’s jobs, medical psychologists and occupational physicians are 
regularly involved in patients’ clinical care pathways [25]. The complexity of this 
condition affecting young couples and its multidisciplinary care pathway possibly 
elucidates the active form in which Freya, the Dutch patients’ association for 
infertility, supports infertile patients (www.freya.nl).
Development of the tool
The principles guiding the initial design of the specialized online participatory 
tool for patients in CPG development were derived from a previous feasibility 
study on a basic wiki as a participatory tool for Dutch fertility patients in CPG 
development [20]. Based on these results, a prototype of the specialized online 
participatory tool for CPG development that can be adapted to every healthcare 
setting and usable for both end-users (i.e. guideline developers and patients) was 
developed and pilot tested.
Prototype development and pilot test
In January 2010, a multidisciplinary team (two clinical guideline developers, two 
gynaecologists, a website developer, and a board member of Freya) was assembled 
to develop a prototype of the specialized online participatory tool. Goals for 
improving the basic wiki tool included lowering the level of moderation of 
patients’ recommendations needed and increasing the direct usability of patients’ 
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recommendations for uptake in the guidelines. Facilitating the formulation of 
these recommendations by patients using a standardized format as well as creating 
the ability to continuously prioritize recommendations introducing a star-rating 
system were other important improvement goals. The initial prototype of the 
specialized online participatory tool was pilot tested and re-designed by two expert 
panels including the two types of end-users of the tool: one patients’ panel (n=8) 
and one clinical guideline developers’ panel (n=6), including one web designer. 
The tool was successively re-designed through the input of both panels through 
three steps: 1) redesign of the homepage and registration page; 2) redesign of the 
recommendations pages, including the prioritization of recommendations; and 3) 
final assessment of the re-designed tool. In each round, both types of end-users 
provided their suggestions for improvement as a whole by completing a written 
questionnaire regarding their perceived advantages and disadvantages as well as 
their suggestions for improvement. This questionnaire was based on the relevant 
items of the framework of Yusof and colleagues for the evaluation of e-health 
initiatives [26].  Items included: ease of use of the tool, layout of the tool’s website, 
value of the participatory tool for CPG development, content of the tool’s website, 
and experienced privacy on the tools’ website. Additionally, the first and the 
last step included an assessment of the usability of the tool by using the System 
Usability Scale (SUS) questionnaire [27].
Description of the specialized online participatory tool
The final version of the specialized online participatory tool was fully based on 
open-source software and made accessible over 12 months at www.freyawiki.nl. 
The homepage included a description of the tools’ goals and a navigation menu 
for linking to five main pages: the recommendations page, the discussion page, the 
chat page, the frequently asked questions page, and the registration page (Figure 1). 
On the recommendations page, visitors could define or modify recommendations 
according to the statements of the GuideLine Implementability Appraisal (GLIA) 
instrument [28]. To help patients formulate clear recommendations as supported 
by this instrument, a template was used to address the following questions: (1) 
under what circumstances?, (2) has who?, (3) with what level of obligation?, (4) 
to do what?, (5) to whom?, and (6) how? Controlled natural language was applied 
to create and populate a template for recommendations (Figure 2). The question 
‘why’ was posed on a linked, but separate, motivation page to enable patients 
to express their motivation for their recommendation. By using the template, 
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Figure 1: Screenshot of the homepage of the specialized online participatory tool
Figure 2: Screenshot of the recommendations’ page
participants were also able to modify existing recommendations. The specialized 
online participatory tool was firstly populated with 21 initial recommendations 
based on the prioritized patients’ recommendations included in the Dutch 
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network guideline on subfertility [20,29]. These initial recommendations for 
high-quality fertility care were distributed according to seven different phases of 
fertility care: General care (n=3), General practitioner care (n=5), Gynaecologic 
care (n=5), Urologic care (n=5), and Laboratory phase (n=3). To help participants 
search existing recommendations, a search engine was added to each page of 
the website. Furthermore, participants were asked to rate (1–5 stars) the existing 
recommendations, including their own recommendation(s), according to each 
one’s level of importance for high-quality fertility care. The actual top five per care 
phase were illustrated on the individual recommendation pages. A discussion 
forum page and a chat page provided visitors the opportunity to discuss the 
recommendations with co-users of the tool.
Evaluation of the tool 
Study population
Potential participants for the evaluation of the tool were invited through an 
advertisement on the website of the previous pilot version of the basic wiki tool 
[20]. Furthermore, they were invited through mailings to members of Freya, 
advertisements in Freya’s quarterly journal, links on Freya’s website, links on 
websites of allied professional societies (i.e. general practitioners, gynaecologists, 
urologists, and clinical embryologists), and links on social media channels (i.e. 
Twitter and Facebook). In addition, we sent advertising posters and business cards 
to all 103 Dutch clinics offering fertility treatments in the Netherlands for their 
waiting rooms at the departments of urology and gynaecology.
Evaluation design of the tool
We evaluated the tool with automatically generated data and questionnaires 
regarding its use and benefits for CPG development. Outcome measurements 
for use included: actual use of the tool (number of unique visitors, registered 
participants, and visits), the usability of the tool, and representativeness of 
participants. Outcome measurements to evaluate its benefits for CPG development 
included: number of newly developed and modified recommendations, number of 
performed prioritizations (total and per care phase), and the change over time of 
the top five recommendations (overall and per care phase).
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Data collection
Use of the tool
Actual use
On the homepage, all visitors were asked to create a nickname and password, 
which was mandatory for actively using the tool. Additionally, visitors were asked 
to voluntarily fill out a registration form for study purposes. This registration 
form consisted of two parts, including questions on: 1) conventional background 
characteristics (i.e. age, gender, and level of education) and 2) infertility-related 
variables (i.e. source of infertility (primary/secondary), having a living child (yes/
no), duration of infertility (months), and last treatment phase). Additionally, 
participants were asked to provide their email address for receiving a monthly 
newsletter. To assess the use of the tool, the number of unique visitors, registered 
participants, and visits were recorded. Members of the project were excluded from 
participation. Data were automatically generated on the website and collected. 
Usability of the tool
For assessing the usability of the tool, we used the validated ten-item System 
Usability Scale (SUS), which has a high level of face validity for measuring 
usability of software or information technology [27]. With this SUS all registered 
participants of the specialized online participatory tool were asked to score 
10 usability statements on a five-point Likert scale. The statements covered a 
variety of aspects of system usability (such as the need for support, training, and 
complexity) measured with scores from 0 to 100. The target SUS score was >70, 
representing ‘good’ usability [30]. The link to this survey was included in the 
monthly newsletters, which are sent to all registered participants who provided 
their email address as willing participants in the evaluation of the tool.
Representativeness of users
To assess the representativeness of the registered participants, their background 
characteristics were compared to the characteristics of a valid representative 
Dutch hospital cohort of female infertile patients [31]. The sample size of this 
hospital population was calculated at 170 by applying the formula on a precise 
estimate of a proportion: N=(p*(1–p) *Z2 a/2)/d2, using an estimated proportion of 
p=0.5, a proportion of error of d=0.075, and a degree of confidence of Z2a/2=1.96. 
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Considering the possibility of missing data, the N was enlarged to 200 patients. 
Based on the results of the cohort study of Brandes and colleagues, the hospital 
group was distributed between patients in an IVF clinic and a satellite clinic into 
a 2:3 ratio [31]. Accordingly, we used background characteristics of 80 patients 
visiting the regional IVF clinic and 120 female infertile patients visiting the regional 
satellite clinic. Both clinics were based in the east region of the Netherlands. 
Data of the hospital group were collected from patients’ electronic and written 
health records. Patients’ education level was derived from their occupations, 
since education level was not registered. If their occupation did not refer to the 
education level directly, data were recorded as missing.
Benefits of the tool
Recommendations
To collect data on newly developed and modified recommendations, the following 
aspects were automatically generated on and collected from the website: (1) 
the total number of unique patients’ recommendations, (2) the total number of 
modifications to these recommendations, (3) the total number of prioritizations on 
these recommendations, (4) the change over time of the top five recommendations 
and (5) total number of performed prioritizations. Next, we collected all final 
top 3 or top 5 rankings per care phase and compared them with the initial 21 
recommendations used to populate the tool at the start of the project. Additionally, 
we identified differences in the top fives of recommendations per care phase over 
time.
Data analysis
All data collected from the website (participants’ background characteristics, 
number of new and modified recommendations, number of prioritizations) and 
scores on the items of the SUS were descriptively analysed using SPSS 16.0. 
For calculating the SUS score, we firstly summed the score contributions of each 
item (0–4). For items 1, 3, 5, 7, and 9, the score contribution was calculated as the 
scale position minus 1. For items 2, 4, 6, 8, and 10, the contribution is 5 minus the 
scale position. Finally, the sum of the scores was multiplied by 2.5 to obtain the 
overall value of System Usability ranging from 0–100 [27–30]. For comparisons 
between users’ characteristics and the characteristics of the representative Dutch 
hospital population, we statistically analysed the data using the unpaired t-test (i.e. 
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age, infertility duration, and total treatment duration) and the chi-square test (i.e. 
education level, primary/secondary infertility, childless, and type of treatment). 
All reported P values were two sided, with P<0.05 considered to be significant. 
Results
Use of the tool
Actual Use
In 12 months, the specialized online participatory tool welcomed 3028 unique 
Dutch visitors. Of these visitors, 95 visitors completed a registry form. Of the 
registered participants, eight participated in the project and were therefore 
excluded. The remaining 87 registered participants included 12 men and 75 
women. Those 3028 visitors viewed 11.658 pages and 649 (21%) of them visited 
the tool more than once. Visitors viewed on average 3.28 pages per visit. Overall, 
visitors spent a mean time of 2 minutes and 26 seconds on the tool, new visitors 
1 minute and 36 seconds, and recurrent visitors 5 minutes and 36 seconds per 
visit. Of all visitors, 23% visited the tool directly. Other landing pages included the 
website of the previous basic wiki tool (50%), Google (13%), Twitter (13%), and 
other (1%).
Usability of the tool
Of the 87 registered participants, 45 (52%) indicated on the registry form that they 
were willing to participate in the SUS evaluation of the tool. Of these 45 potential 
participants for the evaluation that received the link to the questionnaire by email, 
39 (87%) performed the SUS evaluation of the tool. The median overall score was 
82.5, ranging from 70 to 90, corresponding with good usability for the tool.
Representativeness of users
Female active registered participants (n=75) of the specialized online participatory 
tool were representative regarding their age (P=0.39), type of infertility (i.e. 
primary/secondary) (P=0.31), and percentage of childlessness (P=0.71) compared 
to a valid hospital group. They had a significantly longer duration of infertility and 
treatment period, were within a more advanced treatment phase, and were more 
highly educated than the hospital group (Table 1).
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Table 1: Characteristics of registered female participants of the specialized online participatory tool
Characteristics Participants (n=75) Hospital cohort (n=200)
Median [Range] or (%) Median [Range] or (%) P 
value
Age (years)
<25
25–35
>35
Missing
34 [19–51]
4   (6%)
45 (62%
23 (32%)
3
32 [21–43]
10   (5%)
142 (71%)
48   (24%)
0
0.06a
0.39a
Education levelb
Low
Middle
High
Missing
1   (1.5%)
14 (21%)
52 (77.5%)
8
37 (20%)
58 (32%)
90 (48%)
15
<0.01c
Type of infertilityd
Primary
Secondary
Missing
39 (54%)
33 (46%)
3
122 (61%)
78   (39%)
0
0.31c
Childless
Yes
No
Missing
41 (69.5%)
18 (30.5%)
16
144 (72%)
56  (28%)
0
0.71c
Duration of infertility (months)e
0–2 years
2–4 years
>4 years
Missing
38 [12–228]
4   (8 %)
26 (51%)
21 (41%)
24
24 [1–116]
98 (49%)
72 (36%)
30 (15%)
0
<0.01a
<0.01c
Total duration under treatment (months) 24 [0–144] 6 [0–58] <0.01a
Treatment phase
Initial examination
OI/IUI
IVF/ICSI
Pregnant
After/No treatment
Missing
6   (12%)
7   (15%)
19 (40%)
4   (8%)
12 (25%)
27
50 (25%)
86 (43%)
50 (25%)
4   (2%)
10 (5%)
0
<0.01c
a Independent t-test
b  Low: primary or lower vocational education; Middle: secondary or intermediate vocational education;  
High: higher professional education or university
c Chi-square test
d Type of infertility was determined
e  Duration of infertility defined as the period between the start of regular unprotected sexual intercourse and 
date filled out the registry form
Benefits of the tool
Recommendations
In 12 months, 50 new recommendations were generated within the different 
care phases (Table 2). Of these new recommendations, 37 (74%) were generated 
within the gynaecologic section of the tool. Of the 21 initial recommendations, 
3 were modified and the other 18 initial recommendations remained unaffected. 
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Table 2: Recommendations and their ratings
Care phase Recommendations (n) Total ratings (n)a
General care
Total
newly generated
modified
unaffected
6
3
2
1
45
General Practice care
Total
newly generated
modified
unaffected
7
2
1
4
40
Gynaecologic care
Total
newly generated
modified
unaffected
42
37
-
5
479
Urologic care
Total
newly generated
modified
unaffected
5
-
-
-
6
Laboratory
Total
newly generated
modified
unaffected
4
1
-
3
19
Psychologic care
Total
newly generated
modified
unaffected
3
3
-
-
40
Occupational Physician’s care
Total
newly generated
modified
unaffected
3
3
-
-
17
Remaining care
Total
newly generated
modified
unaffected
1
1
-
-
2
a Total number of ratings within 12 months on the specialized online participatory tool
The total number of modifications in all recommendations (n=71) was 37 (Table 
2). Modifications mainly concerned the elimination of grammatical errors or 
making the recommendation more specific. Regarding the prioritizations, 71 
recommendations were ranked with stars 642 times, of which 479 rankings were 
awarded within the gynaecologic section (Table 2). Regarding the comparison of 
the top five rankings between the start and the end of the project, the top five of the 
gynaecologic section had changed the most and consisted of completely different 
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recommendations. The top fives of recommendations within the laboratory and 
urologic care sections remained unaltered. Table 3 provides an overview of the two 
main recommendations per care phase.
Table 3: Main recommendations per treatment phase
Care phase Main patients’ recommendations
General care -  I want the Dutch government to educate and explain to the broader 
public what the law entails regarding artificial donor insemination.
-  I want the Dutch government to reimburse fertility treatments in all 
cases.
General practitioner’s care - I want my GP to provide a clear transferral to the gynaecologist.
-  I want my GP to take the information given to her/him seriously and 
consider this in determining the time of referral.
Gynaecologic care -  I want my gynaecologist to schedule an appointment within 15 days 
after a failed IUI/IVF/ICSI attempt to discuss the treatment plan.
-  I want my gynaecologist to provide me during my first appointment 
with a general brochure explaining how I can increase the chance of 
pregnancy.
Urologic care - I want my urologist to engage my partner in the conversation.
-  I want my urologist to enable patients to make an appointment in the 
first month after referral.
Laboratory -  I want the laboratory’s staff to inform patients as soon as possible when 
embryos are not dividing.
-  I want the laboratory’s staff to inform patients of how many embryos 
developed the day before the embryo transfer instead of by the time of 
the embryo transfer.
Psychologic care -  I want the healthcare system to enable quick and adequate care in case 
of problems due to unwanted childlessness.
-  I want my psychologist or sexologist to be present during the first intake 
as a standard operating procedure.
Occupational Physicians’ 
care
-  I want the occupational physician to educate employers and provide 
tools for employees receiving fertility treatments.
-  I want employers to give every patient the opportunity to have fertility 
treatments during working hours.
Remaining care -  I want the insurance company to offer patients the opportunity to insure 
for a fourth IVF/ICSI attempt if the third attempt has not resulted in a 
pregnancy.
GP=General practitioner
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Discussion
This study shows that a specialized online participatory tool enables patient 
partnership in CPG development in the case of Dutch infertile patients. The 
tool enabled a broad and representative target group that participated in the 
clinical guideline development process by delivering a clear and prioritized set of 
recommendations that meet the statements of the GLIA instrument. Furthermore, 
according to the relatively high SUS scores, participants qualified the tool as 
highly usable. We expect that this specialized online participatory tool has generic 
characteristics and could be adapted to every healthcare setting.
Our original wiki-inspired tool was developed and based on the results of a previous 
evaluation study, as well as custom fit to clinical guideline development in general 
and to the partners in the clinical guideline development process, particularly 
the patients [20]. Thus far, with the exception of our previous pilot study, this is 
the first study that presents a feasible tool for facilitating patient partnerships in 
clinical guideline development by enabling a collaborative of patients to actively 
participate by delivering prioritized high-quality recommendations for Dutch 
clinical guidelines on infertility.
Both research on wiki-inspired tools and on other online tools to facilitate patient 
partnership still mainly focus on (guideline-derived) quality products, such as 
information leaflets and shared decision-making tools [5–10, 21].
With respect to the engagement of patients in the guideline development process, 
the use of other instruments such as focus groups or individual interviews has 
been described previously [11–19,32]. However, apart from the usability of these 
instruments in previous stages of the clinical guideline development process (i.e. 
shaping the key questions, defining/selecting related outcome measurements, 
and considerations), the actual usability of these kinds of instruments in the 
formulation of recommendations can be debated. Firstly, the outcomes of these 
interviews cannot be translated into clear recommendations directly. Secondly, 
members of the guideline development groups are challenged to transform patients’ 
input into recommendations that correspond to patients’ views. Furthermore, the 
tool presented in this study engages far more patients compared to the restricted 
number of patients involved in interviews or focus groups, which can also be time 
consuming, laborious, and bias sensitive.
These barriers may also apply when patients’ representatives participate in the 
guideline development group. These patients need to represent all patients who 
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the guideline is focussed on. Our specialized online participatory tool could form 
an excellent aid to represent the views of a broad group of patients and to take 
a stronger position in the guideline development group for involved patients’ 
representatives. Another strength of this tool is that moderating and prioritizing 
recommendations is continuously performed by patients themselves, which could 
minimalize efforts. We especially believe that our participatory tool is highly 
usable in guideline topics for which the body of evidence is rapidly growing and 
needs a nearly continuous update process.
Nevertheless, some limitations to this study should be mentioned. Firstly, we 
acknowledge that the level of participation (i.e. 95 of the 3028 visitors) is low, 
as is the willingness to fill out a usability questionnaire (i.e. 45 of the 95). The 
fact that registration was mandatory for using the tool and the introduction of 
a new tool could have played a significant role herein. Secondly, we conclude 
that registered female participants of this study are representative for the Dutch 
infertile population regarding important patients’ characteristics, but we must 
acknowledge that participants still represent a specific subgroup that is in a more 
advanced treatment phase, have a longer duration of infertility, and are more 
highly educated. One might argue whether patients who are starting an infertility 
care pathway can shape specific recommendations for high-quality fertility care 
since they are unable to predict the forthcoming steps of their care pathway. This 
inability could explain the fact that registered participants form specific subgroups 
regarding the high duration of treatment and the more advanced treatment phase 
they are in. Moreover, the authors acknowledge challenges in the generalizability 
of the tool to other healthcare fields and in international settings. The level of 
uptake of this tool by health policy organizations might play a crucial role therein. 
This could motivate professional associations and clinical guideline development 
organizations to implement it in the guideline development process. Support 
from patients’ associations by increasing their role in guideline development is 
recommended. Furthermore, it is assumed that the implementation of the tool in 
guideline development practice and using patients’ recommendations directly in 
the guideline can lead to a variety of discussions on financial and political levels 
(i.e. these might be contradictory to professionals’ recommendations). Therefore, 
clear arrangements on this point should be made. Finally, as with all other forms 
of patient involvement in clinical guideline development, concrete evidence of the 
impact of patient involvement on the quality of care is still lacking.
Our tool might be implementable in healthcare settings other than infertility, but 
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it requires uptake in clinical guideline development programs by health policy 
organizations, which would thus motivate allied stakeholders. Furthermore, clear 
guidelines on how to use this tool in practice need to be set.
In conclusion, using a specialized online participatory tool is a feasible method of 
involving a broad group of representative infertile patients in CPG development. 
This study adds to current knowledge using online tools to facilitate patient 
partnership in clinical guideline development. This paper can be used as a 
practical guide for policy organizations, guideline developers, and patients’ 
organizations that are interested in interventions to facilitate patient partnership 
in clinical guideline development in any healthcare setting. Furthermore, using 
the tool for facilitating patient partnership in other components of the clinical 
guideline development process – such as defining the scope of a guideline, defining 
important outcome measurements for patients herein, and prioritizing guideline 
topics by patients – could broaden the value of the tool in the future.
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Abstract
Study question: What value can patients add to the development of guideline-
based quality indicators for patient-centredness in fertility care?
Summary answer: Infertile patients mainly select different indicators and value 
different dimensions of patient-centredness (e.g. information and communication 
and access to care) than professionals (e.g. coordination and integration of care) 
during an indicator development process. 
What is known already: Patient-centredness is an important dimension for the 
quality of fertility care. However, this dimension is not adequately evaluated by 
professionals, due to a lack of quality indicators. Furthermore, it is suggested that 
patients select different indicators for patient-centredness than professionals, 
although exact differences are unknown. 
Study design, size and duration: The RAND-modified Delphi method (a two-
step systematic consensus method) was used to develop two sets of quality 
indicators for patient-centredness. Similarities and differences in the indicators as 
well as in aspects of patient-centredness between patients’ and professionals’ sets 
of indicators were analysed descriptively.
Participants, setting, methods: The development of quality indicators for patient-
centredness was based on the national multidisciplinary Network Guideline 
on infertility. Two panels participated: One patients’ panel (n=19) and one 
multidisciplinary professionals’ panel (n=15).
Main results and the role of chance: From 119 formulated potential indicators of 
patient-centredness, the patients’ panel selected a representative set of 16, while 
the professionals’ panel selected 18. Five indicators were included in both sets. 
These regarded the need to: perform IUI at least 6 days a week; report on treatment 
outcomes and complications; report on results of semen analyses in a standardized 
way; counsel infertile couples about the positive effects on their chance of 
pregnancy of the elimination of a harmful lifestyle and provide information on 
the negative consequences for achieving a pregnancy in case of a high BMI. Both 
patients and professionals put highest value on potential indicators of information 
and communication in fertility care. Patients also emphasized accessibility of care, 
whereas professionals emphasized coordination and integration as important 
quality measures for patient-centredness in fertility care.
Limitations, reasons for caution: First, the total number of developed indicators 
in the final set is relatively large (n=29), which could be a first potential limitation in 
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its use for accreditation and quality monitoring. Second, although panel members 
were asked to take reliability into account during the selection procedure, the 
indicators still need an evaluation of the measurability and the intra- and inter-
observer reliability.
Wider implications of the findings: The final guideline-based indicator set 
consisting of 29 indicators represents a balanced set that is based on the expertise 
of all stakeholders, including patients. A next step should be the application of this 
set in a future practice test to assess the feasibility in daily practice. In our opinion, 
most quality indicators for patient-centredness could be used for monitoring and 
improving the quality of fertility care internationally, occasionally by a more broad 
interpretation (e.g. by replacing the general practitioners with other healthcare 
professionals engaged in the care process).
Study funding/competing interest(s): This study was supported by a research 
grant (number 150020015) from the Dutch Organisation for Health Research and 
Development (ZonMw) in a research programme on broadening and acceleration 
in multidisciplinary guideline development. The authors have no conflicts of 
interest to declare.
Key words: infertility, monitoring healthcare, quality indicator, quality of care, 
patient-centredness.
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Introduction 
The quality of fertility care is usually monitored by outcome measurements such 
as live birth rates [1]. However, high quality fertility care comprises more than 
just the effectiveness of care. Regardless of medical-technical quality, patient-
centredness described as ‘providing care that is respectful of and responsive to 
individual patient preferences, needs, and values and ensuring that patients’ 
values guide all clinical decisions’ also determines the quality of fertility care 
[2]. The multidimensional concept of patient-centredness comprises various 
aspects, such as the coordination and integration of care as well as the provision 
of emotional support [3, 4]. Recent reports have confirmed that infertile patients 
long for patient-centred care and that improvements in several dimensions of 
patient-centred fertility care could play a crucial role in deciding to drop out from 
fertility treatments [3-8]. Moreover, patient-centred fertility care is associated 
with increased patient satisfaction [6,9]. Regrettably, professionals are unable to 
adequately evaluate their performance regarding patient-centredness [10]. This 
hampers the direct quality improvement regarding patient-centredness. It also 
illustrates the need for measurable elements of practice performance derived from 
evidence-based guidelines regarding this quality of care dimension [11-13].
So far, several studies have reported on the development of guideline-based 
indicators within the field of fertility care [14-16]. However, in these studies a 
particular focus on patient-centredness in fertility care is lacking. This could be 
because the involvement of patients in the guideline and indicator development 
process is still not common practice [17,18].  The development of guideline-based 
indicators for patient-centredness has only been reported within the field of cancer 
care [19, 20]. Although patients played a minor role in these indicator development 
panels, the results suggest that including patients will lead to the identification 
of aspects of patient-centredness that may not have been considered previously. 
However, in these studies the exact difference in choice of indicators between 
professionals and patients regarding patient-centredness remains unknown. 
Therefore, as a first step in improving and monitoring patient-centredness 
in fertility care, our aim was to get insight into what patients could add to the 
indicator development by developing two sets of guideline-based quality indicators 
for patient-centredness: one from the patients’ and one from the professionals’ 
perspective, and comparing the content of these two sets.
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Materials and Methods 
Setting
In this study, the development of quality indicators for patient-centredness was 
based on a recently developed national multidisciplinary Network Guideline 
(NG) on infertility (www.nvog.nl). The guideline’s cornerstones consisted of a 
multidisciplinary approach to ensure proper alignment and special attention to 
patient-centredness of care. For this purpose, this NG was initially based on infertile 
patients’ clinical pathways and consisted of separate sections subject to different 
phases of care (e.g. care provided by General Practitioners (GPs), gynaecologists, 
urologists, psychologists and after-care). Next, apart from the involvement of 
patients’ representatives in the guideline development group, a large group of 
infertile patients was involved in the development process. They contributed to 
this process through their input in the formulation of key questions and through 
directly formulating and prioritizing recommendations on a wiki-based website 
[21]. Finally, the prioritized patients’ recommendations were literally integrated 
into the final guideline and provided with a level P (Patients) evidence.
Dutch Fertility care
Overall, the Dutch fertility care has been publically arranged on three levels. Primary 
care is provided by GPs and may comprise a part of an initial fertility assessment. 
Subsequently, a GP can refer couples to a gynaecologist in a general (secondary care) 
or a university (tertiary care) hospital, who could then complete this initial fertility 
assessment, determine a cause of infertility and define a suitable treatment plan. If a 
severe male factor is diagnosed, couples can be referred to a urologist. Nurses, clinical 
biochemists and embryologists are also involved in assessments and preparations 
for Medically Assisted Reproductive (MAR)-techniques, for instance IVF. In the 
Netherlands, IVF is carried out in 13 licensed clinics: 8 university hospitals, 4 general 
hospitals, and 1 private clinic. In clinics without an IVF-license (e.g. satellite clinics), 
professionals have the possibility to start up and monitor ovarian stimulation, 
but they have to refer to a licensed clinic for the retrieval of oocytes and embryo 
transfers. Additionally, in transport clinics, the ovarian stimulation and retrieval of 
oocytes can be performed initially, but retrieved oocytes have to be transported to 
the central IVF laboratory of a licensed clinic. Since infertility has a high emotional 
and psychological impact, which may also interfere with people’s jobs, psychologists 
and occupational physicians are regularly involved in the clinical pathway. 
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Indicator development
The RAND-modified Delphi method (a two-round systematic consensus method 
using expert panels) was used to develop two sets (i.e. one from the patients’ 
and one from the professionals’ perspective) of quality indicators for patient-
centredness [22]. The indicator development process comprised three consecutive 
steps: (1) extraction and classification of NGs’ key recommendations; (2) written 
questionnaire survey and (3) consensus round by email.
Participants
One patients’ panel and one multidisciplinary professionals’ panel were formed in 
order to develop two sets of quality indicators for patient-centredness of fertility 
care. For the patient panel, infertile patients were recruited through a call for 
participation at ‘Freyawiki’ (the tool used for patient involvement in the NG), 
social media channels and mailings from Freya, the Dutch Patients’ Association 
for infertility. Eligibility criteria included (previous) homologous treatment 
with MAR-techniques. Furthermore, two executives of Freya, involved in the 
development of the NG, were added to the patient panel. 
Professionals were recruited by a letter signed by the coordinator (EB), the project 
leader (JK) and the implementation and performance measurements expert (RH) 
of the NG. In this letter, professional societies were asked to officially nominate 
professionals experienced in fertility care as well as in performance monitoring. 
The societies of gynaecologists, urologists and GPs were asked to nominate 
three professionals. For the participation of clinical embryologists, occupational 
physicians, clinical psychologists, and clinical biochemists, each particular 
professional society was asked to nominate two professionals. The intended 
number of participants for inclusion in both panels was 15-17 participants. This 
was based on previously published studies describing the number of participants 
in multidisciplinary expert panels [22, 23]. The rough balance between different 
stakeholders was chosen in proportion to the extent of their key role in fertility 
care. 
Step 1: extraction and classification of NGs’ recommendations
First, all listed recommendations were extracted from the NG (E.B.). Next, the 
extracted recommendations were classified into two quality domains (i.e. medical-
technical and patient-centredness of care) by three researchers independently 
(E.B., W.N. and R.H). The inclusion criteria for the patient-centredness domain 
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were recommendations concerning the 10 dimensions of patient-centredness in 
fertility care according to Dancet et al. (2010) or recommendations provided by a 
level P [3]. Discrepancies in this division of recommendations were easily solved 
through discussion. Furthermore, all recommendations regarding the medical-
technical quality of care were excluded, since these were not a subject of research 
of this study. Lastly, in the final set of indicators a balance was needed between 
organizational indicators (i.e. coordination and integration of care; physical 
comfort; transition and continuity of care; access to care; staffs’ competence and 
technical skills) and non-organizational indicators (i.e. respect for patients’ values, 
preferences and needs; information, communication and education; emotional 
support; partner involvement; attitude fertility clinic staff) for patient-centredness 
in fertility care. To achieve this, the extracted recommendations were subdivided 
as described. Level P recommendations, directly formulated by patients through 
‘Wikifreya’, represent par excellence patients’ personal needs and are therefore 
classified as non-organizational indicators [21].
Discrepancies in this division of recommendations were again resolved through 
discussion. Next, all recommendations for patient-centredness (organizational 
and non-organizational aspects) were formulated into potential indicators (E.B.) 
and checked and eventually adjusted independently by a second researcher (R.H.). 
After reaching consensus on their formulation, the potential indicators were 
included in a written questionnaire and formulated as follows: ‘The healthcare 
provider (e.g. gynaecologist, urologist) should…’ or ‘Patients would like to…’.
Step 2: written questionnaire round
The written questionnaire was sent to the members of both panels by post. The first 
part of the questionnaire comprised questions about background characteristics 
(e.g. age, sex). Secondly, panel members were asked to rate the relevance of all 
potential indicators for patient-centredness on a nine-point Likert-scale ranging 
from 1 (=completely irrelevant) to 9 (=extremely relevant), with respect to their 
usefulness as a measure for the quality of patient-centredness in fertility care [11]. 
Both categories (i.e. organizational and non-organizational) of indicators for 
patient-centredness were presented separately and according to the structure of 
the NG following infertile patients’ clinical pathways (e.g. general care by GPs, 
fertility assessments and treatment by GPs, gynaecologists and urologists as well 
as aftercare). All potential indicators within the professionals’ questionnaire were 
supplemented with levels of evidence to facilitate decision-making. The evidence 
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underlying the recommendations was classified into five levels: I, systematic 
review/Randomized Controlled Trials (RCT); II, RCT; III, comparative studies; IV, 
case studies or expert opinion and level P, patients’ opinion [24]. In collaboration 
with Freya, the patients’ questionnaire was supplemented with additional laymen’s 
information to clarify the jargon used. Thirdly, for the organizational as well as 
the non-organizational potential indicators, all panel members were asked to 
give a top five ranking to promote the discrimination between indicators with a 
high Likert score [16, 25]. Finally, all panel members were invited to rephrase the 
proposed indicators and to add comments. Reminders were sent by email to non-
responders after 2 and 4 weeks.
Data analysis: step 2
Campbell’s criteria and the top five ranking method were used to analyse the results 
of the questionnaire surveys of step 2 [26]. Therefore, per potential indicator, we 
calculated an overall panel median score and an overall ranking score for each 
panel. To calculate the overall ranking score, a potential indicator ranked first, 
second, third, fourth or last in the top five received 5,4,3,2 or 1 point respectively. 
The overall ranking score was expressed as the percentage of the maximum top 
five score that could be obtained (0-100%). A potential indicator was associated 
with face validity and proposed for ‘selection’ in this consensus round if it matched 
the following criteria: (i) an overall panel median score of 8 or 9 combined with a 
top five ranking ≥10th percentile of the percentage of the maximum top five score 
and (ii) an agreement between the ratings of the independent panel members. The 
agreement was reached if 70% or more of ratings within a panel was in the highest 
tertile (7, 8, 9). A potential indicator was ‘rejected’ if none of these criteria were 
met. A potential indicator was considered ‘equivocal’ or open to discussion if it 
matched an overall panel median score of 8 or 9 with agreement, but with low or 
no top five ranking score.
Step 3: consensus round
After rephrasing, the organizational and non-organizational ‘selected’ and 
‘equivocal’ indicators were presented separately in a second questionnaire intended 
for all panel members for commented written approval. In this questionnaire, 
the ‘selected’ and ‘equivocal’ indicators were presented along with the comments 
provided by the particular panel (e.g. patients and professionals), the frequency 
distribution of scores within the panel, the overall median score of the panel as 
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well as the individual panellists’ score for each particular indicator. Both panels, 
including the non-responders of step 2, were asked for their approval (yes or no) of 
the ‘selected’ indicators and to indicate which ‘equivocal’ indicators, if any, should 
be part of the final set of indicators as well. The questionnaire was sent by email. 
Reminders were sent by email to non-responders after 2 and 4 weeks.
Defining final sets of indicators (data analysis step 3)
To gain patients’ and professionals’ final sets of indicators, the approved initially 
‘selected’ indicators were supplemented with the accepted ‘equivocal’ indicators 
(i.e. consensus round) and rephrased or merged at the request of the panel 
members. An ‘equivocal’ indicator was accepted if >50% of the panellists were in 
favour.
Comparison of the two final sets of indicators
The selected quality indicators for patient-centredness from the patients’ and 
the professionals’ perspective were compared and checked for corresponding 
indicators. Furthermore, individual indicators of both sets were descriptively 
analysed by the frequency distribution of the 10 dimensions of patient-centredness 
for fertility care according to Dancet et al. (2010): coordination and integration 
of care; physical comfort; transition and continuity of care; access to care; 
competence and technical skills of staff; respect for patients’ values, preferences 
and needs; information, communication and education; emotional support; 
partner involvement; attitude of the fertility clinic staff [3].
Main outcome measures
Primary outcome measures were two final sets of quality indicators for patient-
centredness, i.e. one from the patients’ and one from the professionals’ perspective. 
Secondary outcome measures were the differences in the distribution over the 10 
dimensions of patient-centredness between the two sets of quality indicators.
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Results
Participants
The patient panel included 19 infertile patients. The professional panel included 15 
professionals nominated from different specialities: 3 gynaecologists, 3 urologists, 
2 GPs, 2 clinical biochemists, 2 occupational physicians, 2 clinical psychologists, 
and 1 clinical embryologist. The society of GPs as well as the society of clinical 
embryologists mandated two and one professionals respectively, instead of the 
requested three and two professionals. Eight professionals (53%) were previously 
involved in the development of the NG on infertility. 
Indicator development
Step 1: extraction and classification of NGs’ recommendations
The NG on infertility contained 201 evidence-based or consensus-based 
recommendations for optimal quality of fertility care. The recommendations 
were classified into 81 medical-technical and 120 recommendations for patient-
centredness. All 81 recommendations regarding the medical-technical quality of 
fertility care were discarded (Figure I). By formulating the 120 recommendations 
into potential indicators for patient-centredness, two recommendations, both 
regarding the indications for referral to a social worker, were merged into 
one potential indicator. Of these 119 potential quality indicators for patient-
centredness, 58 indicators concerned organizational aspects: 12 supported by 
levels I, II or III and 46 by a level IV of evidence. Sixty-one potential indicators 
concerned non-organizational aspects, of which 23 were supported by levels I, II 
or III, 14 by a level IV of evidence and 24 by a level P. 
Step 2: written questionnaire round
From the patient panel 12 out of 19 (63%) and from the professional panel 14 out 
of 15 (93%) of the questionnaires were returned. Of the responding all female 
patients, 75% (n=9) suffered from secondary infertility, and had a median age of 
37 years (range 28-39). Of these women, 67% (n=8) were highly educated. The 
median duration of infertility was 49 months (range 30-77). Most respondents 
(92%) received treatment (n=3) or had been treated (n=8) with MAR-techniques. 
Reasons for drop out included: time restraints (2), emotional distress during 
infertility treatment at the time (3), having difficulty to assess the indicators (1) 
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Figure 1: Development process of quality indicators for patient-centredness in fertility care
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and unknown (1). Most of the professionals (79%, n=11) were attached to general 
or academic teaching hospitals and 57% (n=8) of them were male. 
Th e patients rated 15 of the 119 potential indicators face valid, including seven 
organizational and eight non-organizational aspects of care. Fift y potential 
indicators were rated ‘equivocal’ and 54 potential indicators were rejected. 
Th e professionals rated 13 of the 119 potential indicators face valid, i.e. fi ve 
organizational and eight non-organizational aspects of care. Of the remaining 
potential indicators, 20 were considered ‘equivocal’ and 86 were rejected.
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The members of the patient panel proposed to merge four organizational 
indicators regarding the provision of annual reports on treatment outcomes and 
complications of different MAR-techniques for registration as well as to merge two 
indicators on staff ’s composition of transport and satellite clinics. The members of 
the professional panel proposed to rephrase 12 non-organizational indicators by 
merging 3 indicators on partner involvement by the gynaecologist, urologist and 
GP and by merging 3 sets of 3 indicators on the information provision regarding 
the influence of obesity, smoking cessation and alcohol use on fertility respectively.
All these suggestions for rephrasing the indicators were adopted for the patients as 
well as the professionals. Accordingly, patients’ ‘equivocal’ indicators were reduced 
with 12 indicators. Professionals’ ‘selected’ and ‘equivocal’ indicators were reduced 
with two and six indicators, respectively, and one ‘selected’ indicator was merged 
with two rejected indicators. 
Step 3: consensus round
From the patient panel 10 out of 19 (53%) and from the professional panel nine 
out of 15 (60%) of the second questionnaires were returned. All responding 
patients and professionals gave their approval for the rephrased selected set of 
15 and 11 indicators resulting from step I, respectively. Among the 38 rephrased 
patients’ ‘equivocal’ indicators, only one non-organizational indicator was selected 
by more than 50% of the panel. Among the 14 rephrased ‘equivocal’ indicators 
(i.e. eight organizational and six non-organizational) of the professionals, yet four 
organizational and three non-organizational indicators were selected by more 
than 50% of the panel. 
Final sets of indicators for patient-centredness
The patients’ final set consisted of 16 key indicators, including 7 organizational 
and nine non-organizational indicators (Table 1). All were supported by a level 
IV-evidence or a level P (Patients). 
The professionals’ final set consisted of 18 key indicators, including nine 
organizational and nine non-organizational indicators (Table 2). All professionals’ 
key indicators were supported by a level III- or IV-evidence. 
Breejen, Elvira de.indd   128 15-02-17   14:57
6(Guideline-based) indicators for patient-centredness
129
Table 1: Patients’ final set of quality indicators for patient-centredness
Patients’ final set of 16 quality indicators for  
patient-centredness (PC) 
Sub-dimension 
of PC
Dimension of 
PC
Composition of the infertility treatment team in licensed IVF-
clinics as well as transport- or satellite clinics should be according 
to the NVOG quality norm ‘IVF’
Quality 
management 
Staffs’ 
competence and 
technical skills
Fertility clinics (licensed and non-licensed) should have the 
possibility to perform IUI at least 6 days a weeka
Accessibility 
outside traditional 
working hours
Access to care
In accordance with the Dutch IVF planning decree, every licensed 
IVF centre and their corresponding transport and satellite 
centres must provide annual reports on treatment outcomes and 
complications (OI, IUI, IVF) for uniform national IVF registration 
(NVOG)a
Quality 
management 
Staffs’ 
competence and 
technical skills
The gynaecologist should: complete or perform the initial fertility 
assessment, give information on possible causes of infertility, 
consult a urologist in case of urological problems and start 
treatment if it enhances pregnancy-probabilities (demarcation of 
first, second and third line’s professionals ‘roles)
Role demarcation Coordination 
and integration 
of care
The gynaecologist should preferably accommodate daily 
monitoring in ovulation induction cycles in order to assess the 
individual response as well as to reduce complication risks
Accessibility Access to care
The gynaecologist should keep up detailed correspondence with 
the GP regularly
Continuity in 
policy
Transition and 
continuity of care
Regarding the semen analysis, the laboratory officer should at 
least report on: the test-criteria used, the results including normal 
limits, the calculated total motile sperm count, the completeness 
of the sample, the time span between production and analysis and 
an overall conclusiona
Providing 
adjusted 
professional 
information
Transition and 
continuity of care
Each fertility professional should counsel infertile couples about 
the potential positive effects of eliminating harmful lifestyle 
choices on pregnancy-chancesa
Information 
on helping 
themselves
Information, 
Communication 
& Education
Patients would like to have a consult with a gynaecologist within 
1 month after referral by a GP
Accessibility Access to care
Patients visiting a fertility clinic would like to have separate 
waiting rooms from pregnant women                         
Accommodation 
of clinic
Physical comfort
Patients would like to be able to visit a fertility clinic during 
daytime as well as in the evening.
Accessibility 
outside traditional 
working hours
Access to care
Patients would like to have the possibility of receiving treatments 
on weekends
Accessibility Access to care
Regarding infertility treatment, patients would like to see all 
members of the infertility treatment team following the same 
policy
Continuity in 
policy
Transition and 
continuity of care
With respect to the IVF laboratory phase, patients would like to 
be informed in case their embryos do not divide any further as 
soon as possible
Sufficiency of 
information
Information, 
Communication 
and Education
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Patients’ final set of 16 quality indicators for  
patient-centredness (PC) 
Sub-dimension 
of PC
Dimension of 
PC
Patients would like their gynaecologist to provide them with 
information on all possible infertility treatments
Information on 
alternatives
Information, 
Communication 
and Education
Each fertility professional should inform infertile couples on 
the negative influences and consequences of a high BMI (>29) 
regarding pregnancy-chances and if anovulatory, that losing 
weight increases the pregnancy-chancesa
Information 
on helping 
themselves
Information, 
Communication 
and Education 
IVF, in vitro fertilization; OI, ovulation induction; IUI, intrauterine insemination; GP, General Practitioner; 
NVOG, Dutch society of Obstetrics and Gynaecology.
a Similar indicators in patients’ and professionals’ final set.
Table 2: Professionals’ final set of quality indicators for patient-centredness
Professionals’ final set of 18 quality indicators for  
patient-centredness (PC) 
Sub-dimension 
of PC
Dimension of 
PC
In accordance with the Dutch IVF planning decree, every 
licensed IVF centre and their corresponding transport and 
satellite clinics must provide annual reports on treatment 
outcomes and complications (OI, IUI, IVF) for uniform national 
IVF registration (NVOG)a
Quality 
management
Staffs’ 
competence and 
technical skills
The GP should conduct an initial fertility assessment comprising 
a semen analysis in men and screening for Chlamydia 
trachomatis and when in doubt of an ovulatory cycle a single 
basal body temperature chart in women
Role demarcation Coordination 
and integration 
of care
The GP should perform a semen analysis in an accredited 
laboratory (ISO 15189) or in a referral hospital
Quality 
management
Staffs’ 
competence and 
technical skills
The GP should refer an infertile couple to a gynaecologist if there 
are indications for tubal pathology, such as a positive chlamydia 
antibody test and/or a medical history of (recurrent) abdominal 
infections or abdominal surgery
Transition of care Coordination 
and integration 
of care
Regarding the semen analysis, the laboratory officer should at 
least report on the test-criteria used, the results including normal 
limits, the total motile sperm count, the completeness of the 
sample, the time span between production and analysis and an 
overall conclusiona
Providing 
adjusted 
professional 
information
Transition and 
continuity of care
Fertility clinics (licensed and non-licensed) should at least have 
the possibility to perform IUI 6 days a weeka
Accessibility Access to care
The GP should immediately refer an infertile couple with 
ovulations abnormalities to a gynaecologist
Transition of care Coordination 
and integration 
of care
The gynaecologist should refer the infertile couple with sexual 
dysfunction, male genital abnormalities or azoospermia to a 
urologist
Transition of care Coordination 
and integration 
of care
The laboratory officer (and not the gynaecologist) should ask and 
report the time-span of production and the completeness of the 
semen sample by accepting it
Role demarcation Coordination 
and integration 
of care
Each fertility professional should counsel infertile couples about 
the potential positive effects of eliminating harmful lifestyle 
choices on pregnancy-chancesa
Information 
on helping 
themselves
Information, 
Communication 
and Education
Table 1: Continued
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Professionals’ final set of 18 quality indicators for  
patient-centredness (PC) 
Sub-dimension 
of PC
Dimension of 
PC
Both partners of the infertile couple should be involved in the 
assessment and management of infertility because it is a joint 
problem
Involving the 
partner
Partner 
involvement
The GP should provide a couple experiencing problems in 
conceiving, but with normal preliminary test results, with specific 
information on the fertile period
Information 
on helping 
themselves
Information, 
Communication 
and Education
The GP should offer infertile couples the opportunity to talk 
about their experiences and expectations throughout all phases 
of fertility care 
Provision of 
emotional support
Emotional 
support 
The gynaecologist should offer infertile couples moral and 
psychosocial support throughout all phases of fertility care.
Provision of 
emotional support
Emotional 
support 
With respect to adoption, all fertility professionals should give 
information on: the age limit of 41 years for both adoptive parents 
(as opposed to foster care, i.e. no age limit), lengthy waiting times 
(3-6 years), websites for additional information and make a 
comparison with foster care 
Concrete 
information 
Information, 
Communication 
and Education
Each fertility professional should inform infertile couples on 
the influences and consequences of a high BMI (>29) regarding 
pregnancy-chances and if anovulatory, that losing weight increases 
the pregnancy-chancesa
Information 
on helping 
themselves
Information, 
Communication 
and Education
Each fertility professional should inform infertile men who 
smoke, or use more than 20 glasses of alcohol per week, use drugs 
and or anabolic steroids on the negative influence of this lifestyle 
on the semen quality and fertility
Information 
on helping 
themselves
Information, 
Communication 
and Education
Each fertility professional should inform infertile females, who 
smoke and/or use alcohol on the negative influence on fertility 
as well as motivate them to preventively quit the smoking ore use 
of alcohol
Information 
on helping 
themselves
Information, 
Communication 
and Education
IVF, in vitro fertilization; OI, ovulation induction; IUI, intrauterine insemination; GP, General Practitioner; 
NVOG, Dutch Society of Obstetrics and Gynaecology
a Similar indicators in patients’ and professionals’ final set.
Comparison of the two final sets of indicators
Five indicators were included in both the patients’ and the professionals’ final 
sets. These concerned the need to: perform IUI at least 6 days a week; report on 
treatment outcomes and complications; report the results of a semen analysis in 
a standardized way; counsel infertile couples about positive effects on pregnancy 
chances regarding the elimination of a harmful lifestyle; provide information 
on the negative consequences for achieving a pregnancy in case of a high BMI. 
Both sets comprised a variety of dimensions of patient-centredness. Of the six 
included dimensions for patient-centredness in the patients’ final set of indicators 
(n=16), access to care (31%) and information and communication (25%) were 
Table 2: Continued
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valued mostly. Meanwhile, patients valued transition and continuity of care (19%), 
staff s’ competence and technical skills (13%), coordination and integration of care 
(6%) and physical comfort (6%). Among the professionals’ fi nal set of indicators 
(n=18), information and communication (33%) was one of the key dimensions 
of patient-centredness along with the dimension coordination and integration 
of care (27%). In addition to both these dimensions, professionals also valued 
staff s’ competence and technical skills (11%), transition and continuity of care 
(6%), access to care (6%) partner involvement (6%) and emotional support (11%). 
Overall, two dimensions of patient-centredness were absent from both sets: 
respect for patients’ values, preferences and needs as well as the attitude of the 
fertility clinic staff  (Figure 2, Table 1 and 2).
Figure 2: Indicators of patient-centredness in various dimensions as a percentage of the total number of 
indicators selected by patients (16 indicators) and professionals (18 indicators)
0
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10
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20
25
30
35
Patients (n=12)
Professionals (n=14)
Classifi cation according to the 10 dimensions of patient-centred fertility care as described by Dancet et al. 
(2011 a, b).
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Discussion 
This study shows that the quality indicator development process regarding patient-
centredness is affected by patient involvement. Only five indicators were included 
in both the patients’ and professionals’ final sets of indicators. Although both 
patients and professionals valued information and communication in fertility 
care most prominently, patients also emphasized the importance of access to care, 
whereas professionals emphasized the importance of coordination and integration 
of fertility care.
So far, within fertility care this is the first study that focuses on the development 
of guideline-based quality indicators for measuring and monitoring patient-
centredness. Moreover, this is the first study on separately developing indicators 
among patients as well as a multidisciplinary professional panel. Generic and 
specific guideline-based quality indicators for fertility care have been developed 
previously [14-16]. However, as these studies mainly focused on the medical-
technical quality of fertility care, indicators for patient-centredness were scant. 
Remarkably, since only gynaecologists were involved in the development 
process, instead of patients or other fertility care professionals, the selected 
indicators regarding patient-centredness of care mainly focused on information 
and communication. This is in line with the high percentage of indicators in the 
professionals’ set (33%) on information and communication in our study. Although 
indicators for patient-centredness have previously been developed in the field of 
cancer care, they were not exclusively guideline-based and patients played a minor 
role in the development panel [19, 20]. These studies resulted in largely merged 
indicators that also mainly focused on information and communication regarding 
generic patient-centred cancer care. In one of these studies, patients actually got 
the opportunity to contribute in a face-to-face consensus round, without being 
snowed under by professionals in the development panel. Remarkably, they then 
selected additional indicators regarding access to care and information as well 
as communication, which is in line with our study results [20]. The latter might 
not only suggest uniformity in importance on dimensions of patient-centredness 
according to patients, but also underlines the need to involve patients in such a 
way that they are actually able to contribute to the entire development process. 
Within the field of fertility care, other studies also aimed at measuring the level 
of patient-centredness through patients’ experience surveys [4-6, 9, 27]. These 
studies evaluated patient-centredness in fertility care, but were not supported by 
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critically appraised evidence or consensus in a broad multidisciplinary group of 
professionals, which may hamper the likeliness of associated quality improvement 
initiatives to succeed. In addition, these studies only evaluated the patient-
centredness of the clinical treatment phase within fertility care; other phases 
within patients’ clinical pathways, such as care by GPs, urologists and after-care 
were omitted. Our study emphasises that the importance of including patients’ 
clinical pathways with regard to the high percentage of indicators on coordination 
and transition in professionals’ and access to care in patients’ final set of indicators. 
Recently, studies have also reported on this close linkage between organisational 
determinants of care and other dimensions of patient-centredness as well as the 
need to apply a multidisciplinary approach in fertility care [4, 7, 27, 28]. 
By comparing the dimensions of patient-centredness between these non-
guideline based instruments and our developed indicator sets, similarities but also 
noteworthy differences can be identified. The importance of information provision 
and communication for measuring patient-centredness is also underlined by the 
results of non-guideline based instruments and even assigned to be top priority in 
quality improvement initiatives [4-6, 9, 29]. Even so, the accessibility, coordination 
and integration of fertility care appeared to be proportionally underexposed 
dimensions of patient-centredness [4-6, 9, 27].
The main strength of our study is the involvement of infertile patients and different 
professionals from various phases in fertility care. Furthermore, by separately 
developing the two sets of quality indicators, we were able to get insight into 
patients’ actual contribution and describe the differences in the selected indicators 
as well as dimensions of patient-centredness between patients and professionals. 
However, by respecting different perspectives on patient-centred fertility care, one 
might argue against the development of two separate sets of quality indicators. 
Although mandatory to the aim of our study, three arguments for this approach 
need to be addressed. First, patients are the ultimate experts in patient-centredness 
of care, thus patients’ involvement is necessary [13]. Secondly, to create a high level 
of support and ownership for the developed indicators, professionals also need to 
play a major role in the development process from the start. Finally, this increases 
the chances to use the indicators for actually monitoring and improving the 
quality of patient-centred fertility care [18, 30, 31]. Nevertheless, due to the lack of 
agreement between patients’ and professionals’ selected indicators, our approach 
results in a relatively large aggregated indicator set (n=29), which could become 
an obstacle in the use for accreditation and quality monitoring goals. An option to 
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reduce the set is to integrate them in a further consensus procedure. However, we 
think that the integration of the two developed sets in a further consensus process 
should be considered carefully: there is a risk of patients being “snowed under” 
in the discussion and most of the indicators developed by professionals would 
dominate the final indicator set. Another option is to only use the five similar 
indicators within both final sets in practice. We do think that these five indicators 
are important for quality improvement initiatives, but they do not include the 
whole concept of patient-centredness.  In our opinion, the final indicator set 
consisting of 29 indicators represents a balanced set that is based on the expertise 
of all stakeholders, including patients. A next step should be the application of this 
set in a future practice test to assess the feasibility in daily practice. By evaluating its 
measurability and the intra- and inter-observer reliability the core set of indicators 
might be reduced with 10-20% [11, 32, 33]. 
Besides, we also need to address some other potential methodological limitations 
of this study. First, the worldwide used RAND-modified Delphi method has 
previously proved its effectiveness for developing quality indicators, but the 
influence of the panel composition and type of feedback on the legitimacy of the 
results have been questioned regularly [11, 18, 34, 35]. However, in this study 
we included a balanced group of fertility care professionals mandated by their 
professional societies and reliably reflecting the opinions of all Dutch professionals 
involved in fertility care. Regarding the type of feedback, panel members in our 
study received overall and individual scores, which ensured good consensus 
formation within the panels. Additionally, panellists received written feedback 
instead of face-to-face feedback, which may have minimized the influence on the 
selection of indicators in step 2 by intimidation [11, 35]. In addition, regarding 
the patient panel, we do not know if these patients are representative of the 
general infertile population. The majority of all female members suffered from 
secondary infertility, which may explain the relatively high median age and 
duration of infertility compared with the used and valid Dutch cohort of infertile 
patients described by Brandes and colleagues [36]. Nevertheless, both age and 
duration of infertility are comparable with a larger group used in a study to assess 
patient-centredness in Europe [29]. Moreover, they are eligible since they have 
completed one or more phases within the clinical pathway of fertility care, enabling 
them to appraise indicators regarding different phases of fertility care. Finally, the 
number of patients’ participants might be small, but comparable to panels used in 
other studies developing quality indicators and larger than the involvement of one 
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or two patients in previously described methods [18, 22, 23]. Another discussion 
point is the attrition of the members of both panels over the course of the study, 
which is considerably high, especially of the professional panel members in the 
third step of our study. A plausible explanation for this might be found in the fact 
that indicator development (rating and ranking 120 indicators) is time-consuming 
and within a second round, professionals may feel less urge in adding important 
points to the final set of indicators.
Finally, some considerations for the use of these indicators in daily practice have 
to be addressed. First, the developed indicators in this study were based on a 
national multidisciplinary guideline on infertility, in which patient-centredness 
represented the primary goal in the development phase. This resulted in a high 
number of recommendations (n=120) for patient-centredness. Although patient-
centredness is becoming increasingly important in the field of infertility care, it 
could be questioned if this approach can be performed similarly in all existing 
guidelines, since patient involvement in guideline development is still not common 
practice and the number of recommendations regarding patient-centredness 
might be rather small [17]. Furthermore, we are aware of the fact that some of 
the selected indicators, mainly regarding the access to care, may be specific for 
the Dutch setting (e.g. the unique role of the Dutch GP) and that this might have 
influenced the choice of indicators. However, this guideline was also based on 
international evidence, which implies that most of the developed indicators are 
more or less applicable in other care models as well, occasionally by a broader 
interpretation of the indicators (e.g. by replacing the GP with other engaged 
healthcare professionals).  Moreover, evidence suggests that European patients 
have a similar generic view on patient-centredness of fertility care [27].
Additionally, with regard to the use of indicators for patient-centredness to monitor 
the quality of patient-centred fertility care, we think that professionals do not need 
to set up a quality assurance system for patient-centredness separately, since most 
of the performance measures can be collected by simply asking the patient directly 
or by introducing a periodic questionnaire to be completed. A good example of 
such a questionnaire may be found in the ENDOCARE-questionnaire [27]. 
Conclusion and implications 
This study describes the systematic, stepwise development of patients’ and 
professionals’ guideline-based quality indicators for patient-centredness in fertility 
care and provides an insight into the differences in selection of quality indicators 
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for patient-centredness, especially regarding the accessibility dimension, between 
patients and professionals. Moreover, our results reinforce the importance of 
involving patients - the ultimate experts in patient-centred fertility care - in these 
indicator development processes. The presented final set of quality indicators for 
patient-centredness can be used to monitor and improve the quality of fertility 
care. 
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General discussion
This thesis focused on our first experiences with the participation of Dutch infertile 
couples in ‘shared guideline development’. 
First, we explored the added value of patients to various phases of the guideline 
development process (i.e. defining the guideline’s scope, formulating the 
guideline’s recommendations, and defining performance measurements). Next, we 
introduced a novel network approach to multidisciplinary guideline development, 
in which the infertile couple plays a crucial role. Finally, this thesis described the 
development, evaluation, and potentials for wider implementation of an online 
participatory tool for patients in guideline development.
In the first part of this final chapter, we present answers to the research questions 
as posed in the general introduction. Next, the main findings from the studies 
included in this thesis are discussed in the light of available literature and recent 
policy. Then some methodological considerations are addressed and discussed. 
Finally, this chapter concludes with recommendations for future research, 
implications for practice, and an overall conclusion.
Answers to the research questions:
The following answers to the research questions posed in Chapter 1 can be 
formulated from the studies described in this thesis. 
1. What value do patients add to the scope of a Dutch multidisciplinary guideline on 
infertility when comparing perceived key clinical issues between professionals and 
patients? (Chapter 3)
Including patients in the scoping phase of the guideline development process 
leads to valuable additional main key clinical issues (defined as care aspects that 
need improvement) for the next step of a multidisciplinary guideline development 
process. Infertile couples broadened the scope of the guideline by adding eight 
main key clinical issues regarding patient-centred (e.g. information provision not 
meeting expectations) and organizational (e.g. poor care alignment) aspects of 
care. Infertile patients and professionals mentioned only two main key clinical 
issues collectively: the lack of emotional support and the lack of respect and 
autonomy. Nevertheless, patients posed different interpretations of these issues 
than professionals, which resulted in more patient-centred care aspects to be 
addressed in a multidisciplinary guideline on infertility.
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2. To what extent does a patient-centred network approach to multidisciplinary 
guideline development in infertility provide a feasible format regarding the actual 
performance of a set of guidelines, its time investments, and experiences with the 
approach? (Chapter 2)
The novel patient-centred network approach is a feasible format for simultaneously 
and collaboratively developing a harmonized set of multidisciplinary and 
monodisciplinary guidelines around clinical care pathways for patients with 
fertility problems. Although comparisons of the actual time investments (20 
months) are barely noted in the published literature on this topic, if converted into 
euros, it seems at least comparable to other published multidisciplinary guideline 
development initiatives. Moreover, multiple stakeholders reached agreement on 
the clinical content and perceived the network approach as positive and promising 
for developing multidisciplinary guidelines.
3. To what extent does a participatory tool for Dutch infertile patients in guideline 
development provide a feasible tool to enhance shared guideline development, 
regarding its use, usability, benefits for the guideline, users’ experiences with the tool, 
and implementability in other clinical areas? (Chapters 4 & 5)
In this thesis two interrelated types of participatory tools are described and 
investigated. Chapter 4 answers the question posed for a preliminary wiki-based 
participatory tool and Chapter 5 answers the question posed for a specialized 
online participatory tool.
The wiki-based tool (Chapter 4) is a promising and feasible participatory tool for 
patients in guideline development. The evaluation of this tool led to suggestions 
for new modalities (e.g. automatic limitation of the number and length of 
recommendations, the use of a fixed format for recommendations, inclusion 
of a motivation page, and addition of a continuous prioritization system). 
Furthermore, attention should be paid to the informational character of such a 
wiki. To improve future implementability, a modified tool should preferably be 
co-developed and evaluated by patients themselves in a user-centred design study. 
Furthermore, representativeness of participating patients should be evaluated. 
These recommendations for improvement were used to develop the next 
specialized online participatory tool (Chapter 5). This specialized online tool is a 
usable and suitable participatory tool for guideline development on infertility. This 
tool might be implementable in clinical areas other than infertility, but requires 
cooperation from related professional societies and active patients’ associations. 
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4. What value do patients add to the development of guideline-based quality indicators 
for patient-centredness? (Chapter 6)
The involvement of patients in the development of guideline-based indicators 
had an added value. Patients mainly select different quality indicators than do 
professionals involved in fertility care. Within professionals’ and patients’ final 
sets of 18 and 16 quality indicators, respectively, only 5 indicators were similar. 
Although both patients and professionals most prominently valued information 
and communication in fertility care, patients also emphasised the importance 
of access to care. Professionals emphasised the importance of coordination and 
integration of fertility care.
Discussion of main findings
The studies performed within the span of this thesis revealed that ‘shared guideline 
development’ adds value to current guideline development programmes with 
scarce patient participation. Patients, professionals, guideline developers, and 
policy directors should act upon these gathered experiences and shift the role 
of patients from the periphery towards the centre of the guideline development 
process.
Box 1: Clinical Practice Guidelines
 
Clinical Practice Guidelines (CPGs) are now ubiquitous. Although CPGs 
have a relatively short history, the goals and development process have evolved 
dramatically. From the mid-1970s practice variation and the appropriateness 
of medical procedures have been questioned as a result of the evidence-based 
movement. Since then, guideline production has accelerated and the development 
has been increasingly centrally organized [1]. The increase in international 
publications within the field of CPGs gives an indication of the rapid rise of their 
development. In 1993, the Medical Subject Heading (MeSH) ‘practice guideline’ 
was added to MEDLINE as a topic, and 444 articles were classified under that 
heading. In subsequent years, there has been an increase in the number of articles 
classified per year under the ‘practice guideline’s MeSH’, to a total of 90.922 articles 
in 2016 (www.pubmed.com). Of these published articles, 21.473 articles included 
the description of CPGs and yet a plethora of CPGs has been produced. 
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Clinical practice guidelines are actually designed to support the decision-making 
processes in patient care and reduce inappropriate practice variation [2]. Published 
data confirmed that CPGs can substantially improve daily clinical practice, but 
low-quality guidelines may harm patients [3,4]. 
It is therefore not surprising that in the past 10 years the elements of the guideline 
development process and the quality of the guidelines have been issued and criticized 
nationally and internationally [2, 5–9]. In 2003 The Appraisal of Guidelines for 
Research and Evaluation (AGREE) Collaboration issued criteria to assess the 
quality of guidelines [10]. This collaboration developed a generic instrument to 
assess the methodological quality of Clinical Practice Guidelines using 23 key items 
grouped in 6 domains: scope and purpose, stakeholder involvement, rigour of 
development, clarity and presentation, applicability, and editorial independence. 
Worldwide, this initiative has led to the development of guideline programs and 
manuals by leading institutes, in which the elements and crucial steps have become 
a more standardized process; quality assessment according to the items of the 
AGREE instrument played a major role in the development of this process [11–14]. 
In 2009 in the Netherlands, ‘the regieraad’ was issued by The Dutch Ministry of 
Health to overcome major problems in the development, uptake, and quality of 
guidelines. In 2010, they published the first version of a general guideline manual, 
which included minimal quality requirements for guidelines, called guidelines for 
guidelines. This document was updated twice in 2011 and 2012 [15]. In addition, 
in 2011 the first version of ‘medical specialists’ guidelines 2.0’ was published and 
endorsed by all 32 Dutch Medical Specialty societies [16]. The latter included 
a broader scope, including the minimal requirements regarding the guideline 
development process. 
The guideline development process generally enhances several elements including 
topic selection, definition of the scope, formulation of key questions, answering 
the key questions by systematically reviewing the relevant literature and assessing 
its quality, formulation of conclusions and considerations, formulation of 
recommendations, reviewing the draft guideline (internal and external), and 
authorization and dissemination by relevant stakeholders. In addition, the ‘medical 
specialists’ guidelines 2.0’ recommends that an implementation strategy should be 
conceptualized since guidelines do not implement themselves [3,17,18]. Preferably, 
the last step should be followed by an evaluation, including the monitoring of the 
quality of care when applying guideline-based quality indicators [19,20].
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Guideline development approaches
As highlighted in Box 1, CPG development has been rapidly evolving over the past 
10 years. Despite of all efforts that have been made, the appraised quality of the 
guidelines and the development methods still vary or do not meet the basic quality 
criteria, including the involvement of patients [2,5–9]. Furthermore, patients are 
not in the centre of the guideline development process, which may hinder further 
improvement of the quality of care, which is one of the key goals of CPGs.  Finally, 
several reported problems still hinder CPG development and uptake, namely 
inadequate management of conflicts of interest (COIs), limited panel composition, 
lack of patient involvement, and lack of external review [6]. These problems also 
seem to play a crucial role in the implementability of the CPGs.
One may conclude that healthcare is still fragmented. This conclusion is illustrated 
by a strong focus on the single clinical aspects of diseases issued in the guidelines 
rather than on ensuring more integrated care for patients, including attention to 
matters such as patient-centredness, coordination, and continuity of care. These 
problems are not specific for guideline development and also play a crucial role 
in the efforts to improve the healthcare system worldwide. Different international 
published perspectives on re-designing healthcare have put forward these 
arguments and have strived for integrated and patient-centred care [21–28]. If well 
implemented, CPGs could be the ultimate tools to achieve this shift in healthcare, 
although essential elements in the approach are still lacking. Therefore, the target 
users feel no affinity with the guidelines, which impedes full implementation. 
Extensive collaboration among stakeholders seems to be a determining factor 
in bringing the quality of care to a higher level. Monodisciplinary guidelines, or 
separate multidisciplinary guidelines on the same topic, may not help policymakers, 
professionals, or patients to strive for integrated and patient-centred care. Solutions 
may be found in clustering the guideline development, such as clustering care in 
terms of integrated care and organizing the care with the patient in the centre. The 
use of such clinical networks has previously proven to be effective in increasing 
evidence-based practice and improving care models [29,30]. Therefore, the 
specific aim of the study described in Chapter 2 was to assess the feasibility of a 
patient-centred network approach to guideline development in fertility care. The 
network approach provides a feasible format for guideline developers to bring 
patients and other relevant stakeholders together. The efficiency of this approach 
would benefit from a rigid structure and a supportive organization. Additionally, 
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this approach could be investigated in further detail by organizations that support, 
fund, or initiate the development of CPGs. 
In the Netherlands, the first step has already been taken towards more 
multidisciplinary thinking in the development of CPGs. Recently, the Dutch 
Ministry of Health established the Dutch Quality Institute, which aims to bring 
the quality of CPGs and their development processes to a higher level (www.
zorginstituut.nl). This Dutch quality institute has made significant strides in 
defining CPGs as part of ‘quality’; for example, in documents, they replaced the 
term ‘professional standard’ as defined in the Dutch Health Insurance Act with 
‘quality standards’. This term is now used to refer to a broader spectrum of quality 
documents (i.e. clinical practice guidelines, [care] standards, best practices, 
and quality indicators), which should concern the whole care process (www.
glossarium.zorginstituutnederland.nl).  Although the term ‘quality standard’ may 
refer to a multidisciplinary development process of the underlying documents, it 
still does not imply that patients play a substantial role therein.
In addition to the development and authorization of CPGs, the 32 Dutch 
associations of medical specialists have developed a jungle of (un)related 
and undefined quality documents: protocols, (care) standards, and national 
cooperation agreements. The ability of all these documents to actually contribute 
to the quality of care seems questionable, especially when their content is unrelated 
or even contradictory. To bring the quality of care to a higher level, patients, 
health policymakers, guideline developers, and other allied stakeholders need 
to collaborate on scoping, prioritizing, defining, developing, and maintaining 
clinical practice guidelines. Furthermore, it seems time to develop a uniform 
vision for the definition and the development process of related quality documents 
to achieve this ultimate goal. We are convinced that our format could help these 
organizations further ensure collaboration and patient-centredness in clinical 
guideline development, broadening quality standards, and actualizing content.
Patients and guidelines
When planning to transform the healthcare system from a disease-driven system 
into an integrated and patient-centredness-driven system, it seems logical that 
patients would play a key role in shaping and improving its quality. Corresponding 
with the ultimate goal of CPGs, patients should also play a key role in their 
development process. Although patient involvement in the main phases of Clinical 
Practice Guideline development has been urged internationally, implementing this 
Breejen, Elvira de.indd   147 15-02-17   14:57
Chapter 7
148
involvement still remains a challenge. Several underlying challenges regarding the 
involvement of patients in the main phases of the clinical guideline development 
process have been reported in published literature [2,31–33]. In Chapters 3, 4, and 
5, we aimed to assess the added value of patients in scoping and writing clinical 
guidelines, as well as in developing guideline-based indicators, which facilitate the 
adherence to clinical practice guidelines.
Patients’ role in scoping the guideline
Scoping the guideline is the first and most crucial step of the guideline development 
process. In this step the guideline development group defines what should and 
should not be addressed in a new or revised guideline. Various approaches are 
applied to scope a guideline and identify clinical issues that need improvement, 
including focus groups or workshops with various allied stakeholders in the 
topic of the guideline, written questionnaires, discussion within the guideline 
development group itself, and a written consultation phase to comment on the 
scope of the draft [34,35]. Although several institutes use patient focus groups 
to gather input for guidelines, their impact on the scope remains unclear or is 
not the primary goal [34,35]. Most published initiatives on patient involvement 
focussed on the writing and reviewing phase of the guideline development process 
or on written consultation when the scope has already been drafted [35–39]. 
One can question whether patients are able to have any influence on the scope 
when they are not involved until after the scope has been drafted. In Chapter 
3, we aimed to assess the added value of patients in scoping a Dutch guideline 
on infertility. This study demonstrated that patients can broaden the scope of a 
guideline on infertility, as they suggested different key clinical issues (e.g. issues 
that need improvement and should be addressed in the clinical guideline) than 
did the professionals. Furthermore, patients addressed patient-centred aspects 
of professionals’ key clinical issues (Figure 1). This finding corresponds to the 
results of other studies on the assessment of the quality of fertility care, which 
have shown that patient-centredness is one of the key aspects among all six aspects 
that define the quality of care as proposed by the Institute of Medicine (IOM) 
[2,40–42]. However, professionals working in fertility care still overestimate their 
level of patient-centredness, demonstrating a poor correlation between patients’ 
and physicians’ perceptions of the quality of care [42]. This phenomenon has also 
been seen in healthcare areas other than fertility care [43–45]. 
This finding strengthens our recommendation to enable patients to play a key 
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role in scoping guidelines. As guidelines are currently being transformed from 
‘cookbooks’ to documents based on clinical issues that need improvement while, 
for example, reducing practice variation or optimizing patient care or patient safety, 
the involvement of patients in this phase may help to ensure guidelines address 
issues that are relevant and important to them too. The study presented in Chapter 
3 shows that actual involvement of patients from the start of the scoping process 
can make the guideline more tailored and responsive to patients in terms of key 
questions and defined outcomes regarding fertility care. We therefore suggest that 
guideline developers and policymakers use this approach in other areas as well. In 
the era of high-quality patient-centred care, this approach may positively impact 
patient satisfaction, care costs, and improved outcomes [46]. Future studies on 
the actual impact on the implementability of guidelines and on the quality of care 
may support our recommendation to use this approach systematically. Finally, 
this approach could be used to identify patients’ needs for tailored information or 
to select important questions for developing tools that facilitate shared decision-
making in the clinical setting. 
Figure 1: Shared guideline development: the scoping process (Chapter 3)
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Patients’ role in writing the guideline
Both in the Dutch guideline manual and international manuals, the role of patients 
in the guideline development process is unstructured, lacking in transparency, 
and sometimes unclear. Although patient participation in clinical guideline 
development is emphasized, it faces practical challenges [32,33]. Firstly, several 
methods have been suggested and the level of participation of patients varies 
from very low and passive (i.e. exploring patients’ preferences in interviews or 
focus groups, asking patients’ representatives to comment on draft guidelines) 
to higher and more active (i.e. including patients or patients’ representatives in 
the guideline development group) [34,35,47–51]. Secondly, ‘golden rules’ on how 
and when to apply these methods most effectively are lacking [37,38]. Thirdly, 
all these methods are restricted to including a selected number of patients or 
patients’ representatives. Fourthly, integrating patients’ preferences into guideline 
recommendations is difficult and the result of their input is often unclear [52]. 
Fifthly, important organizational (i.e. recruitment of participants), financial (i.e. 
costs of patients’ education or for conducting focus groups), and socio-political 
barriers (i.e. guideline developers’ resistance to including patients in the guideline 
development group) also impede patient participation in guideline development 
[50]. Finally, studies on the effectiveness and impact of patient participation are 
limited [32,37]. These challenges are determining factors in choosing the extent 
of involving patients in the clinical guideline development process. In Chapters 4 
and 5, we assessed the feasibility of two interrelated participatory online tools to 
facilitate patient participation in clinical guideline development.
Using online participatory tools to involve patients
The Internet has been rapidly evolving from a ‘one-way download medium’ to a 
‘participatory medium’ in which consumers are now playing a more active role. 
This evolution has a considerable impact on the healthcare system and Web 2.0 
technologies are now increasingly used to empower patients. For example, patients 
can become active partners in their own treatment by using online decision-
making tools, accessing and writing patient information, accessing their personal 
health record, and even connecting to medical doctors or professionals via online 
communities [53–59]. Using an online participatory tool may solve most of the 
challenges regarding patient participation in clinical guideline development. In 
Chapter 4 we concluded that a conventional wiki as a participatory tool for patients 
in guideline development for Dutch fertility care is feasible considering the high 
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number of unique visitors and recommendations obtained, although it is also a 
laborious method. In Chapter 5 we discussed the evaluation of a more specialized 
and refined online participatory tool that focussed on the successful improvement 
of the usability for patients and guideline developers. Both chapters add to the 
knowledge on empowering patients in the development of clinical guidelines. 
The specialized online participatory tool described in Chapter 5 may be 
implementable in clinical areas other than infertility, although this would require 
cooperation from related professional societies and active patients’ associations. 
Therefore, we recommend that policy organizations introduce the tool to guideline 
development programs and support their use of it. This approach could motivate 
professional associations to implement this tool in the guideline development 
process and support patients’ associations in increasing their role in guideline 
development. Chapter 4 also acknowledged that the Internet has an important role 
in finding helpful information for patients’ clinical pathways. As such, it seems 
important that reliable information is guideline based and digitized in the same 
place as the guideline. Our tool could also be used to identify patients’ priorities 
in research and informational needs. In the Netherlands, most decisions on how 
to involve patients in the guideline development process are generally made by 
the guideline development institutes and/or the medical specialty associations. 
We acknowledge that time and cost restrictions play an important role herein. 
With the recent introduction of the national guideline database and the hand-
in-hand development of guidelines in sections dedicated to one key question, 
these challenges might play a more prominent role (www.richtlijnendatabse.
nl). Furthermore, there are also the risks that patients’ associations will be 
overwhelmed and unable to meet requests to participate or will need to decide 
which sections they will participate in and which sections they will not. By having 
a set of recommendations, which are continuously updated by patients already 
developed, the use of an online participatory tool could help patients’ associations 
and guideline developers gather input on a specific subject without losing time. We 
therefore suggest that guideline development institutes together with the Dutch 
Federation of Patients continue to explore patient participation in the guideline 
development process using tools such as our participatory tool.
Patients’ role in developing measures to guideline adherence
In addition to clinical effectiveness, safety, and cost effectiveness, patient-
centredness is another important dimension of the quality of care [2]. The ultimate 
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goal of clinical practice guidelines is to optimize the quality of care and guideline-
based indicators are being developed to monitor the adherence to them. 
Quality indicators can focus on the process, structure, or outcome of care, including 
important domains of the patient-centredness of care. However, patients are, for 
the most part, surprisingly not involved in the development process of guideline-
based quality indicators. Guideline-based indicators are usually developed by 
panels of experts, who may be unable to adequately evaluate their performance 
regarding patient-centredness [41]. 
The study in Chapter 6 showed that infertile patients can broaden a set of guideline-
based quality indicators for fertility care by selecting different indicators representing 
different domains of patient-centred care (e.g. accessibility, coordination, 
and integration of care) than professionals select, which appeared earlier as 
underexposed dimensions of patient-centredness [60–65]. This finding strengthens 
the recommendation to involve patients in the guideline indicator development 
process. Following this recommendation is even more important in complex 
chronic conditions where a high adherence to treatment is inevitable. Nevertheless, 
there is still not an existing uniform methodological gold standard for patient 
involvement in the development process of quality indicators [66]. Additionally, the 
Netherlands is still facing challenges in measuring quality indicators, since adequate 
registration is lacking, and in determining responsibilities in the registration 
process. Furthermore, there is a tendency to develop all kinds of instruments to 
measure quality of care and, consequently, healthcare professionals may face a huge 
burden in registration load. To alleviate this burden, the effective use of existing data 
and education on the importance of registering data and its value in improving the 
quality of care should be considered to be key factors in motivating professionals to 
pave the way to continuously improving the quality of care [67].
Methodological considerations
Setting of the studies
The majority of the studies included in this thesis were conducted within a 
national project aiming to innovate, broaden collaboration, and improve the level 
of patient-centredness in guideline development. This setting could influence the 
results of our studies since participants were more committed to collaborate at 
first.
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Study design
This thesis consists of mainly qualitative exploratory and feasibility studies. In 
Chapter 2, we used qualitative research methods and data analysis to explore 
and compare patients’ and professionals’ perceived key clinical issues. The value 
of qualitative methods has been widely proven in exploratory studies [68]. In 
our first study, for practical reasons, we used two types of qualitative research 
methods, namely semi-structured interviews with infertile couples and focus 
group interviews among professionals involved in fertility care. Research has been 
previously suggested that social desirability plays an important role in focus group 
discussions, which could have restricted the number of and variety in key clinical 
issues [69]. Nevertheless, various key clinical issues were addressed. 
 In Chapters 3, 4, and 5 we performed feasibility studies. The term ‘feasibility study’ 
is still a contested term that refers to the exploration of new methodologies or 
interventions [70]. Traditionally part of feasibility studies, experience with a new 
approach or intervention, barriers and facilitators, and suggestions for improvement 
are important outcome measures and input for further study [70]. In this thesis, we 
used a mixed-method evaluation. Mixed methods are frequently used to quantify 
predefined qualitative outcome data and are therefore highly applicable to our 
described studies. However, potential disadvantages of this methodology regarding 
our studies include potential sampling bias and the low response rates on the written 
questionnaires described in Chapter 5. Furthermore, we used interviews as input for 
designing a written questionnaire while saturation of data was not reached.
In Chapter 6 we described the development of guideline-based quality indicators 
for patient-centredness using a RAND modified Delphi method. This method has 
been widely used in the development of quality indicators in healthcare [66,71]. 
While this method is a useful approach to facilitating consensus, the influence of 
the panel composition and type of feedback on the legitimacy of the results have 
been questioned regularly [66,72–74]. However, in our study, a balanced group of 
stakeholders mandated by their professional societies participated. Furthermore, 
the panel members received written feedback instead of face-to-face feedback, 
which may have minimized intimidation factors while selecting potential 
indicators [73,74]. 
Outcome
The main goal of developing quality instruments is monitoring and finally improving 
the quality of care. However, there is still no direct, sufficient evidence that patient 
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involvement in guideline development leads to a higher quality of care. This thesis 
focussed on the added value of the involvement of patients in the scoping and 
writing phase of guideline development and the indicator development process 
(i.e. key clinical issues as input on key questions and recommendations being part 
of a Dutch national guideline on infertility and on quality indicators for patient-
centredness). We focussed particularly on the evaluation of a new approach in 
terms of barriers, facilitators, suggestions for improvement, and the feasibility 
of a participatory tool to involve patients in the guideline development process. 
Among these outcomes, the effect on the implementability of the guideline and on 
the quality of care have not been evaluated in the studies as presented in this thesis. 
These final outcomes need to be a topic of future studies.
Discussion of future research
In this thesis, we explored the added value of patients in several phases of the 
guideline development process. However, some questions remain unanswered, 
namely the impact of the level of patient involvement in guideline development 
on both the implementability of the guideline and on the quality of care. Firstly, 
to evaluate the impact on implementability, The Guideline Implementability 
Appraisal (GLIA) instrument can be used [75]. This instrument is based on 
a set of guideline characteristics that predict potential challenges of effective 
implementation.  However, implementation is determined by both intrinsic and 
extrinsic factors, and the latter is not included in this instrument [76]. Studies to 
compare the level of implementation of guidelines developed with a high level 
of patient involvement to guidelines developed without involving patients are 
generally impossible. The content of the guidelines would not be comparable 
since patients can broaden the scope of the guideline and add recommendations. 
Furthermore, extrinsic factors that determine implementation, such as differences 
in the organization of healthcare professionals between hospitals, would make it 
bias sensitive. 
Next, to evaluate interventions for healthcare improvement, performing 
a randomised controlled trial (RCT) is considered the gold standard in 
implementation research.  However, it could be debated whether the impact of 
patient involvement on the quality of care could be captured within a study design 
as a (clustered) RCT. In practice, developing two types of guidelines crosses 
ethical barriers (i.e. stakeholders’ participation could have been pointless in 
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one of the guidelines). Furthermore, developing CPGs include whole-intensive 
processes, which costs time and commitment from stakeholders. The differences 
in the content and structure of the final guidelines would also make them non-
comparable in the baseline. Finally, performing a budget-impact analysis on 
the network approach to multidisciplinary guideline development could be 
considered as well.
Implementation and evaluation of the participatory tool for patients in guideline 
development within other clinical areas (predominantly within other complex 
multidisciplinary diseases, such as cancer) should be the next step.
The developed indicators for patient-centredness should be followed by a further 
practice test to assess its feasibility in daily practice. By evaluating its measurability 
and the intra- and inter-observer reliability, the core set of 29 indicators for 
patient-centredness could be reduced by 10–20% [73,77,78]. Finally, its effects on 
the quality of patient-centred care needs to be investigated and compared to other 
instruments that have been developed to improve patient-centred care, such as 
Patient Reported Outcome Measurements for infertility (i.e. the FertiQol, QPP-
IVF instrument, and the PCQ infertility) [41,62,79].
Key implications for future research:
-  To evaluate the impact on the implementability of guidelines with a high 
level of patient involvement is generally impossible since implementation is 
determined by intrinsic and extrinsic factors.
-  It could be debated whether the impact of patient involvement on the 
quality of care could be captured within a study design such as a (clustered) 
RCT since ethical barriers, commitment of stakeholders, and costs play a 
crucial role.
-  A budget-impact analysis on the network approach to multidisciplinary 
guideline development could be considered.
-  Implementation and evaluation of the participatory tool for patients in 
guideline development within other clinical areas (predominantly within 
other complex multidisciplinary diseases, such as cancer) should be the 
next step.
-  The developed indicators for patient-centredness should be followed by a 
further practice test to assess its feasibility in daily practice.
-  The effects of the developed set of indicators for patient-centredness on the 
quality of patient-centred care needs to be investigated and compared to 
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other instruments, such as Patient Reported Outcome Measurements for 
infertility (i.e. the FertiQol, QPP-IVF instrument, and the PCQ infertility).
Key implications for policy and practice
Implications for professionals’ associations and policymakers:
-  Clinical Practice Guidelines should focus on clinical issues, which are 
relevant to all stakeholders, including patients.
- Facilitate patients to play a key role in scoping the guideline.
-  The development of monodisciplinary guidelines, even those developed by 
a multidisciplinary development group, should not be permitted anymore.
-  Explore patient-centred approaches, such as our network approach to 
enhance shared guideline development.
-  Collaborate with patients, health policymakers, guideline developers, and 
all allied stakeholders in prioritizing, scoping, developing, and maintaining 
clinical practice guidelines.
-  Change the introduced term ‘quality standards’ into collaborative standards 
since patients and all relevant stakeholders should be involved as well.
-  Develop a uniform vision for the definition and development process of all 
quality documents that are part of quality standards.
-  Ideally, include patients in the scoping phase to identify their needs for 
tailored information and to select important questions for developing tools 
that facilitate shared decision-making in the clinical setting.
-  Introduce the online participatory tool to guideline development programs, 
further explore its possibilities regarding major clinical issues (first with the 
Dutch Federation of Patients), and assure the cooperation of professional 
associations.
- Involve patients in the guideline-indicator development process.
-  Create an efficient infrastructure for measuring quality indicators, including 
the level of patient-centredness.
-  Educate professionals on the importance of registering data on the quality 
of care and their value in improving the quality of care.
-  Stress the importance of patient involvement in all different phases (i.e. 
scoping, writing, and developing quality indicators) of the guideline 
development process and encourage associations’ members to be actively 
involved in guideline development to implement this approach.
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Key implications for patients and patients’ associations:
-  Encourage patients and patients’ associations to contribute to the guideline 
development process since their involvement will help enhance the level of 
patient-centredness of clinical practice guidelines. 
-  Collaborate with health policymakers, guideline developers, and all allied 
stakeholders in prioritizing, defining, developing, and maintaining clinical 
practice guidelines.
- Take a key role in scoping a clinical practice guideline. 
-  Introduce and implement tools, such as an online participatory tool, to 
facilitate patient participation in guideline development programs and to 
further explore its possibilities regarding major clinical issues.
- Involve patients in the guideline-indicator development process.
-  Stress the importance of involvement in all different phases (i.e. scoping, 
writing, and developing quality indicators) of the guideline development 
process and encourage associations’ members to be actively involved in 
guideline development to implement this approach.
Final conclusions and remarks
This thesis demonstrates the added value of involving patients in all phases of the 
guideline development process and of using a patient-centred approach therein; 
‘shared guideline development’ is the future of guideline development. In fact, all 
involved healthcare professionals, their associations, patients, and policymakers are 
now in the lead to collaborate on implementing this concept. Online participatory 
tools could contribute to bringing shared guideline development to a higher level 
while transparently using patients’ input in the guideline development process.
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English Summary
Healthcare is fragmented and does not pay enough attention to patients’ needs 
and values. As is true of other diseases that require complex multidisciplinary 
care, reproductive care is generally offered by various types of independently 
organized professionals (e.g. general practitioners, gynaecologists, and urologists). 
Furthermore, the care provided is usually based on evidence or professional 
consensus irrespective of patients’ needs and values. Well-developed clinical 
practice guidelines (CPGs) could be valuable tools to close the gap between this 
fragmented continuum of evidence-based reproductive healthcare and infertile 
couples’ need to be in charge of their own care pathway.
However, reliable contributions of other stakeholders – especially infertile patients 
– are mostly lacking. Furthermore, guideline development methodologies mainly 
focus on the disease instead of on patients’ clinical pathways. Therefore, we have 
attempted to put the patients in the centre of the various stages of the guideline 
development process. This thesis focuses on the experiences with shifting the role 
of Dutch infertile patients in guideline development from the periphery towards 
the centre and introduces ‘shared guideline development’ in fertility care. 
The aim of this thesis, as outlined in Chapter 1, was to answer four specific 
questions.
Chapter 2 focuses on the first question:
What value do patients add to the scope of a Dutch multidisciplinary guideline on 
infertility when comparing perceived key clinical issues between professionals and 
patients? 
To answer this question a qualitative interview study was performed among 12 infertile 
couples and 17 professionals. We listed and compared the couples’ and professionals’ 
key clinical issues (i.e. care aspects that need improvement) to be addressed in the 
guideline according to four domains: current guidelines, professionals, patients, 
and organization of care. Main Outcome Measures of this study included the 
main key clinical issues, which were the key clinical issues suggested by more than 
three-quarters of the infertile couples and/or at least two professionals.
Overall, we identified 32 key clinical issues among infertile couples and 23 among 
professionals. Of the defined main key clinical issues, infertile couples mentioned 
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eight issues that were not mentioned by the professionals. These main key clinical 
issues mainly concerned patient-centred aspects of care on the professional and 
organizational domain (e.g. poor information provision and poor alignment of 
care). Both groups mentioned two main key clinical issues collectively that were 
interpreted differently: the lack of emotional support and respect for patients’ 
values. 
We concluded that including patients in the guideline development process 
beginning in the first phase leads to the identification of valuable additional main 
key clinical issues for the next step of a multidisciplinary guideline development 
process and broadens the scope of the guideline, particularly regarding patient-
centredness and organizational issues from a patients’ perspective.
Chapter 3 focuses on the second question:
To what extent does a patient-centred network approach to multidisciplinary 
guideline development in infertility provide a feasible format for multidisciplinary 
guideline development regarding the actual performance of a set of guidelines, its 
time investments, and experiences with the approach?
To answer this question a feasibility study was performed, including a detailed 
process evaluation of the guideline development process, professionals’ experiences 
with the network approach, and time invested. We used a patient-centred network 
approach to develop five harmonized guidelines (one multidisciplinary and four 
monodisciplinary) around clinical pathways in fertility care.
The network structure comprised the centrally located patients and the steering 
committee; a multidisciplinary guideline development group (gynaecologists, 
physicians, urologists, clinical embryologists, clinical chemists, a medical 
psychologist, an occupational physician, and two patient representatives); and 
four monodisciplinary guideline development groups. The guideline development 
addressed patient-centred, organizational, and medical-technical key questions 
derived from interviews with patients and professionals. These questions 
were elaborated and distributed among the groups. We evaluated the project 
performance, participants’ perceptions of the approach, and the time needed, 
including time for analysis of secondary sources, interviews with eight key figures, 
and a written questionnaire survey among 35 participants.
Within 20 months, this approach helped us develop a multidisciplinary guideline 
for treating infertility and four related monodisciplinary guidelines for general 
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infertility, unexplained infertility, male infertility, and semen analysis. The 
multidisciplinary guideline included recommendations for the main medical-
technical matters and for organizational and patient-centred issues in clinical care 
pathways. The project was carried out as planned except for minor modifications 
and three extra consensus meetings. The participants were enthusiastic about the 
approach, the respect for autonomy, the project coordinator’s role, and patient 
involvement. Suggestions for improvement included timely communication about 
guideline formats, the timeline, participants’ responsibilities, and employing a 
librarian and more support staff. The 35 participants spent 4497 hours in total 
on this project. We concluded that the novel patient-centred network approach 
is feasible for simultaneously and collaboratively developing a harmonized set of 
multidisciplinary and monodisciplinary guidelines around clinical care pathways 
for patients with fertility problems. Further research is needed to compare the 
efficacy of this approach with more traditional approaches.
Chapter 4 and Chapter 5 both focus on the third question:
To what extent does a participatory tool for Dutch infertile patients in guideline 
development provide a feasible tool to enhance shared guideline development, 
regarding its use, usability, benefits for the guideline, users’ experiences with the tool, 
and implementability in other clinical areas?
To answer this question two feasibility studies were performed. In Chapter 4 the 
feasibility of a basic wiki as a participatory tool for patients in the development of a 
guideline on infertility was assessed. A multimethod evaluation strategy was used 
to assess the feasibility of the wiki as a participatory tool for patients in guideline 
development.
The evaluation included (1) the use of the wiki (number of page views and 
visitors), (2) benefits of the wiki (i.e. number, content, and eligibility of the 
recommendations to be integrated into the guideline), and (3) patients’ facilitators 
of and barriers to adoption, as well as the potential challenges to be overcome in 
improving this wiki.
To obtain initial content for the wiki, we conducted in-depth interviews (n = 12) 
with infertile patients. Transcripts from the interviews were translated into 90 
draft recommendations. These were presented on a wiki. Over 7 months, infertile 
patients were invited through advertisements or mailings to formulate new or 
modify existing recommendations. After modifying the recommendations, we 
Breejen, Elvira de.indd   166 15-02-17   14:57
8Summary
167
asked patients to select their top five or top three recommendations for each of the 
five sections on fertility care. Finally, the guideline development group assessed 
the eligibility of the final set of recommendations within the scope of the guideline. 
The wiki attracted 298 unique visitors, yielding 289 recommendations. We assessed 
the 21 recommendations ranked as the top five or top three for their eligibility 
for being integrated into the clinical practice guideline. The evaluation identified 
some challenges needed to be met to improve the wiki tool, namely its ease of use, 
website content and layout, and characteristics of the wiki tool.
We concluded that the wiki is a promising and feasible participatory tool for 
patients in guideline development. A modified version of this tool, including new 
modalities (e.g. automatically limiting the number and length of recommendations, 
using a fixed format for recommendations, including a motivation page, and 
adding a continuous prioritization system), should be developed and evaluated in 
a patient-centred design.
In Chapter 5 the use and benefits of a specialized online participatory tool to 
facilitate patient partnership in guideline development were evaluated. This 
specialized tool was developed and based on the barriers and facilitators that 
resulted from a previous pilot study on a wiki tool as described in Chapter 
4. To answer the question a mixed method evaluation was applied. Outcome 
measurements for use included: actual use (number of unique visitors, number 
of registries, and number of visits), the usability of the tool measured on a SUS-
scale (0–100), and representativeness of users compared to a valid representative 
Dutch hospital cohort. Outcome measurements for benefits on guideline 
development included: number of new and modified recommendations, number 
of prioritizations, and the change over the time period (months) of the top five 
recommendations.
In 12 months, the specialized participatory tool welcomed 3028 unique visitors, 
of which 87 registered. The tool enabled a broad and mostly representative 
target group regarding their age, type of infertility, and duration of childlessness 
compared to a hospital group. The visitors delivered a set of 50 clear and prioritized 
recommendations for guidelines on Dutch fertility care. According to 39 out of 45 
registries the tool was qualified as highly usable.
We concluded that the specialized online participatory tool is a feasible method 
to involve a broad group of generally representative infertile patients in guideline 
development. This study adds to current knowledge using online tools to facilitate 
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patient partnership in clinical guideline development. This thesis can be used 
as a practical guide for policy organizations, guideline developers, and patient 
organizations that are interested in interventions to facilitate patient partnership 
in clinical guideline development in any clinical setting.
Chapter 6 focuses on the fourth question:
What value do patients add to the development of guideline-based quality indicators 
for patient-centredness?
To answer this question the RAND-modified Delphi method (a two-step systematic 
consensus method) was used to develop two sets of quality indicators for patient-
centredness. The development of these quality indicators for patient-centredness 
was based on the national multidisciplinary Network Guideline on infertility. 
Two panels participated: one patients’ panel (n= 19) and one multidisciplinary 
professionals’ panel (n=15). Similarities and differences in the indicators and 
in aspects of patient-centredness between patients’ and professionals’ sets of 
indicators were analysed descriptively. From 119 formulated potential indicators 
of patient-centredness, the patients’ panel selected a representative set of 16, while 
the professionals’ panel selected 18. Five indicators were included in both sets. 
These indicators regarded the need to perform IUI at least six days a week, report 
on treatment outcomes and complications, report on results of semen analyses in a 
standardized way, counsel infertile couples about the positive effects on their chance 
of pregnancy of the elimination of a harmful lifestyle, and provide information on 
the negative consequences of achieving a pregnancy when the patient has a high 
BMI. Both patients and professionals put the highest value on potential indicators 
of information and communication in fertility care. Patients also emphasized 
accessibility of care, whereas professionals emphasized coordination and 
integration as important quality measures for patient-centredness in fertility care. 
Infertile patients mainly select different indicators and value different dimensions 
of patient-centredness (e.g. information, communication, and access to care) 
than professionals (e.g. coordination and integration of care) during an indicator 
development process. 
Therefore, we concluded that infertile patients add value to the development of 
guideline-based quality indicators for patient-centredness. The final guideline-
based indicator set, consisting of 29 indicators, represents a balanced set that is 
based on the expertise of all stakeholders, including patients. A next step should 
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be the application of this set in a future practice test to assess the feasibility in daily 
practice. In our opinion, most quality indicators for patient-centredness could be 
used for monitoring and improving the quality of fertility care internationally, 
occasionally by a broader interpretation (e.g. by replacing the general practitioners 
with other healthcare professionals engaged in the care process).
Chapter 7 discusses the main findings from the studies included in this thesis 
in the light of available literature and recent policy relating to the main phases 
of the guideline development process. Furthermore, some methodological 
considerations regarding the exploratory studies performed within the span of 
this thesis were addressed and discussed. 
We concluded that this thesis demonstrates the added value of involving patients 
in all phases of the guideline development process, as well as of using a patient-
centred approach therein; ‘shared guideline development’ is the future of guideline 
development. In fact, all involved healthcare professionals, their associations, 
patients, and policymakers are now in the lead to collaborate on implementing 
this concept. Online participatory tools could contribute to bringing shared 
guideline development to a higher level while transparently using patients’ input 
in the guideline development process.
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Nederlandse samenvatting
De gezondheidszorg is versnipperd en houdt nog te weinig rekening met de 
behoeften en waarden van patiënten. Zoals bij andere aandoeningen die complexe 
zorg behoeven, wordt ook de voortplantingsgeneeskundige zorg verleend door 
meerdere onafhankelijk opererende medische professionals, zoals huisartsen, 
gynaecologen en urologen. Daarnaast is de inhoud van de geleverde zorg 
meestal gebaseerd op wetenschappelijk bewijs of op professionele consensus, die 
onafhankelijk zijn van de behoeften en waarden van patiënten. Richtlijnen, mits op 
de juiste manier ontwikkeld, kunnen waardevolle instrumenten zijn om het gat te 
dichten tussen de voortplantingsgeneeskundige zorg gebaseerd op wetenschappelijk 
bewijs en gebaseerd op de behoeften van paren met vruchtbaarheidsproblemen 
die de leiding hebben in hun eigen af te leggen zorgpad. Echter, een aanzienlijke 
bijdrage van andere belanghebbenden, bij uitstek die van subfertiele patiënten, 
ontbreekt vooralsnog in richtlijnontwikkeling. Verder beperkt de aanpak van 
richtlijnontwikkeling zich meestal tot de aandoening zelf, in plaats van dat ze 
gericht is op het totale zorgpad dat patiënten afleggen. 
Daarom hebben wij getracht patiënten in het middelpunt van de verschillende 
ontwikkelingsstadia van het richtlijnontwikkelingsproces te positioneren. Dit 
proefschrift richt zich op de ervaringen met het verplaatsen van de positie van de 
patiënt van de zijlijn naar het middelpunt en introduceert het concept ‘gezamenlijke 
richtlijnontwikkeling’ in de voortplantingsgeneeskunde.
Het doel van dit proefschrift, zoals uiteengezet in Hoofdstuk 1, is om vier specifieke 
vragen te beantwoorden.
Hoofdstuk 2 richt zich op de eerste vraag:
Wat is de toegevoegde waarde van de belangrijkste klinische knelpunten zoals 
ervaren door patiënten vergeleken met die van professionals voor het vaststellen van 
het bestek van een Nederlandse multidisciplinaire richtlijn subfertiliteit?
Om deze vraag te beantwoorden, is een kwalitatieve studie verricht met behulp 
van interviews onder twaalf subfertiele paren en zeventien professionals. Op 
basis van deze interviews zijn twee lijsten samengesteld met de in de richtlijn op 
te nemen klinische knelpunten (aspecten van de zorg die verbetering behoeven) 
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die aangedragen zijn door zowel patiënten als door professionals binnen de 
vier domeinen (huidige richtlijnen, professionals, patiënten en organisatie van 
zorg). Door beide lijsten met elkaar te vergelijken, zijn de belangrijkste klinische 
knelpunten naar voren gekomen zoals gedefinieerd door meer dan drie kwart van 
de subfertiele paren en/of ten minste twee professionals. 
In totaal hebben subfertiele paren 32 klinische knelpunten aangedragen en 
professionals 23. Van de belangrijkste klinische knelpunten zijn acht aangedragen 
door de subfertiele paren die de professionals niet hebben genoemd. Deze 
belangrijkste klinische knelpunten betreffen hoofdzakelijk de patiëntgerichte 
aspecten van zorg op het domein van de professional en de organisatie. De groepen 
hebben gezamenlijk twee belangrijke klinische knelpunten aangedragen, hoewel ze 
deze knelpunten echter anders interpreteren: enerzijds het gebrek aan emotionele 
steun en anderzijds het gebrek aan respect voor de waarden van patiënten.
Hieruit is geconcludeerd dat het betrekken van patiënten vanaf de eerste fase 
van het richtlijnontwikkelingsproces tot waardevolle en aanvullende belangrijke 
klinische knelpunten leidt, die als input kunnen dienen voor de volgende stap 
van het multidisciplinaire richtlijnontwikkelingsproces. Bovendien breidt dit 
het bestek van de richtlijn uit, met name ten aanzien van patiëntgerichte en 
organisatorische onderwerpen vanuit het perspectief van de patiënt.  
Hoofdstuk 3 is gericht op de tweede vraag:
In hoeverre is in geval van subfertiliteit een netwerkbenadering waarin de patiënt 
centraal staat een haalbaar format voor multidisciplinaire richtlijnontwikkeling 
ten aanzien van daadwerkelijke ontwikkeling van een set van richtlijnen, de 
tijdsinvestering en de ervaringen met deze benadering?
Om deze vraag te beantwoorden, is een haalbaarheidsstudie uitgevoerd bestaande 
uit een gedetailleerde procesevaluatie van het richtlijnontwikkelingsproces, de 
ervaringen van professionals met de netwerkbenadering en de daarmee gemoeide 
tijdsinvesteringen.
Hierbij is gebruikgemaakt van een netwerkbenadering waarin de patiënt 
centraal staat om vijf op elkaar afgestemde (een multidisciplinaire en vier 
monodisciplinaire) richtlijnen te ontwikkelen rondom de klinische zorgpaden 
binnen de voortplantingsgeneeskundige zorg. De netwerkstructuur bestond hierbij 
uit: de centraal gepositioneerde patiënt en de adviescommissie; een werkgroep ten 
behoeve van de ontwikkeling van een multidisciplinaire richtlijn (gynaecologen, 
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huisartsen, urologen, klinische embryologen, klinisch chemici, een medisch 
psycholoog, een arbeidsgeneeskundige en twee patiëntafgevaardigden); en tot slot 
vier werkgroepen ten behoeve van de ontwikkeling van vier monodisciplinaire 
richtlijnen. De volledige richtlijn is gericht op patiëntgerichte, organisatorische 
en medisch-technische uitgangsvragen die naar voren gekomen zijn uit de 
interviews met patiënten en professionals. Deze uitgangsvragen zijn uitgewerkt 
en verdeeld over de werkgroepen. Vervolgens zijn de projectprestaties, de 
deelnemerservaringen met deze benadering en de benodigde tijdsinvestering ook 
geëvalueerd. Deze evaluatie baseerde zich op de analyse van secundaire bronnen, 
interviews met acht sleutelfiguren en een schriftelijk vragenlijstonderzoek onder 
alle 35 deelnemers.
Binnen twintig maanden zijn met deze benadering een multidisciplinaire 
richtlijn subfertiliteit en vier gerelateerde monodisciplinaire richtlijnen (een 
voor subfertiliteit in het algemeen, een voor onverklaarde subfertiliteit, een 
voor mannelijke subfertiliteit en een voor semenanalyse) ontwikkeld. De 
multidisciplinaire richtlijn bestaat uit aanbevelingen voor de belangrijkste medisch-
technische onderwerpen en uit organisatorische en patiëntgerichte thema’s die 
onderdeel zijn van het klinische zorgpad. Het project is verlopen zoals gepland, 
met uitzondering van kleine aanpassingen en drie extra consensusbijeenkomsten. 
De deelnemers waren enthousiast over de toegepaste benadering, het respect 
voor de autonomie, de rol van de projectcoördinator en de betrokkenheid van 
patiënten. Verbeteringssuggesties waren tijdige communicatie over het format 
van de richtlijnen, de tijdslijnen van het project, de verantwoordelijkheden 
van de deelnemers, het aanstellen van een medisch bibliothecaresse en meer 
ondersteuning. De 35 deelnemers hebben in totaal gezamenlijk 4497 uur aan dit 
project besteed. 
Hieruit is geconcludeerd dat de nieuwe netwerkbenadering waarin de patiënt 
centraal staat, geschikt is voor het gelijktijdig en gezamenlijk ontwikkelen van een 
op elkaar afgestemde set richtlijnen bestaande uit een multidisciplinaire richtlijn 
en monodisciplinaire richtlijnen rondom het klinische zorgpad van patiënten met 
voortplantingsgeneeskundige problemen. Verdiepend onderzoek is nodig om de 
efficiëntie van deze benadering te vergelijken met traditionelere benaderingen.
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Hoofdstuk 4 en Hoofdstuk 5 richten zich allebei op de derde vraag:
In hoeverre is een participatie-instrument voor Nederlandse patiënten geschikt om 
gezamenlijke richtlijnontwikkeling te bewerkstelligen ten aanzien van het gebruik, 
de gebruiksvriendelijkheid, de meerwaarde voor de richtlijn, de ervaringen met 
het instrument en de toepasbaarheid ervan in andere klinische aandachtsgebieden 
binnen de zorg?
Om deze vraag te beantwoorden, zijn twee haalbaarheidsstudies verricht. 
Hoofdstuk 4 gaat in op de eerste haalbaarheidsstudie naar het gebruik van een 
basiswiki (zoals Wikipedia) als een participatie-instrument voor patiënten in de 
ontwikkeling van een richtlijn subfertiliteit. Hierbij is gebruikgemaakt van een 
evaluatiestrategie bestaande uit verschillende toegepaste methoden. Hierbij is 
gekeken naar (1) het gebruik van de wiki (aantal pagina bezoeken en bezoekers), 
(2) de voordelen van de wiki (aantal, inhoud en de directe toepasbaarheid van 
de aanbevelingen voor opname in de richtlijn en (3) de voor- en nadelen volgens 
patiënten voor ingebruikneming van de wiki en de potentiële uitdagingen 
om de wiki te verbeteren. Om de wiki te vullen, zijn twaalf diepte-interviews 
onder subfertiele patiënten afgenomen. Uitwerkingen van de interviews zijn 
vertaald in negentig conceptaanbevelingen, die vervolgens op de wiki zijn 
gepresenteerd. Gedurende zeven maanden zijn subfertiele patiënten uitgenodigd 
via advertenties en e-mails om nieuwe aanbevelingen te formuleren of bestaande 
aanbevelingen aan te passen. Na aanpassing van de aanbevelingen zijn de 
patiënten gevraagd om hun top 5 of top 3 uit de aanbevelingen te geven voor elk 
van de vijf onderdelen van de voortplantingsgeneeskundige zorg. Uiteindelijk 
heeft de richtlijnontwikkelingsgroep de inpasbaarheid van de uiteindelijke set 
aanbevelingen beoordeeld ten aanzien van het bestek van de richtlijn. De wiki 
heeft 298 unieke bezoekers getrokken en omvatte 289 aanbevelingen. Daarvan 
zijn 21 aanbevelingen door patiënten geprioriteerd in de top 5 en top 3-lijsten op 
hun inpasbaarheid in de klinische richtlijn. Uit de evaluatie zijn uitdagingen naar 
voren gekomen ter verbetering van de wiki, onder andere met betrekking tot het 
gebruikersgemak, de inhoud en lay-out van de website en de karakteristieken van 
het wiki-instrument.
Uiteindelijk is geconcludeerd dat de wiki een veelbelovend en geschikt instrument 
is voor patiëntparticipatie in richtlijnontwikkeling. Een aangepaste versie van dit 
instrument dient ontwikkeld en geëvalueerd te worden, die vormgegeven moet 
worden op een wijze waarbij de patiënt centraal staat. Hierbij moeten nieuwe 
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modaliteiten worden meegenomen, zoals het aantal aanbevelingen en de lengte 
ervan automatisch beperken, een vast format voor aanbevelingen instellen, een 
motivatie-pagina inbedden en een continu prioriteringssysteem toevoegen.
In hoofdstuk 5 zijn het gebruik en de baten geëvalueerd van een gespecialiseerd 
online-instrument om patiëntpartnerschap in richtlijnontwikkeling te 
vergemakkelijken. De ontwikkeling van dit gespecialiseerde instrument is 
gebaseerd op de voor- en nadelen die naar voren gekomen zijn uit een voorgaande 
pilotstudie over een op wiki gebaseerd instrument, zoals beschreven in 
hoofdstuk 4. Om de specifieke vraag te beantwoorden, is een evaluatie verricht 
met behulp van verschillende methoden. Uitkomstmaten voor het gebruik 
betreffen: het daadwerkelijke gebruik (het aantal unieke bezoekers, het aantal 
geregistreerde bezoekers en het aantal bezoeken), de gebruiksvriendelijkheid 
van het instrument gemeten op een gebruiksvriendelijkheidsschaal (0-100) 
en de representativiteit van de bezoekers vergeleken met een representatief 
valide Nederlands ziekenhuiscohort. Uitkomstmaten voor de meerwaarde voor 
richtlijnontwikkeling betreffen: het aantal nieuwe en aangepaste aanbevelingen, 
het aantal prioriteringen en de veranderingen in de top-5 geprioriteerde 
aanbevelingen per maand en over de gehele periode van de studie. Gedurende 
twaalf maanden heeft het gespecialiseerde participatie-instrument 3028 unieke 
bezoekers getrokken, waarvan 87 bezoekers zich hebben geregistreerd. Via 
het instrument heeft een brede en, vergeleken met een ziekenhuiscohort, 
voornamelijk representatieve doelgroep geparticipeerd met betrekking tot leeftijd, 
type subfertiliteit en duur van kinderloosheid. De participanten hebben een set 
van vijftig duidelijke en geprioriteerde aanbevelingen voor richtlijnen over de 
Nederlandse voortplantingsgeneeskundige zorg opgeleverd. Volgens 39 van de 45 
geregistreerde bezoekers is het instrument zeer goed bruikbaar. 
Uiteindelijk is geconcludeerd dat het gebruik van een gespecialiseerd online 
participatie-instrument een haalbare methode is om een brede en representatieve 
groep subfertiele patiënten te laten participeren in richtlijnontwikkeling. Deze studie 
draagt bij aan de huidige kennis over de inzetbaarheid van online instrumenten 
om patiëntpartnerschap in richtlijnontwikkeling te vergemakkelijken. Deze 
publicatie kan worden gebruikt als praktische richtlijn voor beleidsinstanties, 
richtlijnontwikkelaars en patiëntenorganisaties in alle takken van klinische zorg die 
geïnteresseerd zijn in interventies om patiëntpartnerschap in richtlijnontwikkeling 
vorm te geven.
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Hoofdstuk 6 richt zich op de vierde vraag:
Wat is de toegevoegde waarde van patiënten bij de ontwikkeling van op richtlijn-
gebaseerde kwaliteitsindicatoren voor patiëntgerichtheid?
Om deze vraag te beantwoorden, is de aangepaste RAND Delphi-methode 
(een systematische consensus methode bestaande uit twee stappen) gebruikt 
om twee sets van kwaliteitsindicatoren voor patiëntgerichtheid te ontwikkelen. 
De ontwikkeling van deze kwaliteitsindicatoren voor patiëntgerichtheid is 
gebaseerd op de Landelijke multidisciplinaire netwerkrichtlijn subfertiliteit. Twee 
panels hebben hierin geparticipeerd: een panel met patiënten (n=19) en een 
multidisciplinair samengesteld panel met professionals (n=15). Vervolgens zijn de 
indicatorensets voor patiëntgerichtheid van de patiënten en van de professionals 
vergeleken op indicatorniveau en op aspecten van patiëntgerichtheid en zijn 
beschrijvend geanalyseerd. Uit de 119 geformuleerde potentiële indicatoren heeft 
het patiëntenpanel een representatieve set van 16 indicatoren geselecteerd en de 
professionals een set van 18. Vijf indicatoren kwamen voor in beide sets. Deze 
omvatten de noodzaak om zes dagen per week Intra Uteriene Inseminatie (IUI) 
uit te voeren, om behandelingsuitkomsten en complicaties te rapporteren, om de 
resultaten van een semenanalyse op een gestandaardiseerde wijze te rapporteren 
en om subfertiele paren te counselen ten aanzien van de positieve effecten op de 
zwangerschapskansen bij vermijding van een slechte leefstijl en om subfertiele 
paren te informeren over de negatieve effecten van een verhoogde Body Mass 
Index (BMI) op de zwangerschapskansen. Zowel patiënten als professionals 
kennen de meeste waarde toe aan potentiële indicatoren over communicatie en 
informatie in de voortplantingsgeneeskundige zorg. Patiënten benadrukken 
tevens de toegankelijkheid van zorg, terwijl professionals juist zorgcoördinatie 
en -integratie als cruciale kwaliteitsmaten voor patiëntgerichtheid in de 
voortplantingsgeneeskundige zorg bestempelen. Hieruit is gebleken dat subfertiele 
patiënten over het algemeen andere indicatoren selecteren en waarde toekennen 
aan andere aspecten van patiëntgerichtheid (met name informatie, communicatie 
en de toegankelijkheid van zorg) dan professionals (coördinatie en integratie 
van zorg) tijdens het indicatoren-ontwikkelingsproces. Daarom concluderen de 
onderzoekers dat subfertiele patiënten waarde toevoegen aan de ontwikkeling van 
op richtlijn gebaseerde kwaliteitsindicatoren voor patiëntgerichtheid.
De uiteindelijke op richtlijnen gebaseerde set van 29 indicatoren vertegenwoordigt 
een gebalanceerde set die gebaseerd is op de expertise van alle belanghebbenden, 
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inclusief patiënten. Een volgende stap kan bestaan uit het onderwerpen van 
deze set aan een praktijktest, om zo de haalbaarheid in de dagelijkse praktijk te 
onderzoeken. Naar onze mening zouden, eventueel met een bredere interpretatie 
(bijvoorbeeld door huisartsen door andere medische professionals te vervangen 
die onderdeel uitmaken van het zorgproces), de meeste kwaliteitsindicatoren 
voor patiëntgerichtheid gebruikt kunnen worden om de kwaliteit van de 
voortplantingsgeneeskundige zorg op internationaal niveau te monitoren en te 
verbeteren.
Hoofdstuk 7 gaat aan de hand van de verschillende fasen van het 
richtlijnontwikkelingsproces in op de belangrijkste bevindingen uit de studies 
van dit proefschrift in het kader van de beschikbare literatuur en de beleidsmatige 
ontwikkelingen. Tevens worden een aantal methodologische overwegingen ten 
aanzien van de verkennende studies van dit proefschrift aangehaald en besproken. 
Dit proefschrift laat de toegevoegde waarde zien van actief betrokken patiënten en 
het gebruik van een benadering waarin de patiënt centraal staat bij alle fasen van 
het richtlijnontwikkelingsproces; het concept ‘gezamenlijke richtlijnontwikkeling’ 
representeert de toekomst van richtlijnontwikkeling. 
Vanaf heden zijn alle betrokken gezondheidszorgprofessionals, de medisch 
wetenschappelijke beroepsverenigingen, patiënten en beleidsmakers aan zet om 
samen dit concept te implementeren. Online participatie-instrumenten kunnen 
een bijdrage leveren om dit concept van gezamenlijke richtlijnontwikkeling nog 
beter ten uitvoer te brengen en kunnen helpen om op transparante wijze gebruik 
te maken van de geleverde input van patiënten in het richtlijnontwikkelingsproces.
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Wanneer een project als dit proefschrift na dik acht jaar voltooid is, kan het 
niet anders dan dat heel veel mensen hier op diverse manieren een bijdrage aan 
geleverd hebben. Graag maak ik dan ook van de gelegenheid gebruik om iedereen 
te bedanken en de volgende mensen in het bijzonder.
In de eerste plaats wil ik alle patiënten die meegewerkt hebben aan de totstandkoming 
van de publicaties uit dit proefschrift bedanken voor de tijd en moeite die zij gestoken 
hebben in interviews of het invullen van vragenlijsten. Jullie verhalen hebben mij 
doen beseffen hoe belangrijk het nastreven van patiëntgerichte zorg is en de enorme 
meerwaarde die patiënten kunnen bieden in het richtlijnontwikkelingsproces. Mijn 
ambitie dit te benadrukken zal ik mijn gehele verdere loopbaan uitdragen, met 
jullie leerzame verhalen in mijn achterhoofd. 
Professor J.A.M. Kremer, beste Jan. Door jouw enthousiasme en visie verruilde ik 
het Amsterdamse voor het Nijmeegse. Jouw kritische ‘helikopterview’ zette mij 
altijd aan het denken. Soms raakte ik de draad kwijt en dan was jij daar om het 
te versimpelen in woord en beeld. Jij zorgde ervoor dat ik focus hield. Je steunde 
mij in moeilijke tijden, gaf mij vertrouwen en hielp mij op geweldige wijze door 
de allerlaatste fase heen. Ongelofelijk veel dank daarvoor! Ik hoop dat onze wegen 
nog vaak mogen kruisen.
Dr. R.P.M.G. Hermens, lieve Rosella. Jij hebt mij al die tijd gesteund en tot op 
het laatste moment geholpen om de eindstreep voor ogen te blijven zien. ‘24/7’ 
stond jij voor mij klaar. Jouw kritische blik, hielp mij dit proefschrift te verbeteren. 
Als copromotor, was jij een kundig en zeer meelevend persoon en steunde je mij 
door dik en dun. Ik draag je een zeer warm hart toe en ben je heel veel dank 
verschuldigd. Ik hoop nog vele fijne momenten met je mee te mogen maken!
Dr. W.L.D.M. Nelen, lieve Willianne. Als ik na hard zwoegen mijn stuk wat 
gekleurder terugkreeg, wist ik in ieder geval dat jij er kritisch naar gekeken had en 
dat het er vele malen beter op geworden was. Jouw up-to-date referentiedatabase 
voor de fertiliteitzorg is altijd van enorme meerwaarde voor mij geweest. In al die 
jaren hebben jouw zorg en medeleven mij bijzonder geraakt. Ik ben je heel veel 
dank verschuldigd! Ik hoop dat onze wegen nog mogen blijven kruisen!
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Patiëntvertegenwoordigers van Freya, beste Jose Knijnenburg en 
Marjolein Grömminger. Ongelofelijk veel dank voor jullie tomeloze inzet 
en hulp bij het verwoorden van de wensen en behoeften van patiënten 
met vruchtbaarheidsproblemen! Als iemand weet hoe een achterban te 
vertegenwoordigen, dan zijn jullie dat! Ik ben jullie zeer dankbaar!
De leden van het projectteam van de landelijke netwerkrichtlijn subfertiliteit, beste 
Sander Flikweert (in memoriam), dank voor jouw creatieve en verbindende geest. 
Onze samenwerking was veel te kort, maar zeer waardevol… Beste Elske Faber, 
Tjerk Wiersma en Jacintha van Balen, dank voor jullie hulp en vooruitstrevende 
blik. Ik had de samenwerking met jullie niet willen missen!
Alle medeauteurs, beste Jako Burgers, Wim Willemsen, Miriam Hilbink en alle 
andere medeauteurs. Heel veel dank voor jullie hulp bij de totstandkoming van 
de artikelen!
Mijn (toen nog) stagiaires, beste, Suzanne, Wienke, en Fleur. Dank voor jullie 
inzet en hulp!
Beste (oud) kantoortuin-collegae, het was fijn om met jullie te mogen sparren, 
te genieten van gezellige taartmomenten en hilarische onderzoekersweekendjes. 
Annemijn, Inge, Selma, Bea, Gwendolyn, Helga Dana, Angelique en Fleur, veel 
dank voor jullie gezelligheid en hulp toen nog vanuit ons VPG-eilandje in de tuin, 
maar ook tijdens de laatste loodjes van de afronding van dit proefschrift! Fleur, zet 
hem op: veel succes met de afronding van jouw proefschrift!
Beste leden van de promotiecommissie, dank voor het kritisch doorlezen en 
beoordelen van mijn proefschrift en jullie aanwezigheid bij mijn verdediging.
Dr. K.Boer,  beste Kees. Wat is het een eer om na jaren weer eens met jou samen 
te mogen werken, maar dan nu op een heel ander vlak. Veel dank voor jouw tijd, 
creativiteit en inspiratie. Dankzij jou is de kaft van mijn proefschrift prachtig 
geworden.
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Lieve Caroline, lieve ‘Car’. Dank voor jouw onvoorwaardelijke steun en hechte 
vriendschap. Wat is het bijzonder mooi om te zien dat onze bijzondere vriendschap 
ook nog kan uitvloeien in een mede door jou kritische blik vormgegeven 
proefschrift. Onze eerste kennismaking stamt uit onze entree op de Gooische 
Hockeyclub en is sindsdien alleen maar hechter geworden. Ik vind het een enorme 
eer dat jij mijn paranimf wil zijn en had mij geen betere kunnen wensen!
Beste collegae van het Kennisinstituut van Medisch Specialisten en de Federatie 
Medisch Specialisten, dank voor jullie begrip en steun, vooral in de laatste fase van 
de afronding van dit proefschrift. Saskia, Joppe en Dunja: zet hem op! Straks ligt er 
van jullie ook zo’n mooi eindresultaat! 
Beste Kristie, veel succes met het uitzetten van een mooie onderzoekslijn! Beste 
Marjolein, eindelijk heb ik straks weer meer tijd om het kennisforum ‘patient 
empowerment’ samen met jou en Kristie verder vorm te geven, daar kijk ik enorm 
naar uit! Beste Joyce, ik hoop dat onze leerzame samenwerking op het gebied van 
patiëntenparticipatie in richtlijnontwikkeling samen met de Patiëntenfederatie 
nog lang zo blijft bestaan. Dank voor jouw steun!
Beste Teus, Margreet, Annefloor, Pieter, Marleen en Dunja, dank voor jullie steun 
en begrip in de afgelopen periode!
Beste collegae van de Nederlandse Vereniging voor Obstetrie en Gynaecologie, 
in het bijzonder de commissie kwaliteitsdocumenten, Esther van Wissen en 
Veronique van Dooren. Dank voor jullie begrip en steun. Ik kan me nog goed 
mijn introductie als kandidaat-promovenda door Ben Willem Mol herinneren. 
Sindsdien ben ik altijd nauw betrokken geweest bij jullie vereniging. Dank voor de 
leerzame tijd! Ik hoop nog lang onderdeel te mogen uitmaken van jullie vereniging.
Beste collegae van de Nederlandse Vereniging voor Kindergeneeskunde. Jullie 
interesse in de afronding van mijn proefschrift en medeleven heeft mij enorm 
gesteund! Dank daarvoor! Ik hoop nog lang onderdeel te mogen uitmaken van 
jullie vereniging.
Liefste vriendinnetjes en hockeyteamgenootjes, in het bijzonder Marieke, Shemara, 
Uschi en Jasmijn en Jill. Wat ben ik jullie allemaal dankbaar voor jullie steun en 
fijne hechte momenten in de afgelopen jaren. Ondanks dat ik af en toe te weinig 
tijd voor jullie heb gehad, zijn jullie mij blijven steunen en altijd geïnteresseerd 
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geweest in de voortgang van dit proefschrift. Vaak hebben jullie jezelf afgevraagd 
of dit proefschrift nog af zou komen. Vanaf nu zullen de koffie-momentjes er 
niet meer onder leiden. Ook zal ik niet meer de grote afhaker zijn bij de hot yoga 
tijdens de winterstop!  Dank voor jullie steun door dik en dun!
Mijn schoonouders, lieve Rob en Ria, Dank voor jullie oprechte interesse en steun. 
Mijn zussen, lieve Marije en Laetitia. Ook al hebben jullie niet altijd evenveel 
inzage in waar ik de afgelopen jaren mee bezig geweest ben, jullie medeleven, 
begrip en steun hebben mij mede geholpen dit boekje af te ronden. Dank dat jullie 
er altijd voor mij zijn, in het bijzonder tijdens de intense en zeer hechte afgelopen 
twee jaar! Ik ben supertrots dat jullie mijn zussen zijn; ik vind jullie geweldig! Nu 
snel op naar ons zussen-weekend!
Lieve Maarten en Robert, dank je wel dat jullie er altijd voor mij en mijn zussen 
zijn en onderdeel uitmaken van mijn familie! 
Mijn Vader; lieve papa, dankzij jouw onvoorwaardelijke liefde, steun en 
vertrouwen heb ik bereikt wat ik voor ogen had. Ik heb diep respect voor hoe jij 
weer een nieuwe modus hebt gevonden na het overlijden van mama. Dat je je dan 
ook nog kunt bekommeren over de laatste loodjes van de afronding en hulp biedt 
waar nodig is kenmerkend voor hoe jij in het leven staat. Ik hoop nog vele jaren te 
kunnen genieten met jou als vader en ‘lieve opa’ van mijn kindjes!
Mijn Moeder; de allerbelangrijkste vrouw in mijn leven, mijn lieve schat. Helaas 
heb je de eindstreep niet meer mogen meemaken… Zelfs tot op het laatste 
moment kon jij je interesseren voor de voortgang van dit proefschrift en zag je 
mij worstelen. Als iemand een ongekend doorzettingsvermogen had om iets af 
te ronden was jij het wel. Daar heb ik veel van geleerd. Ook heb ik door jouw 
intensieve ziekteperiode geleerd dat je moet genieten van de kleine dingen in het 
leven. En dat is wat ik nu nog meer dan ooit ga doen!
Sophie, Pepijn en Annefleur; mijn allerliefste en mooiste kindjes. Dankzij jullie 
werd ik er al die tijd herinnerd aan wat echt belangrijk is in het leven. Het 
veelbesproken ‘boekje’ is nu eindelijk echt af! Nu heeft mama nog meer tijd om te 
genieten van leuke dingen samen. Daar kijk ik enorm naar uit!
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Dennis, liefste en maatje. Wat ben ik gelukkig met jou! Jouw onvoorwaardelijke 
steun heeft mij gebracht tot waar ik nu ben gekomen. Hoewel de opvoeding van 
3 kinderen, het opzetten van een bedrijf een drukke baan en in de laatste fase 
de zorg voor mijn zieke moeder naast het afronden van een proefschrift wat 
ambitieus bleek, voelde ik mij door jou altijd gesteund. Ik ben trots en dankbaar 
dat we samen op deze wijze een hoofdstuk kunnen afsluiten. Dank je wel dat jij 
mijn paranimf bent.
Ik hou ongelofelijk veel van jou!
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Curriculum vitae
De auteur van dit proefschrift zag op 3 Juni 1980 het levenslicht in Delft. Zij 
groeide haar eerste levensjaren op in Delft en verhuisde op 3-jarige leeftijd naar 
Rotterdam. Zij was de oudste van drie kinderen. Zij genoot samen met haar 2 
zussen van een onbezorgde en vrolijke jeugd. Zij behaalde haar vwo-diploma 
aan het Zadkine College te Capelle aan den IJssel. Op haar 18- jarige leeftijd 
leerde zij haar vriend en maatje Dennis kennen en vanaf dat moment waren zij 
onafscheidelijk. In 2000 begon zij haar studie geneeskunde aan de Vrije Universiteit 
van Amsterdam. Tijdens haar studie verrichte zij wetenschappelijk onderzoek 
naar de effecten van enterale glutaminesuppletie bij te vroeg of te klein geboren 
neonaten (Begeleiding Dr. A. van den Berg, neonatologie VUMC) en naar de 
behandeling van het androgenitaal syndroom (Begeleiding professor H.A. Heij, 
kinderchirurg VU Medisch Centrum). Zij werd in het kader van dit laatste 
onderzoek genomineerd voor de studentenonderzoeksprijs van het VUMC. Tijdens 
haar extra lange wetenschappelijke stage verrichte zij onderzoek naar de invloed 
van het opleidingsklimaat onder studenten geneeskunde. (Begeleiding Dr. K. Boor 
en Prof. Dr. F. Scheele). Haar keuze, en oudste- coschappen volgde zij op de afdeling 
Obstetrie en Gynaecologie in het Sint Lucas Andreas Ziekenhuis te Amsterdam 
en de afdeling Voortplantingsgeneeskunde van het VU Medisch Centrum. Het 
artsexamen met profiel Voortplanting, Endocrinologie en Metabolisme werd 
behaald in 2006. In datzelfde jaar startte zij als ANIOS Obstetrie en Gynaecologie in 
de Isala Klinieken te Zwolle. In 2007 startte zij als ANIOS Obstetrie en Gynaecologie 
van het AMC te Amsterdam. In 2008 verruilde zij het Amsterdamse voor het 
Nijmeegse en begon zij haar promotieonderzoek aan het Radboud Universitair 
Medisch Centrum op de afdeling voortplantingsgeneeskunde onder supervisie 
van Prof. dr. Jan Kremer. In 2013 startte zij als adviseur bij de toenmalige ‘Orde 
van Medisch Specialisten.’ Inmiddels is zij werkzaam als Senior-adviseur kwaliteit/ 
teamleider en tevens trekker van het kennisforum ‘patient empowerment’ bij 
het Kennisinstituut van Medisch Specialisten, te Utrecht. Tevens is zij 1 dag per 
week werkzaam als Senior-beleidsadviseur bij de Nederlandse Vereniging voor 
Kindergeneeskunde (NVK) en sinds de start van haar promotieonderzoek lid 
van de commissie kwaliteitsdocumenten van de Nederlandse Vereniging voor 
Obstetrie en Gynaecologie (NVOG).
De auteur woont samen met Dennis Klompalberts en zij hebben samen 
3 fantastische kinderen: Sophie (8jaar), Pepijn (5 jaar) en Annefleur (3jaar).
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07-02-2000 Els van der Molen
  Disturbed homocysteine metabolism endothelial dysfunction and 
placental vasculopathy 
29-06-2000 Willianne Nelen
  Risk factors for recurrent early pregnancy loss. 
Hyperhomocysteinaemia, thrombophilia and impaired 
detoxification 
05-09-2000 Ina Beerendonk
  Sodium and ovarian hyperstimulation. Some clinical and 
psychological aspects 
04-12-2000 Anne-Marie van Cappellen van Walsum
 Cerebral metabolism of hypoxic fetal sheep by NMR spectroscopy 
18-12-2000 Friso Delemarre
  Vascular aspects of human pregnancy. Clinical studies on sodium 
restriction and angiotensin infusion 
2001 
10-01-2001 Way Yee Wong
  Male factor subfertility. The impact of lifestyle and nutritional 
factors 
05-06-2001 Petra Zusterzeel
 Biotransformation enzymes and oxidative stress in preeclampsia 
05-10-2001 Cathelijne van Heteren
 Development of habituation and memory in the human fetus 
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  Cytomegalovirus and herpes simplex virus infections in pregnancy 
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2002 
25-01-2002 Ron van Golde
 Male subfertility and genetics 
21-05-2002 Tanja de Galan-Roosen
 Perinatal Mortality 
2003 
08-01-2003 Maarten Raijmakers
  Oxidative stress and detoxification in reproduction with emphasis 
on glutathione and preeclampsia
18-2-2003 Sabine de Weerd
 Preconception counselling. Screening & periconceptional health
22-4-2003 Iris van Rooij
  Etiology of orofacial clefts. Gene-environment interactions and 
folate
17-12-2003 Chris Verhaak
 Emotional impact of unsuccessful fertility treatment in women 
2004 
14-01-2004 Liliana Ramos 
 The quality of epididymal sperm in azoospermia
04-10-2004 Pascal Groenen
  Nutritional and environmental factors in human spina bifida. An 
emphasis on myo-inositol 
24-11-2004 Tanya Bisseling
  Placental function in maternal disease. Ex vivo assessment of 
foetoplacental vascular function and transport in diabetes and 
preeclampsia 
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15-12-2004 Eva Maria Roes
  Oxidant-antioxidant balance and maternal health in preeclampsia 
and HELLP syndrome 
2005 
01-06-2005 Marieke Rijnsaardt-Lukassen
 Single Embryo Transfer: clinical and immunological aspects 
10-11-2005 Ingrid Krapels
  The etiology of orofacial clefts. An emphasis on lifestyle and 
nutrition other than folate 
2006 
14-06-2006 Reini Bretveld
 Fertility among greenhouse workers
09-11-2006 Jesper Smeenk
 Stress and IVF. Clinical consequences 
2007 
08-02-2007 Inge Ebisch
  Human subfertility: explorative studies on some pathophysiologic 
factors in semen and follicular fluid 
01-11-2007 Alwin Derijck
  The transmission of chromatin and DNA lesions by sperm and 
their fate in de zygote(1) 
01-11-2007 Godfried van der Heijden
  The transmission of chromatin and DNA lesions by sperm and 
their fate in de zygote(2) 
03-12-2007 Kirsten Kluivers
 On the measurement of recovery following hysterectomy 
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10-12-2007 Rene Kok
 Proton Magnetic Resonance Spectroscopy of Human fetal brain 
2008 
10-12-2008 Trudie Gerrits
  Clinical encounters: Dynamics of patient-centred practices in a 
Dutch fertility clinic 
12-12-2008 Wouter Tuil
 IVF and Internet 
2009 
06-03-2009 Ineke Krabbendam
  Venous reserve capacity & autonomic function in formerly 
preeclamtic women 
03-09-2009 Arno van Peperstraten
 Implementation of single embryo transfer 
07-10-2009 Wilson Farid Abdo
 Parkinsonism: possible solutions to a diagnostic challenge
2010 
10-03-2010 Suzan Broekhuis
 Dynamic MR imaging in female pelvic floor disorders 
12-03-2010 Bea Lintsen
  IVF in the Netherlands: success rates, lifestyle, psychological factors 
and costs 
21-04-2010 Selma Mourad
  Improving fertility care: the role of guidelines, quality indicators 
and patients 
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2011 
24-02-2011 Monique Brandes
 Observational studies in reproductive medicine 
04-04-2011 Marijn Brouwers
  Why foetal development of the male reproductive structures 
sometimes fails. An epidemiologic study on hypospadias and 
undescended testis with a focus on endocrine disruptors. 
22-06-2011 Marian Spath
  Risk estimate for fragile X-associated primary ovarian insufficiency: 
Genetic, environmental and reproductive factors 
30-06-2011 Inge van Empel
 Patient-centredness in fertility care
18-11-2011 Gwendolyn Woldringh
  ICSI children. Follow-up after ICSI with ejaculated or non-
ejaculated sperm
17-06-2011 Tiny de Boer
  Aspects of surgery for pelvic organ prolapse and its relation to 
overactive bladder symptoms 
2012 
20-01-2012 Esther Haagen
 Guidelines in IUI care. Implications for quality improvement 
17-02-2012 Loes van der Zanden
 Aetiology of hypospadias. From genes to environment and back 
11-04-2012  Reda Z Mahfouz
 Oxidative stress and apoptotic biomarkers in human semen 
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06-06-2012 Marleen van Gelder
  The role of medical and illicit drug use in the etiology of birth defects. 
Epidemiological studies and methodological considerations.
12-09-2012 Annemijn Aarts
 Personalized fertility care in the Internet era 
17-09-2012 Eline Dancet
  Bridging the gap between evidence based and patient-centred 
infertility and endometriosis care in Europe 
09-10-2012 Bertho Nieboer
 Minimally invasive surgery: patients and doctors perspectives 
25-10-2012 Sanne van Leijsen
  The value of urodynamics prior to surgery for stress urinary 
incontinence 
21-12-2012 Marieke de Vries
  A cytological exploration of human spermatogenesis in non-
obstructive azoospermia patients: an analysis of variation 
16-01-2013 Jacqueline Pieters
  Incidental Findings of Sex Chromosomal Aneuploidies in Routine 
Prenatal Diagnostic Procedures 
04-09-2013 Ellen Lensen
  Surgery for pelvic organs prolapse with emphasis on the anterior 
compartment 
16-12-2013 Renne Gerritse
 Cryopreservation of an intact ovary
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2014 
23-01-2014 Dana Huppelschoten
 Improving patient-centredness of fertility care
07-02-2014 Tom van de Belt
 #HCSM Social media en wiki’s in de gezondheidszorg
19-02-2014 Lucie Martijn
 Patient safety in primary midwifery care
 
25-02-2014 Kim van Delft
 Levator ani muscle avulsion following childbirth
 
04-04-2014 Karin Lammers
  Pelvic organ prolapse and a magnetic resonance imaging view on 
pubovisceral muscle avulsions
 
22-08-2014 Joris van Drongelen
 Vascular adaptation to pregnancy and relaxin
19-09-2014 Yvette Geels
 Improved Identification of High Risk Endometrial Carcinoma
23-09-2014 Lobke Bastings
 Improving female fertility preservation care
14-11-2014 Kim Meeuwis
  Clinical studies on genital psoriasis and HPV-related lesions: a 
multidisciplinary approach
20-11-2014 Anika Dam
  (Partial) Globozoospermia, an allround study on what is not all 
round
02-12-2014 Remko Bosgraaf
 Improving cervical cancer screening in the HPV era
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18-12-2014 Carline Roos
 Maintenance tocolysis with nifedipine in treatened preterm labor
2015
19-10-2015 Droïma Stevens
 Decidual vasculopathy in Preeclampsia
01-12-2015 Martijn van der Eijk
 Patient-centered care in Parkinson’s disease
2016
12-01-2016 Joanne in ’t Hout
  On trees and forests. Meta-analysis and between-study heterogeneity 
in practice
14-01-2016 Loes van den Einden
 Improving care for women with vulvar squamous (pre)malignicies
05-02-2016 Renée Detollenaere
  Uterus preservation versus hysterectomy in surgical treatment of 
uterine prolapse
29-06-2016 Marloes Hessel
 Diagnosis, treatment and outcome in non-obstructive azoospermia
10-11-2016 Aukje Meijerink
  safety and efficacy of assisted reproductive techniques in male 
infertility
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